None(e1,e2)	44	46	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
None(e1,e2)	77	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	11	chloramphenicol has been shown to be antagonistic to beta-lactam_antibiotics , including ceftazidime , based on in vitro studies and time kill curves with enteric gram-negative bacilli .
None(e1,e2)	15	17	the effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide , ketoconazole , methotrexate , phenytoin , tolbutamide , and warfarin have been studied in vivo and clinically important interactions have not been found .
effect(e1,e2)	9	21	vecuronium : when used in the perioperative period , piperacillin has been implicated in the prolongation of the neuromuscular blockade of vecuronium .
advise(e1,e2)	2	4	patients receiving flurbiprofen and furosemide or other diuretics should be observed closely to determine if the desired effect is obtained .
None(e1,e2)	26	45	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	0	3	anticoagulants : combination hormonal_contraceptives may increase or decrease the effects of coumarin derivatives .
None(e1,e2)	24	60	clinical experience with concomitant administration of bosentan and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in inr or warfarin dose ( baseline vs. end of the clinical studies ) , and the need to change the warfarin dose during the trials due to changes in inr or due to adverse events was similar among bosentan - and placebo-treated patients .
None(e1,e2)	107	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	8	38	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine_class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine_oxidase_inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	13	34	in a parallel group drug interaction study comparing the intravenous prodrug form of valdecoxib at 40 mg bid ( n=10 ) vs placebo ( n=9 ) , valdecoxib had no effect on in vitro aspirin -mediated inhibition of arachidonate- or collagen-stimulated platelet aggregation .
None(e1,e2)	43	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	9	37	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	1	32	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	67	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	24	35	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	0	12	mao_inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	0	8	antibiotics ( e.g. , erythromycin , trimethoprim and sulfamethoxazole , amoxicillin ) .
None(e1,e2)	0	10	saquinavir : the combination of hivid , saquinavir , and zdv has been studied ( as triple combination ) in adults .
None(e1,e2)	0	2	anesthetics /sedatives/ hypnotics /opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	24	40	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	0	8	probenecid : probenecid increases both free and bound ketoprofen by reducing the plasma clearance of ketoprofen to about one-third , as well as decreasing its protein binding .
None(e1,e2)	118	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	27	effects of other antiepilepsy drugs ( aeds ) on gabitril : carbamazepine : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking carbamazepine with or without other enzyme- inducing aeds .
None(e1,e2)	29	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	12	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
None(e1,e2)	12	30	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	6	8	other reported interactions with amiodarone : fentanyl ( cyp3a4 substrate ) in combination with amiodarone may cause hypotension , bradycardia , and decreased cardiac output .
None(e1,e2)	18	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	57	80	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	28	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole_antifungal_agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	21	27	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	4	20	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	9	16	additive depressant effect when used with general anesthetics , sedatives , antianxiety drugs , hypnotics , alcohol , and other opiate analgesics .
None(e1,e2)	15	30	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	0	21	lithium : lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium , including ace_inhibitors .
None(e1,e2)	20	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	0	24	indinavir steady-state cmax , a.c. and cmin were decreased by 22 % , 38 % , and 27 % , respectively , by concomitant amprenavir .
advise(e1,e2)	16	26	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
None(e1,e2)	16	21	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , angiotensin_converting_enzyme_inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	0	9	prednisolone : ethinyl estradiol may inhibit the metabolism of prednisolone , leading to increased plasma concentrations .
None(e1,e2)	15	37	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	36	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	26	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	131	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	25	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	31	41	ketoconazole : when a single 125-mg dose of aprepitant was administered on day5 of a 10-day regimen of 400 mg/day of ketoconazole , a strong cyp3a4 inhibitor , the auc of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold .
None(e1,e2)	85	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	31	a study in six healthy volunteers has shown a significant increase in peak diltiazem plasma levels ( 58 % ) and auc ( 53 % ) after a 1-week course of cimetidine 1200 mg/day and a single dose of diltiazem 60mg .
effect(e1,e2)	14	21	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
effect(e1,e2)	9	36	hypotension - patients on diuretic therapy : patients on diuretics , and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with prinivil .
None(e1,e2)	14	52	hypotension patients on diuretic therapy : patients on diuretics and especially those in whom diuretic therapy was recently instituted , as well as those on severe dietary salt restriction or dialysis , may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril .
None(e1,e2)	13	17	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine_oxidase_inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	26	37	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin_b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin_b .
None(e1,e2)	12	31	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine_hcl was not altered .
None(e1,e2)	1	24	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl_estradiol and 1 mg of norethindrone , decreased the auc of ethinyl estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	5	29	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	15	17	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	69	81	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	39	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	25	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	0	25	anticholinergics : concurrent administration of certain anticholinergic compounds , such as belladonna alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
None(e1,e2)	41	43	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
effect(e1,e2)	4	28	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	0	23	ketoconazole : coadministration of ketoconazole ( 200 mg/day for 14 days ) with a 15-mg single dose of aripiprazole increased the auc of aripiprazole and its active metabolite by 63 % and 77 % , respectively .
None(e1,e2)	104	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	6	17	the potential for drug interactions with emtriva has been studied in combination with indinavir , stavudine , famciclovir , and tenofovir disoproxil fumarate .
None(e1,e2)	0	17	monoamine_oxidase_(_mao_)_inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	26	33	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
effect(e1,e2)	11	13	in single and multiple dose studies in healthy subjects receiving both warfarin and rofecoxib , prothrombin time ( measured as inr ) was increased by approximately 8 % to 11 % .
None(e1,e2)	41	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	17	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta_blockers , cardiac_glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	87	101	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	15	the urinary excretion of meclofenamate sodium is unaffected by aspirin , indicating no change in meclofenamate_sodium absorption .
advise(e1,e2)	5	22	brovana , as with other beta2-agonists , should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors , tricyclic_antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents .
mechanism(e1,e2)	5	14	probenecid : as with other b-lactam_antibiotics , renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80 % increase in the auc for loracarbef .
advise(e1,e2)	7	11	therefore you may need to take a vitamin_b12 supplement while taking aminosalicylic_acid .
None(e1,e2)	12	21	table 1 effects on plasma concentrations ( auc 0-24 hrs ) of loratadine and descarboethoxyloratadine after 10 days of coadministration ( loratadine 10 mg ) in normal volunteers
None(e1,e2)	3	14	antacid : when atorvastatin and maalox tc suspension were coadministered , plasma concentrations of atorvastatin decreased approximately 35 % .
None(e1,e2)	80	142	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	12	digoxin : in patients with hypercholesterolemia , concomitant administration of lovastatin and digoxin resulted in no effect on digoxin plasma concentrations .
None(e1,e2)	7	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	39	53	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	45	47	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	25	30	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
None(e1,e2)	0	2	monoamine_oxidase_inhibitors : guanethidine or similarly acting compounds ;
None(e1,e2)	6	12	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	13	17	these data indicate that levetiracetam does not influence the plasma concentration of other aeds and that these aeds do not influence the pharmacokinetics of levetiracetam .
None(e1,e2)	0	11	anticholinergics : concurrent administration of certain anticholinergic compounds , such as belladonna_alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
None(e1,e2)	36	49	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	93	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	22	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	19	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	32	34	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel_blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	40	42	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	15	33	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	11	16	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium_channel_blockers , beta blockers , cardiac_glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
mechanism(e1,e2)	1	21	when duloxetine was administered ( at a dose of 60 mg bid ) in conjunction with a single 50-mg dose of desipramine , a cyp2d6 substrate , the auc of desipramine increased 3-fold .
mechanism(e1,e2)	2	21	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	7	15	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	9	20	in vitro studies have shown no binding displacement between entacapone and other highly bound drugs , such as warfarin , salicylic_acid , phenylbutazone , and diazepam .
None(e1,e2)	9	22	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
mechanism(e1,e2)	18	45	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	2	20	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	52	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	29	in vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the pk properties of anagrelide , nor does anagrelide affect the pk properties of digoxin or warfarin .
None(e1,e2)	4	8	antacids , kaolin-pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	109	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	110	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	4	24	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central nervous system depressants such as narcotics , non-narcotic_analgesics and barbiturates .
None(e1,e2)	2	14	amiodarone or verapamil : the risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the hmg-coa reductase inhibitor class ( see warnings , myopathy/rhabdomyolysis ) .
None(e1,e2)	13	18	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	8	14	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
advise(e1,e2)	7	23	monoamine oxidase inhibitors and tricyclic antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic_antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	0	5	anakinra : concurrent administration of anakinra ( an interleukin-1 antagonist ) and another tnf-blocking agent has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
None(e1,e2)	28	84	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	16	drugs metabolized by cytochrome p450 enzymes the drug interaction study evaluating the effect of grepafloxacin on theophylline indicates that grepafloxacin inhibits theophylline metabolism , which is mediated by cyp1a2 .
mechanism(e1,e2)	13	26	it is known that cyp1a2 is inhibited by several medicinal products , including fluvoxamine , and such medicinal products could theoretically adversely influence the clearance of anagrelide .
None(e1,e2)	0	22	central_nervous_system_depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	25	32	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants .when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	6	28	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	114	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	52	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	10	- antihypertensives : bumetanide may potentiate the effect of various antihypertensive_drugs , necessitating a reduction in the dosage of these drugs .
None(e1,e2)	75	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	78	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	5	11	colestipol-concomitant intake of colestipol and vitamin_k may reduce the absorption of vitamin_k .
None(e1,e2)	4	11	urinary alkalinizers : decrease aspirin effectiveness by increasing the rate of salicylate renal excretion .
effect(e1,e2)	0	38	isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	59	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	15	diphenhydramine hydrochloride has additive effects with alcohol and other cns_depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	3	7	ketoconazole ) , macrolide_antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	16	20	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	45	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	16	as with other antihypertensive agents , the antihypertensive effect of losartan may be blunted by the non-steroidal_anti-inflammatory_drug indomethacin
None(e1,e2)	31	34	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	68	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	28	hormonal contraceptives co-administration of trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components , ethinylestradiol ( ee ) and levonorgestrel ( lng ) .
None(e1,e2)	28	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	6	8	anticoagulants , oral : co-administration of corticosteroids and warfarin usually results in inhibition of response to warfarin , although there have been some conflicting reports .
None(e1,e2)	0	15	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	4	30	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	16	33	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	12	19	additional reductions in blood pressure may occur when flolan is administered with diuretics , antihypertensive agents , or other vasodilators .
advise(e1,e2)	2	24	if additional adrenergic_drugs are to be administered by any route , they should be used with caution because the pharmacologically predictable sympathetic effects of brovana may be potentiated .
None(e1,e2)	0	21	steroids enhance the renal toxicity of edetate calcium disodium in animals . 7 edetate calcium disodium interferes with the action of zinc_insulin preparations by chelating the zinc . 7
None(e1,e2)	11	34	although there have been no formal interaction studies other than with antipyrine , based on these in vivo and in vitro studies , it is unlikely that co-administration of a 1 mg dose of arimidex with other drugs will result in clinically significant drug inhibition of cytochrome p450-mediated metabolism of the other drugs .
None(e1,e2)	0	14	morphine pharmacokinetic parameter values were not affected by administration of neurontin 2 hours after morphine .
None(e1,e2)	22	27	therefore , esomeprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( eg , ketoconazole , iron salts and digoxin ) .
None(e1,e2)	42	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	7	isoflurane or enflurane administered with nitrous oxide/ oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
effect(e1,e2)	5	7	clonidine : concomitant administration of clonidine with agents_with_b-blocking_properties may potentiate blood-pressure- and heart-rate-lowering effects .
None(e1,e2)	35	41	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	11	serious toxicity may result if dextromethorphan is coadministered with monoamine_oxidase_inhibitors ( maois ) .
None(e1,e2)	11	18	more than 600 parkinsons disease patients in clinical trials have used selegiline in combination with entacapone and levodopa/ dopa_decarboxylase_inhibitor .
None(e1,e2)	40	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	32	34	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	105	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	6	8	the use of mao inhibitors or tricyclic_antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone .
None(e1,e2)	39	41	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop_diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
mechanism(e1,e2)	2	17	theophylline : enoxacin is a potent inhibitor of the cytochrome p-450 isozymes responsible for the metabolism of methylxanthines .
None(e1,e2)	2	12	co-administration of tacrolimus and bosentan resulted in markedly increased plasma concentrations of bosentan in animals .
None(e1,e2)	0	6	noncardioselective_beta-blockers ( nadolol , porpranolol , timolol ) may exacerbate rebound hypertension when guanfacine is withdrawn .
None(e1,e2)	11	23	no depressant effect on blood levels in humans was noted when colestipol_hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
advise(e1,e2)	6	16	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	15	17	allopurinol : in a study of healthy male volunteers no significant pharmacokinetic interaction occurred when captopril and allopurinol were administered concomitantly for 6 days .
None(e1,e2)	2	10	coadministration of viracept and drugs that inhibit cyp3a may increase nelfinavir plasma concentrations .
None(e1,e2)	8	19	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	8	10	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	17	43	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central_nervous_system_depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal_muscle_relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	5	38	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin_b .
None(e1,e2)	9	11	specific studies have confirmed these effects with sevoflurane , isoflurane , propofol , alfentanil , and midazolam .
int(e1,e2)	4	6	the extent to which ssri - tca interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the ssri involved .
None(e1,e2)	2	5	gemfibrozil other fibrates niacin ( nicotinic_acid ) ( =1 g/day )
None(e1,e2)	8	15	pharmacokinetic studies indicate that administration of disulfiram or diazepam does not affect the pharmacokinetics of acamprosate .
None(e1,e2)	13	25	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	21	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	30	43	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	8	18	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	14	48	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
None(e1,e2)	0	20	digoxin : in a study in 12 patients with congestive heart failure where ketoprofen and digoxin were concomitantly administered , ketoprofen did not alter the serum levels of digoxin .
None(e1,e2)	6	8	anesthetics/sedatives/hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
int(e1,e2)	3	10	clinical studies with celecoxib have identified potentially significant interactions with fluconazole and lithium .
None(e1,e2)	39	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	24	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	7	oral hypoglycemic_agents : in pharmacokinetic studies of mevacor in hypercholesterolemic noninsulin dependent diabetic patients , there was no drug interaction with glipizide or with chlorpropamide
None(e1,e2)	57	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	0	21	ibandronate should be taken at least 60 minutes before any oral medications containing multivalent cations ( including antacids , supplements or vitamins ) .
mechanism(e1,e2)	4	17	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl_estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	33	42	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	17	23	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	5	16	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	22	24	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central nervous system depressants such as narcotics , non-narcotic_analgesics and barbiturates .
effect(e1,e2)	4	22	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	6	12	observations from drug interaction studies with fortovase may not be predictive for invirase .
mechanism(e1,e2)	11	38	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	10	13	concomitant crohn s disease medications were antibiotics , antivirals , corticosteroids , 6-mp/ aza and aminosalicylates .
None(e1,e2)	15	33	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	0	20	hydrochlorothiazide ( hctz ) alone or in combination with triamterene : concomitant use of hctz alone or in combination with triamterene is contraindicated .
None(e1,e2)	16	22	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic_acid , and tolbutamide in vitro .
None(e1,e2)	0	4	antacids : enteric coated aspirin should not be given concurrently with antacids , since an increase in the ph of the stomach may effect the enteric coating of the tablets .
None(e1,e2)	5	18	lithium reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ace_inhibitors , and with some angiotensin ii receptor antagonists .
None(e1,e2)	23	25	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	2	10	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
mechanism(e1,e2)	8	19	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	13	27	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	22	25	studies in healthy volunteers have shown that acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin , nifedipine , propranolol , or ranitidine .
mechanism(e1,e2)	2	4	coadministration of amprenavir and methadone as compared to a non-matched historicalcontrol group resulted in a 30 % , 27 % , and 25 % decrease in serum amprenavir auc , cmax , andcmin , respectively .
None(e1,e2)	0	9	cyclosporine - l-arginine may counteract the antinaturetic effect of cyclosporin .
None(e1,e2)	11	20	these results would seem to dictate against the clinical use of methotrexate with elspar , or during the period following elspar therapy when plasma asparagine levels are below normal .
None(e1,e2)	7	10	rifampin : rifampin increases the metabolism of ethinyl_estradiol and some progestins ( norethindrone ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
None(e1,e2)	0	14	estrogens , including oral contraceptives : estrogens may decrease the hepatic metabolism of certain corticosteroids , thereby increasing their effect .
None(e1,e2)	40	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	12	antidepressants , tricyclic amphetamines may enhance the activity of tricyclic antidepressants or sympathomimetic_agents ;
None(e1,e2)	6	54	cancidas reduced the blood auc0-12 of tacrolimus by approximately 20 % , peak blood concentration ( cmax ) by 16 % , and 12-hour blood concentration ( c12hr ) by 26 % in healthy subjects when tacrolimus ( 2 doses of 0.1 mg/kg 12 hours apart ) was administered on the 10th day of cancidas 70 mg daily , as compared to results from a control period in which tacrolimus was administered alone .
None(e1,e2)	20	31	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum_hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium_polystyrene_sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	14	38	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
effect(e1,e2)	17	24	phase ii clinical trial data , where iressa and vinorelbine have been used concomitantly , indicate that iressa may exacerbate the neutropenic effect of vinorelbine .
None(e1,e2)	63	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	6	certain antibiotics , especially neomycin , streptomycin and kanamycin , have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block .
None(e1,e2)	81	102	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	19	25	although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral agents , including protease_inhibitors , macrolide antibiotics , and azole_antifungals , the effect of panretin gel on the steady-state concentrations of these drugs is not known .
effect(e1,e2)	12	35	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1_agonists .
None(e1,e2)	34	51	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	12	17	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
None(e1,e2)	15	25	quinidine : immediate release capsules : there have been rare reports of an interaction between quinidine and nifedipine ( with a decreased plasma level of quinidine ) .
None(e1,e2)	71	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	9	47	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	6	15	no dose adjustment is necessary when simulect is added to triple-immunosuppression regimens including cyclosporine , corticosteroids , and either azathioprine or mycophenolate mofetil .
None(e1,e2)	0	1	digoxin keppra ( 1000 mg twice daily ) did not influence the pharmacokinetics and pharmacodynamics ( ecg ) of digoxin given as a 0.25 mg dose every day .
None(e1,e2)	14	19	in addition , certain drugs that are metabolized by this isoenzyme , including many antidepressants ( tricyclic antidepressants , selective_serotonin_reuptake_inhibitors , and others ) , may inhibit the activity of this isoenzyme , and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system , leading to drug interactions .
None(e1,e2)	28	38	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	24	29	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	22	24	no differences in adverse events or qtc interval were observed when subjects were administered fexofenadine hydrochloride alone or in combination with either erythromycin or ketoconazole .
effect(e1,e2)	6	11	the potential for increased sedation when guanfacine is given with other cns-depressant_drug should be appreciated .
None(e1,e2)	27	29	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
effect(e1,e2)	4	18	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co-administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
None(e1,e2)	34	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	2	18	although trough citalopram plasma levels were unaffected , given the enzyme-inducing properties of carbamazepine , the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered .
None(e1,e2)	7	48	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
None(e1,e2)	11	15	potential interactions between taxol , a substrate of cyp3a4 , and protease_inhibitors ( ritonavir , saquinavir , indinavir , and nelfinavir ) , which are substrates and/or inhibitors of cyp3a4 , have not been evaluated in clinical trials .
None(e1,e2)	41	43	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	47	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	21	reports in the literature suggest that plasma levels of doxorubicin ( and its active metabolite doxorubicinol ) may be increased when paclitaxel and doxorubicin are used in combination .
None(e1,e2)	8	12	in vitro mixing of an aminoglycoside with beta-lactamtype antibiotics ( penicillins or cephalosporins ) may result in a significant mutual inactivation .
None(e1,e2)	45	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	23	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	3	11	mao inhibitors : maoi_antidepressants , as well as a metabolite of furazolidone , slow amphetamine metabolism .
None(e1,e2)	0	18	ssris : weakness hyperreflexia , and incoordination have been reported rarely when 5-ht1 agonists have been co-administered with ssris ( e. g .
None(e1,e2)	76	110	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	45	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	2	inh ( isoniazid ) is also reported to affect ketoconazole concentrations adversely .
None(e1,e2)	19	30	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	2	23	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	0	21	rifabutin , another rifamycin , is structurally similar to rifampin and may possibly have some of the same drug interactions as rifampin .
effect(e1,e2)	14	21	furosemide : clinical studies , as well as random observations , have shown that ibuprofen can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	26	33	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
advise(e1,e2)	0	29	videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because these products may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
advise(e1,e2)	3	8	accordingly , when diflunisal is administered with oral anticoagulants , the prothrombin time should be closely monitored during and for several days after concomitant drug administration .
None(e1,e2)	15	22	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	23	28	monoamine oxidase inhibitors and tricyclic antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic_antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	0	4	ascorbic_acid : doses of ascorbic_acid ( vitamin c ) 1 g/day have been reported to increase plasma concentration of synthetic estrogens by ~47 % , possibly by inhibiting conjugation ;
mechanism(e1,e2)	2	19	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	19	37	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	93	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	20	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic_agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
None(e1,e2)	4	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	38	46	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic_acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	2	4	influence of trileptal on aed concentration ( mean change , 90 % confidence interval )
None(e1,e2)	116	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	4	13	coadministration of gly-buride and metformin did not result in any changes in either metformin pharmacokinetics or pharmaco-dynamics .
None(e1,e2)	0	3	acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16 % ( 90 % confidence interval : 8-23 % ) , decrease mean c max digoxin by 26 % ( 90 % confidence interval : 16-34 % ) and decrease mean trough concentrations of digoxin by 9 % ( 90 % confidence limit : 19 % decrease to 2 % increase ) .
None(e1,e2)	107	143	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	18	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic_analgesic s , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	28	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	8	30	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	15	30	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
mechanism(e1,e2)	3	5	concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels .
None(e1,e2)	17	40	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
effect(e1,e2)	22	24	myocardial injury , including myocardial infarction , myocarditis , ventricular hypokinesia , and severe rhabdomyolysis appear to be increased in patients receiving proleukin and interferon-alfa concurrently .
None(e1,e2)	15	21	h-2 antagonists : in studies with human volunteers , co-administration of cimetidine or ranitidine with ibuprofen had no substantive effect on ibuprofen serum concentrations .
None(e1,e2)	10	12	in the diamond trials , 1252 patients were treated with tikosyn and diuretics concomitantly of whom 493 died compared to 508 deaths among the 1248 patients receiving placebo and diuretics .
None(e1,e2)	18	20	because of the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of thioridazine , duloxetine and thioridazine should not be co-administered .
None(e1,e2)	71	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	23	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	68	73	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
mechanism(e1,e2)	5	17	the elimination half life of midazolam and triazolam also increased ( 1.5-2.5 fold ) during coadministration with diltiazem .
None(e1,e2)	30	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	25	27	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg-coa reductase inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
None(e1,e2)	52	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	40	concomitant administration of fenofibrate ( equivalent to 145 mg tricor ) with atorvastatin ( 20 mg ) once daily for 10 days resulted in approximately 17 % decrease ( range from 67 % decrease to 44 % increase ) in atorvastatin auc values in 22 healthy males .
None(e1,e2)	5	7	serotonergic agents : co-administration of linezolid and serotonergic_agents was not associated with serotonin syndrome in phase 1 , 2 or 3 studies .
None(e1,e2)	24	26	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	50	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting_enzyme_inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
advise(e1,e2)	3	5	therefore , when inspra and nsaids are used concomitantly , patients should be observed to determine whether the desired effect on blood pressure is obtained .
None(e1,e2)	17	38	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	31	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	23	28	since amiodarone is a substrate for cyp3a4 , there is the potential that the use of st. john s wort in patients receiving amiodarone could result in reduced amiodarone levels .
None(e1,e2)	39	45	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle_relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	57	69	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	100	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	23	of over 3500 patients enrolled in the ibandronate osteoporosis treatment and prevention studies , 15 % used anti-peptic agents ( primarily h2_blockers and ppis ) .
None(e1,e2)	31	36	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	24	31	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	73	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	33	51	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	14	there was no effect on the 3 major metabolites ( 5-dfur , 5-fu and fbal ) .
None(e1,e2)	26	56	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	50	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	15	33	the concurrent use of two or more drugs with anticholinergic activity -- such as an antipsychotic_drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and/or a tricyclic_antidepressant ( eg , amitriptyline ) -- commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
effect(e1,e2)	19	26	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns_depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	1	9	- valproic_acid ( e.g. , depakene ) use of sulfapyridine with these medicines may increase the chance of side effects affecting the liver
effect(e1,e2)	15	22	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	3	26	therefore , when chlorothiazide and non-steroidal anti-inflammatory agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained
effect(e1,e2)	0	18	warfarin and anticoagulants : increased prothrombin time , with or without clinical bleeding , has been reported when cefixime is administered concomitantly .
None(e1,e2)	20	26	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl_alcohol , phenothiazines , barbiturates , mao_inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	0	22	macrolide_antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	14	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	5	12	propanolol : the pharmacokinetics of almotriptan were not affected by coadministration of propranolol .
mechanism(e1,e2)	6	12	ketoconazole - combined administration of racemic citalopram ( 40 mg ) and ketoconazole ( 200 mg ) decreased the cmax and auc of ketoconazole by 21 % and 10 % , respectively , and did not significantly affect the pharmacokinetics of citalopram .
None(e1,e2)	22	24	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	21	48	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	2	21	lithium : lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium , including ace_inhibitors .
None(e1,e2)	16	30	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium_hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	34	44	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	58	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	25	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	9	21	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	2	4	fluoxetine , ocs , sertraline , diltiazem , macrolide antibiotics ( exercise caution ) .
None(e1,e2)	0	31	rifampin : when a single 375-mg dose of aprepitant was administered on day9 of a 14-day regimen of 600 mg/day of rifampin , a strong cyp3a4 inducer , the auc of aprepitant decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold .
None(e1,e2)	13	30	in a drug interaction study , co-administration of orally inhaled ciclesonide and oral erythromycin , an inhibitor of cytochrome p450 3a4 , had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin .
None(e1,e2)	6	34	iron supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	0	8	warfarin : meclofenamate sodium enhances the effect of warfarin .
None(e1,e2)	28	106	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	36	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	26	55	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary_vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout_drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
effect(e1,e2)	24	36	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	14	16	for example , since cholestyramine may reduce the gastrointestinal absorption of both the oral anticoagulants and vitamin_k , the net effects are unpredictable .
None(e1,e2)	32	38	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	42	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	14	non-nucleoside reverse transcriptase inhibitors ( nnrtis ) : nevirapine may decrease plasma levels of combination_hormonal_contraceptives ;
mechanism(e1,e2)	7	15	tricyclic antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination_hormonal_contraceptives , increasing plasma levels of antidepressant ;
None(e1,e2)	69	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	14	a single dose of pravastatin had no clinically important effect on the pharmacokinetics of fenofibric_acid .
None(e1,e2)	8	54	paroxetine : coadministration of once daily doses of aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation , with paroxetine 20 mg once daily , resulted in a decrease in auc by approximately 25 % and cmax , by approximately 20 % of both aprepitant and paroxetine .
None(e1,e2)	31	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	3	morphine : combination hormonal_contraceptives may increase the clearance of morphine .
None(e1,e2)	33	38	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	8	50	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	18	20	drugs whose absorption can be affected by the level of acidity in the stomach : drugs such as ketoconazole and itraconazole should be administered at least 2 hours prior to dosing with videx .
None(e1,e2)	4	19	if replacing clonidine by beta-blocker therapy , the introduction of beta blockers should be delayed for several days after clonidine administration has stopped .
effect(e1,e2)	14	49	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
effect(e1,e2)	1	8	when amiloride hcl is administered concomitantly with an angiotensin-converting_enzyme_inhibitor , the risk of hyperkalemia may be increased .
None(e1,e2)	6	23	in clinical studies , coadministration of welchol with atorvastatin , lovastatin , or simvastatin did not interfere with the lipid-lowering activity of the hmg-coa_reductase_inhibitor .
None(e1,e2)	2	23	effects of gabitril on other antiepilepsy drugs ( aeds ) : phenytoin : tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy .
None(e1,e2)	3	14	potential interactions between taxol , a substrate of cyp3a4 , and protease inhibitors ( ritonavir , saquinavir , indinavir , and nelfinavir ) , which are substrates and/or inhibitors of cyp3a4 , have not been evaluated in clinical trials .
None(e1,e2)	38	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	13	22	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	4	26	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	4	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel_blocking_drugs , and isoniazid .
effect(e1,e2)	11	20	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
None(e1,e2)	13	65	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	0	9	furosemide : toradol iv/im reduced the diuretic response to furosemide in normovolemic healthy subjects by approximately 20 % ( mean sodium and urinary output decreased 17 % ) .
advise(e1,e2)	0	2	nevirapine and ketoconazole should not beadministered concomitantly becausedecreases in ketoconazole plasmaconcentrations may reduce the efficacy of the drug .
None(e1,e2)	13	20	digoxin : in a study in 12 patients with congestive heart failure where ketoprofen and digoxin were concomitantly administered , ketoprofen did not alter the serum levels of digoxin .
None(e1,e2)	24	38	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	25	37	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	0	2	doxorubicin : doxorubicin caused a decrease in zalcitabine phosphorylation ( 50 % inhibition of total phosphate formation ) in u937/molt 4 cells .
None(e1,e2)	23	29	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
mechanism(e1,e2)	2	41	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	10	28	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	2	18	methotrexate : valdecoxib_10_mg bid did not show a significant effect on the plasma exposure or renal clearance of methotrexate .
None(e1,e2)	6	28	benzthiazide may interact with alcohol , blood_thinner s , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
effect(e1,e2)	0	15	cytosine_arabinoside , a cytostatic agent , has been reported to inactivate the antifungal activity of flucytosine by competitive inhibition .
None(e1,e2)	0	9	phenytoin : serum phenytoin levels may be increased by aspirin .
None(e1,e2)	14	45	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	31	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	45	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace_inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	30	32	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic_blocking_agents , calcium channel blockers , antihistamines or h1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	25	34	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	9	46	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
mechanism(e1,e2)	0	2	itraconazole decreases busulfan clearance by up to 25 % , and may produce aucs 1500 m min in some patients .
None(e1,e2)	16	26	after the coadministration of 200 mg oral ketoconazole twice daily and one 20 mg dose of loratadine to 11 subjects , the auc and cmax of loratadine averaged 302 % ( 142 s.d . ) and 251 % ( 68 s.d . ) , respectively , of those obtained after co-treatment with placebo .
None(e1,e2)	0	22	anticoagulants : coagulation parameters should be tested more frequently and monitored regularly during simultaneous administration of high doses of heparin , oral anticoagulants , or other drugs that may affect the blood coagulation system or the thrombocyte function .
None(e1,e2)	38	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	9	20	fentanyl anesthesia : severe hypotension has been reported during fentanyl anesthesia with concomitant use of a beta blocker and a calcium_channel_blocker .
mechanism(e1,e2)	3	8	magnesium- and aluminum-containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability ( 48 % ) of lomefloxacin .
None(e1,e2)	17	28	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	18	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	0	37	methotrexate vioxx 12.5 , 25 , and 50 mg , each dose administered once daily for 7 days , had no effect on the plasma concentration of methotrexate as measured by auc0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis .
None(e1,e2)	21	33	toxicology studies of heroin-related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	67	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	25	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	2	24	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	21	46	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	13	18	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	0	27	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating_drugs .
int(e1,e2)	0	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	39	42	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	33	40	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone_classes_of_antipsychotic_agents , monoamine oxidase inhibitors and the tricyclic_antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	28	37	the following drug interactions have been identified involving nizoral tablets and other drugs metabolized by the cytochrome p450 3a4 enzyme system : ketoconazole tablets inhibit the metabolism of terfenadine , resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite .
None(e1,e2)	15	29	interactions for vitamin d analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat_soluble_vitamins ;
None(e1,e2)	14	26	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	0	12	diltiazem : in patients with mild to moderate hypertension , administration of aprepitant once daily , as a tablet formulation comparable to 230 mg of the capsule formulation , with diltiazem 120 mg 3 times daily for 5 days , resulted in a 2-fold increase of aprepitant auc and a simultaneous 1.7-fold increase of diltiazem auc .
None(e1,e2)	41	54	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	6	10	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	0	10	calcium_channel_blockers , dihydropyridine : e.g. , felodipine , nifedipine , nicardipine
None(e1,e2)	16	24	because the tetracyclines have been shown to depress plasma prothrombin activity , patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage .
effect(e1,e2)	14	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	12	41	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure_agonist_opioid_analgesic such as levo-dromoran .
None(e1,e2)	88	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	83	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	12	when patients being treated with labetalol have a positive urine test for amphetamine using these techniques confirmation should be made by using more specific methods such as a gas chromatographic-mass spectrometer technique .
None(e1,e2)	1	18	magnesium/aluminum-containing antacid_products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium/ aluminum -containing antacid products .
None(e1,e2)	21	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	18	20	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	66	104	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	15	although this interaction has not been reported with cinoxacin , caution should be exercised when cinoxacin is given concomitantly with caffeine-containing products .
None(e1,e2)	4	10	use of prinivil with potassium-sparing_diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .
mechanism(e1,e2)	11	52	binding to serum proteins : the following agents may either inhibit levothyroxine_sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
advise(e1,e2)	2	43	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium_salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
effect(e1,e2)	7	33	however , the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly .
advise(e1,e2)	15	27	since pletal is extensively metabolized by cytochrome p-450 isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a . such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
None(e1,e2)	23	25	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	21	37	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
mechanism(e1,e2)	16	20	pharmacokinetic data from these patients demonstrated a decrease in paclitaxel clearance of approximately 33 % when taxol was administered following cisplatin .
None(e1,e2)	39	48	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide_diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	25	33	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	0	2	nonsteroidal_anti-inflammatory_agents ( nsaids ) : concomitant use of aspirin ( or other nonsteroidal antiinflammatory agents ) and corticosteroids increases the risk of gastrointestinal side effects .
None(e1,e2)	15	22	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic_antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	13	21	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	5	42	in a multiple-dose study , enoxacin caused a dose-related increase in the mean elimination half-life of caffeine , thereby decreasing the clearance of caffeine by up to 80 % and leading to a five-fold increase in the auc and the half-life of caffeine .
None(e1,e2)	1	8	hormonal contraceptives co-administration of trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components , ethinylestradiol ( ee ) and levonorgestrel ( lng ) .
None(e1,e2)	0	3	quinolones , including nalidixic_acid , may enhance the effects of the oral anticoagulant warfarin or its derivatives .
None(e1,e2)	26	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	79	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	32	38	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	65	67	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	6	the administration of naratriptan with other 5-ht1_agonists has not been evaluated in migraine patients .
advise(e1,e2)	1	25	if antacid therapy is needed , the antacid dose should be administered at least 2 hours prior to or 2 hours after the dose of sprycel .
None(e1,e2)	10	32	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole_antifungal_agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	36	38	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	27	39	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic_antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	8	18	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	4	22	an increase in serum lithium concentration has been reported during concomitant administration of lithium with atacand , so careful monitoring of serum lithium levels is recommended during concomitant use .
None(e1,e2)	0	11	warfarin : the effect of celecoxib on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin .
mechanism(e1,e2)	3	30	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	114	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	uricosuric_agents : aspirin may decrease the effects of probenecid , sulfinpyrazone , and phenylbutazone .
None(e1,e2)	4	6	while all the selective serotonin_reuptake_inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	11	21	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
int(e1,e2)	0	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	7	zinecard does not influence the pharmacokinetics of doxorubicin .
None(e1,e2)	17	19	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	1	14	oral contraceptives : coadministration of atorvastatin and an oral contraceptive increased auc values for norethindrone and ethinyl estradiol by approximately 30 % and 20 % .
None(e1,e2)	78	107	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	27	34	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg-coa reductase inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
None(e1,e2)	1	24	when lansoprazole was administered concomitantly with theophylline ( cyp1a2 , cyp3a ) , a minor increase ( 10 % ) in the clearance of theophylline was seen .
None(e1,e2)	27	37	cisapride should not be used concomitantly with other drugs known to prolong the qt interval : certain antiarrhythmics , including those of class ia ( such as quinidine and procainamide ) and class iii ( such as sotalol ) ;
mechanism(e1,e2)	17	32	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
mechanism(e1,e2)	6	24	urinary acidifying agents these agents ( ammonium_chloride , sodium acid phosphate , etc . ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .
None(e1,e2)	80	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	59	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	17	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	23	51	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	8	coadministration of itraconazole and cyclosporine , tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs .
None(e1,e2)	14	17	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
effect(e1,e2)	4	7	the pressor effects of ergomar and other vasoconstrictor_drugs can combine to cause dangerous hypertension .
None(e1,e2)	16	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	7	patients receiving flurbiprofen and furosemide or other diuretics should be observed closely to determine if the desired effect is obtained .
None(e1,e2)	0	5	intestinal_adsorbents ( e. g. , charcoal ) and digestive enzyme preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
None(e1,e2)	7	9	auranofin should not be used together with penicillamine ( depen , cuprimine ) , another arthritis medication .
None(e1,e2)	27	41	although no clinical studies have been conducted , it is likely that the metabolism of levobupivacaine may be affected by the known cyp3a4 inducers ( such as phenytoin , phenobarbital , rifampin ) , cyp3a4 inhibitors ( azole antimycotics e.g. , ketoconazole ;
None(e1,e2)	66	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	10	28	since there have been conflicting results regarding the effect of digoxin levels , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing diltiazem_hydrochloride therapy to avoid possible over- or under-digitalization .
mechanism(e1,e2)	2	13	carbamazepine : carbamazepine causes an approximate 50 % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate 40 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	16	21	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	44	100	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	72	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	38	digoxin - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of citalopram and digoxin ( single dose of 1 mg ) did not significantly affect the pharmacokinetics of either citalopram or digoxin .
None(e1,e2)	0	24	beta_blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	23	25	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	117	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	30	51	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	51	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	14	in a study of schizophrenic patients who received clozapine under steady state conditions , fluvoxamine or paroxetine was added in 16 and 14 patients , respectively .
None(e1,e2)	16	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	7	magnesium /aluminum-containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium/aluminum-containing antacid products .
None(e1,e2)	17	19	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric_acid_derivatives , niacin ( nicotinic acid ) , erythromycin , azole antifungals .
None(e1,e2)	26	32	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	29	31	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
advise(e1,e2)	8	25	for this reason , the dose of the anticoagulant should be reduced by 30 - 50 % at the start of treatment with bezalip or bezalip retard and then titrated according to the blood clotting parameters
None(e1,e2)	9	21	co-administration of tikosyn with verapamil resulted in increases in dofetilide peak plasma levels of 42 % , although overall exposure to dofetilide was not significantly increased .
None(e1,e2)	78	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	31	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	3	10	routine administration of vaccines or toxoids should be deferred until corticosteroid therapy is discontinued if possible .
None(e1,e2)	0	3	monoamine_oxidase_(_mao_)_inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
mechanism(e1,e2)	8	16	drugs that inhibit cytochrome p450iid6 , such as quinidine , might increase the plasma concentrations of flecainide in patients that are on chronic flecainide therapy ;
effect(e1,e2)	3	21	the effectiveness of progestin -only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
None(e1,e2)	0	37	venlafaxine : coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine er ( extended release ) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine .
None(e1,e2)	26	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	16	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
None(e1,e2)	23	37	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	16	52	however , the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly .
None(e1,e2)	85	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	23	40	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	18	44	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic_antidepressants , and by other anticonvulsant drugs .
advise(e1,e2)	12	15	as with most psychoactive medications , patients should be advised to avoid alcohol while taking abilify
None(e1,e2)	102	112	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	15	other cyp3a4 inducers include , but are not limited to , rifabutin , rifapentine , phenytoin , carbamazepine , phenobarbital and st. johns wort .
None(e1,e2)	50	59	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	38	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	0	2	chlorpropamide : chlorpropamide s plasma half-life may be prolonged by allopurinol , since allopurinol and chlorpropamide may compete for excretion in the renal tubule .
None(e1,e2)	1	20	high-dose cyclosporin_a resulting in concentrations above 2000 ng/ml administered with oral etoposide has led to an 80 % increase in etoposide exposure with a 38 % decrease in total body clearance of etoposide compared to etoposide alone .
None(e1,e2)	32	34	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	13	19	dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
mechanism(e1,e2)	19	57	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	12	38	antihypertensives : amiodarone should be used with caution in patients receiving - receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	56	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	0	11	ketamine is clinically compatible with the commonly used general and local anesthetic_agents when an adequate respiratory exchange is maintained .
advise(e1,e2)	18	31	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	36	38	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium_channel_blockers , antihistamines or h1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	56	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	44	46	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal_muscle_relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	7	40	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist_analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure_agonist_opioid_analgesic such as levo-dromoran .
mechanism(e1,e2)	7	25	multiple-dose administration of the potent cyp3a4 inducer rifampin ( 600 mg every 24 hours , q24h , for 14 days ) , however , reduced zaleplon cmax and auc by approximately 80 % .
None(e1,e2)	15	86	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood_thinner s ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	23	65	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	selegiline - l-phenylalanine and the selective mao inhibitor selegiline may have synergistic antidepressant activity if used concomitantly .
None(e1,e2)	19	35	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	53	55	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	13	37	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot_alkaloid_class , of which d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	0	17	allopurinol : in a study of healthy male volunteers no significant pharmacokinetic interaction occurred when captopril and allopurinol were administered concomitantly for 6 days .
None(e1,e2)	3	17	ketoconazole ) , macrolide_antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	7	11	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	2	12	administration of diltiazem_hydrochloride with digoxin in 24 healthy male subjects increased plasma digoxin concentrations approximately 20 % .
None(e1,e2)	74	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
effect(e1,e2)	6	21	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	11	dopamine d2 receptor antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
None(e1,e2)	20	33	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
mechanism(e1,e2)	11	17	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
None(e1,e2)	28	30	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	29	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	31	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	8	18	the potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via cyp3a4 ( alprazolam , triazolam ) should be considered when coadministering these agents with aprepitant .
None(e1,e2)	5	19	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	8	18	when used in external subcutaneous infusion pumps for insulin , novolog should not be mixed with any other insulins or diluent .
None(e1,e2)	36	39	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal_anti-inflammatory_agents ] is contraindicated .
None(e1,e2)	42	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	19	erythromycin use in patients who are receiving high doses of theophylline may be associated with an increase in serum theophylline levels and potential theophylline toxicity .
None(e1,e2)	9	62	medications can interfere with folate utilization , including : anticonvulsant_medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic_acid .
None(e1,e2)	0	13	mao_inhibitors : duragesic is not recommended for use in patients who have received maoi within 14 days because severe and unpredictable potentiation by mao inhibitors has been reported with opioid analgesics
None(e1,e2)	10	18	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	3	8	heparin , other anticoagulants , thrombolytics , and anti_platelet_agents are associated with an increase in bleeding .
None(e1,e2)	7	30	zebeta should be used with care when myocardial_depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	0	9	digoxin : studies of concomitant administration of flurbiprofen and digoxin to healthy men ( n= 14 ) did not show a change in the steady state serum levels of either drug .
None(e1,e2)	25	48	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel_blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	5	10	caution should be used when cyp3a4 inhibitors are co-administered with felodipine .
None(e1,e2)	5	12	concurrent administration of hexalen and antidepressants_of_the_mao_inhibitor_class may cause severe orthostatic hypotension . cimetidine , an inhibitor of microsomal drug metabolism , increased altretamines half-life and toxicity in a rat model .
None(e1,e2)	10	19	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	11	22	spontaneous reports of serotonin syndrome associated with co-administration of zyvox and serotonergic_agents , including antidepressants such as selective serotonin reuptake inhibitors ( ssris ) , have been reported .
None(e1,e2)	1	42	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	28	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	61	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	20	diclofenac : administration of morning and lunch doses of starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent .
None(e1,e2)	26	45	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
effect(e1,e2)	8	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	3	5	effects of other antiepileptic_drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
mechanism(e1,e2)	0	6	clarithromycin exposure was significantly decreased by nevirapine ;
effect(e1,e2)	11	42	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	9	14	however , in clinical studies the consequences of concomitant irbesartan on the pharmacodynamics of warfarin were negligible .
effect(e1,e2)	7	15	however , it has been established that acitretin interferes with the contraceptive effect of microdosed progestin minipill preparations .
effect(e1,e2)	25	28	in post-marketing experience , bleeding events have been reported , predominantly in the elderly , in association with increases in prothrombin time in patients receiving vioxx concurrently with warfarin .
None(e1,e2)	0	10	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	7	20	therefore , if digoxin is administered with vaprisol , the clinician should be alert to the possibility of increases in digoxin levels .
None(e1,e2)	62	101	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	40	43	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	26	76	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	77	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	7	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
advise(e1,e2)	16	18	accordingly , careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin .
None(e1,e2)	0	41	central_nervous_system_depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	74	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	35	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	18	36	because severe hypoglycemia has been reported in patients concomitantly receiving oral miconazole ( an imidazole ) and oral hypoglycemic_agents , such a potential interaction involving the latter agents when used concomitantly with ketoconazole tablets ( an imidazole ) can not be ruled out .
None(e1,e2)	0	4	fluoxetine , fluvoxamine , paroxetine , sertraline ) .
advise(e1,e2)	4	21	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	0	52	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	54	75	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	21	57	however , in the second study , administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg cerivastatin_sodium approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin auc of less than 8 % , and a decrease in cmax of about 30 % when compared to dosing cerivastatin_sodium alone .
None(e1,e2)	25	44	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim /sulfamethoxazole or zidovudine .
None(e1,e2)	25	40	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
None(e1,e2)	0	25	eprosartan ( up to 400 mg b.i.d . or 800 mg q.d . ) doses have been safely used concomitantly with a thiazide diuretic ( hydrochlorothiazide ) .
None(e1,e2)	12	25	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	19	21	potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( phenytoin , valproate , oral contraceptive , digoxin , warfarin , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .
None(e1,e2)	8	48	this drug may interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine_oxidase_(_mao_)_inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	0	22	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
None(e1,e2)	25	49	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety_agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant_drugs .
None(e1,e2)	9	11	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
effect(e1,e2)	5	38	isoflurane or enflurane administered with nitrous_oxide /oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	10	33	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	24	26	until further data are developed regarding drug interactions when azithromycin and these drugs are used concomitantly , careful monitoring of patients is advised : digoxin elevated digoxin concentrations .
None(e1,e2)	0	15	cimetidine : a study in 6 healthy volunteers has shown a significant increase in peak nifedipine plasma levels ( 80 % ) and area-under-the-curve ( 74 % ) after a 1 week course of cimetidine at 1000 mg per day and nifedipine at 40 mg per day .
None(e1,e2)	62	84	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	100	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	23	34	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	26	32	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	28	95	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	16	resins : since bile acid sequestrants may bind other drugs given concurrently , patients should take tricor at least 1 hour before or 4-6 hours after a bile acid binding resin to avoid impeding its absorption .
None(e1,e2)	0	2	digitalis : vitamin_d dosage must be determined with care in patients undergoing treatment with digitalis , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
None(e1,e2)	23	28	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	22	45	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle_relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	23	31	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	47	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	13	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e. g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	4	12	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium_channel_antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	102	120	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	30	32	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	16	26	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	0	8	methotrexate : ibuprofen , as well as other nonsteroidal_anti-inflammatory_drugs , probably reduces the tubular secretion of methotrexate based on in vitro studies in rabbit kidney slices .
None(e1,e2)	6	17	trimethoprim alone or in combination with sulfamethoxazole : concomitant use of trimethoprim alone or in combination with sulfamethoxazole is contraindicated .
None(e1,e2)	39	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
effect(e1,e2)	4	17	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum alkaloids may be reduced by sympathomimetics .
None(e1,e2)	59	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	5	12	antidepressants ( tricyclic ) , atropine or other anticholinergic agents , or digitalis_glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	0	21	warfarin : multiple oral doses of sonata ( 20 mg q24h for 13 days ) did not affect the pharmacokinetics of warfarin ( r+ ) - or ( s- ) -enantiomers or the pharmacodynamics ( prothrombin time ) following a single 25-mg oral dose of warfarin .
None(e1,e2)	81	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	27	45	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/ sulfamethoxazole or zidovudine .
None(e1,e2)	0	2	cimetidine : albendazole_sulfoxide concentrations in bile and cystic fluid were increased ( about 2-fold ) in hydatid cyst patients treated with cimetidine ( 10 mg/kg/day ) ( n=7 ) compared with albendazole ( 20 mg/kg/day ) alone ( n=12 ) .
None(e1,e2)	27	43	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium_salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	33	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	8	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	6	11	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
None(e1,e2)	22	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	13	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	22	24	eprosartan ( up to 400 mg b.i.d . or 800 mg q.d . ) doses have been safely used concomitantly with a thiazide_diuretic ( hydrochlorothiazide ) .
advise(e1,e2)	5	18	brovana , as with other beta2-agonists , should be administered with extreme caution to patients being treated with monoamine_oxidase_inhibitors , tricyclic antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	18	23	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide_diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	8	13	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	65	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	9	erythromycin : in healthy individuals , plasma concentrations of atorvastatin increased approximately 40 % with coadministration of atorvastatin and erythromycin , a known inhibitor of cytochrome p450 3a4 .
None(e1,e2)	21	27	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	9	11	other agents : prinivil has been used concomitantly with nitrates and/or digoxin without evidence of clinically significant adverse interactions .
None(e1,e2)	30	43	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	10	19	in about 30 % of patients , the dose of cyclosporine had to be reduced in order to maintain cyclosporine concentrations within the therapeutic range , while in the remainder no adjustment was needed .
None(e1,e2)	80	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	3	15	pyrazolone derivatives ( phenylbutazone , oxyphenbutazone , and possibly dipyrone ) : concomitant administration with aspirin may increase the risk of gastrointestinal ulceration .
None(e1,e2)	118	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	52	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	39	53	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	31	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
effect(e1,e2)	7	22	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	26	85	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	9	12	in a study in hypertensive patients , addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects , and isradipine had an additional antihypertensive effect .
None(e1,e2)	5	16	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	44	62	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	13	vitamin_a and oral retinoids : concomitant administration of vitamin a and/or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis a .
None(e1,e2)	0	39	theophylline vioxx 12.5 , 25 , and 50 mg administered once daily for 7 days increased plasma theophylline concentrations ( auc ( 0- ) ) by 38 to 60 % in healthy subjects administered a single 300-mg dose of theophylline .
None(e1,e2)	66	117	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	27	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
advise(e1,e2)	22	45	also , due to the potential for additive effects such as bradycardia and av block , caution is warranted in patients receiving clonidine with agents known to affect sinus node function or av nodal conduction ( e.g. , digitalis , calcium channel blockers , and beta-blockers . )
None(e1,e2)	1	19	digoxin keppra ( 1000 mg twice daily ) did not influence the pharmacokinetics and pharmacodynamics ( ecg ) of digoxin given as a 0.25 mg dose every day .
None(e1,e2)	4	6	hmg-coa reductase inhibitors : simvastatin ( cyp3a4 substrate ) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis .
effect(e1,e2)	0	6	furosemide may decrease arterial responsiveness to norepinephrine .
None(e1,e2)	56	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	7	28	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	24	26	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	10	20	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	49	51	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	20	22	caution is advised when trisenox is coadministered with other medications that can prolong the qt interval ( e.g . certain antiarrhythmics or thioridazine ) or lead to electrolyte abnormalities ( such as diuretics or amphotericin b ) .
None(e1,e2)	9	13	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	26	69	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
advise(e1,e2)	14	21	in order to maintain phenytoin levels , limit adverse experiences , and achieve the felbamate dose of 3600 mg/day , a phenytoin dose reduction of approximately 40 % was necessary for eight of these 10 subjects .
None(e1,e2)	100	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	10	21	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
None(e1,e2)	5	7	bromocriptine mesylate may interact with dopamine_antagonists , butyrophenones , and certain other agents .
None(e1,e2)	72	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	35	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	25	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	68	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
int(e1,e2)	0	54	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	21	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	63	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	6	27	ketoconazole : in healthy subjects receiving ketoconazole , a cyp3a4 inhibitor , at 200 mg twice daily for 7 days , systemic exposure ( auc ) to lapatinib was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control .
None(e1,e2)	102	116	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	0	18	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide_diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	26	46	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	39	the extent of plasma protein binding of atovaquone in human plasma is not affected by the presence of therapeutic concentrations of phenytoin ( 15 mcg/ ml ) , nor is the binding of phenytoin affected by the presence of atovaquone .
None(e1,e2)	33	37	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	21	potential interactions between taxol , a substrate of cyp3a4 , and protease inhibitors ( ritonavir , saquinavir , indinavir , and nelfinavir ) , which are substrates and/or inhibitors of cyp3a4 , have not been evaluated in clinical trials .
None(e1,e2)	19	77	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	71	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	30	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
advise(e1,e2)	2	14	digitalis : vitamin_d dosage must be determined with care in patients undergoing treatment with digitalis , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
None(e1,e2)	12	14	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	12	20	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic_acid , and warfarin .
None(e1,e2)	11	13	mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	45	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	83	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	23	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	37	46	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	9	14	if desipramine hydrochloride is to be combined with other psychotropic_agents such as tranquilizers or sedative /hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	4	21	another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel ( cyp3a4 substrates ) .
mechanism(e1,e2)	2	13	mao inhibitors maoi_antidepressants , as well as a metabolite of furazolidone , slow amphetamine metabolism .
None(e1,e2)	8	31	ketoconazole : when a single 125-mg dose of aprepitant was administered on day5 of a 10-day regimen of 400 mg/day of ketoconazole , a strong cyp3a4 inhibitor , the auc of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold .
None(e1,e2)	3	9	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	0	4	anticonvulsants : carbamazepine , phenobarbital , phenytoin
None(e1,e2)	26	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	37	because severe hypoglycemia has been reported in patients concomitantly receiving oral miconazole ( an imidazole ) and oral hypoglycemic agents , such a potential interaction involving the latter agents when used concomitantly with ketoconazole tablets ( an imidazole ) can not be ruled out .
None(e1,e2)	149	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
effect(e1,e2)	0	10	antihistamines may partially counteract the anticoagulation effects of heparin or warfarin .
None(e1,e2)	33	59	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
int(e1,e2)	0	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	26	29	because of foscarnets tendency to cause renal impairment , the use of foscavir should be avoided in combination with potentially nephrotoxic drugs such as aminoglycosides , amphotericin_b and intravenous pentamidine unless the potential benefits outweigh the risks to the patient .
None(e1,e2)	9	35	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	11	22	a case report of one patient taking amiodarone 200 mg and indinavir 800 mg three times a day resulted in increases in amiodarone concentrations from 0.9 mg/l to 1.3 mg/l .
None(e1,e2)	79	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	9	vitamin_a : because of the relationship of accutane to vitamin_a , patients should be advised against taking vitamin supplements containing vitamin a to avoid additive toxic effects
None(e1,e2)	1	38	as mhd , the predominant plasma substrate , is only a weak inducer of udp-glucuronyl transferase , it is unlikely to have an effect on drugs that are mainly eliminated by conjugation through udp-glucuronyl transferase ( e.g. , valproic_acid , lamotrigine ) .
None(e1,e2)	0	4	maalox * coadministration of maalox_tc had no effect on nicardipine hcl absorption .
None(e1,e2)	0	25	ritonavir ( 600 mg b.i.d . ) co-administered with vardenafil 5 mg resulted in a 49-fold increase in vardenafil auc and a 13-fold increase in vardenafil cmax .
None(e1,e2)	7	31	isoflurane or enflurane administered with nitrous oxide/ oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	12	22	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	43	51	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	6	19	magnesium/aluminum-containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium/aluminum-containing antacid_products .
None(e1,e2)	21	24	effect of clonazepam on the pharmacokinetics of other drugs : clonazepam does not appear to alter the pharmacokinetics of phenytoin , carbamazepine , or phenobarbital .
None(e1,e2)	11	13	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	2	17	the effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide , ketoconazole , methotrexate , phenytoin , tolbutamide , and warfarin have been studied in vivo and clinically important interactions have not been found .
None(e1,e2)	9	18	concurrent use of rifampin increases the metabolic clearance of zebeta , resulting in a shortened elimination half-life of zebeta .
None(e1,e2)	24	32	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	28	50	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
mechanism(e1,e2)	2	7	coadministration of itraconazole with oral midazolam or triazolam has resulted in elevated plasma concentrations of the latter two drugs .
None(e1,e2)	14	18	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	6	11	interactions for vitamin d analogues ( vitamin_d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	7	9	in rheumatoid arthritis , concomitant medications besides mtx were nonsteroidal_anti-inflammatory_agents , folic acid , corticosteroids and/or narcotics .
None(e1,e2)	19	162	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	10	15	nicardipine hcl usually does not alter the plasma levels of digoxin , however , serum digoxin levels should be evaluated after concomitant therapy with nicardipine hcl is initiated .
None(e1,e2)	59	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	19	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	0	6	potassium supplements and potassium-sparing diuretics : fosinopril_sodium can attenuate potassium loss caused by thiazide diuretics .
None(e1,e2)	0	14	anticoagulants : there have been reports of increased anticoagulant effects when erythromycin and oral anticoagulants were used concomitantly .
None(e1,e2)	3	9	drug interactions with antacids administration of 120 mg of fexofenadine_hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	30	56	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
mechanism(e1,e2)	3	13	the administration of guanfacine concomitantly with known microsomal enzyme inducer ( phenobarbital or phenytoin ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half-life and plasma concentration .
None(e1,e2)	20	22	in vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites with the known cytochrome cyp 2c9 substrates/inhibitors sulphenazole , tolbutamide and nifedipine .
effect(e1,e2)	8	31	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic_drugs .
None(e1,e2)	0	4	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
None(e1,e2)	17	19	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
advise(e1,e2)	2	9	consequently , estazolam should be avoided in patients receiving ketoconazole and itraconazole , which are very potent inhibitors of cyp3a .
None(e1,e2)	0	20	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
None(e1,e2)	0	8	aspirin : concurrent administration of aspirin may lower meclofenamate_sodium plasma levels , possibly by competing for protein-binding sites .
None(e1,e2)	22	28	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	0	2	cyclosporine , tacrolimus and digoxin concentrations should be monitored at the initiation of itraconazole therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
None(e1,e2)	22	37	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	43	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	2	cyclosporine , hexobarbital and phenytoin concentrations .
None(e1,e2)	42	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	11	neuroleptic_drugs - l-phenylalanine may potentiate the tardive dyskinesia side reactions of neuroleptic_drugs if used concomitantly with them .
None(e1,e2)	1	25	since pletal is extensively metabolized by cytochrome p-450 isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a . such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
None(e1,e2)	18	37	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline_salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
effect(e1,e2)	2	14	warfarin : quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives .
None(e1,e2)	28	36	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	29	31	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	6	10	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
None(e1,e2)	28	42	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	2	35	nifedipine : vardenafil 20 mg , when co-administered with slow-release nifedipine 30 mg or 60 mg once daily , did not affect the relative bioavailability ( auc ) or maximum concentration ( cmax ) of nifedipine , a drug that is metabolized via cyp3a4 .
None(e1,e2)	8	10	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	29	42	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3_antagonist_class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	11	14	although there are no study data to evaluate the possibility , nitric_oxide_donor_compounds , including sodium_nitroprusside and nitroglycerin , may have an additive effect with inomax on the risk of developing methemoglobinemia .
effect(e1,e2)	5	10	in vitro mixing of an aminoglycoside with beta-lactamtype antibiotics ( penicillins or cephalosporins ) may result in a significant mutual inactivation .
None(e1,e2)	43	51	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	0	7	nafazodone , fluvoxamine , cimetidine ( consider xanax dose reduction ) .
None(e1,e2)	2	9	antacids , kaolin -pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	6	10	in clinical studies , coadministration of welchol with atorvastatin , lovastatin , or simvastatin did not interfere with the lipid-lowering activity of the hmg-coa reductase inhibitor .
None(e1,e2)	85	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	18	33	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	34	36	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	10	15	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	0	5	antiepileptic_drugs : potential interactions between trileptal and other aeds were assessed in clinical studies .
None(e1,e2)	13	15	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
advise(e1,e2)	0	29	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	4	6	after multiple dosing , interferon_beta-1a ( avonex 30 mcg im once weekly ) reduced tysabri clearance by approximately 30 % .
None(e1,e2)	5	7	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
None(e1,e2)	8	11	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	7	38	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin_b .
None(e1,e2)	55	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	40	50	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	44	70	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	20	31	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic_antidepressants or some antihistamines .
None(e1,e2)	93	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	83	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	10	12	there has been too little experience with the coadministration of tambocor with nifedipine or diltiazem to recommend concomitant use .
None(e1,e2)	25	35	ace inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin_ii_receptor_antagonists ( acei/arb ) .
effect(e1,e2)	18	25	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective_beta-adrenergic-blocking_agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	2	6	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	0	5	sedative /hypnotics : midazolam , triazolam
None(e1,e2)	50	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	46	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	12	55	cns-active drugs ethanol : sonata 10 mg potentiated the cns-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test ( dsst ) , symbol copying test , and the variability component of the divided attention test for 2.5 hours after ethanol administration .
None(e1,e2)	10	15	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin 500 mg bid , verapamil 240 mg qd , saquinavir 1200 mg tid , fluconazole 200 mg qd ) resulted in increases in cmax of eplerenone ranging from 1.4- to 1.6- fold and auc from 2.0- to 2.9- fold .
None(e1,e2)	17	24	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic acid , sali-cylates , nsaids ( including ketorolac tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	0	20	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic_acid , and warfarin .
None(e1,e2)	16	17	another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive_agents ethinyl_estradiol and levonorgestrel ( cyp3a4 substrates ) .
None(e1,e2)	27	32	however , in a study of 12 normal subjects , concurrent administration of aspirin decreased ketoprofen protein binding and increased ketoprofen plasma clearance from 0.07 l/kg/h without aspirin to 0.11 l/kg/h with aspirin .
None(e1,e2)	23	29	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	24	50	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	40	55	in three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days ( n=18 ) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine ( n=18 ) or with cimetidine 600 mg every 12 hours for 14 days ( n=18 ) under steady state conditions to normal healthy male and female volunteers .
None(e1,e2)	15	20	nabilone has been shown to have an additive cns depressant effect when given with either diazepam , secobarbitone sodium , alcohol or codeine .
None(e1,e2)	0	11	theophylline : as with some other quinolones , concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life .
None(e1,e2)	39	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	4	nitroglycerin : dynacirc ( isradipine ) has been safely coadministered with nitroglycerin .
None(e1,e2)	11	30	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
int(e1,e2)	0	17	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	0	20	aspirin : vardenafil ( 10 mg and 20 mg ) did not potentiate the increase in bleeding time caused by aspirin ( two 81 mg tablets ) .
None(e1,e2)	10	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	13	because of its lack of anti-platelet effect valdecoxib is not a substitute for aspirin for cardiovascular prophylaxis .
None(e1,e2)	23	37	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal_anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	12	38	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	18	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	17	these data indicate that levetiracetam does not influence the plasma concentration of other aeds and that these aeds do not influence the pharmacokinetics of levetiracetam .
None(e1,e2)	2	4	diltiazem , nifedipine , verapamil
effect(e1,e2)	9	17	other depressasnts such as alcohol , barbiturates , and maois may enhance cns depression when administered with ethchlorvynol .
None(e1,e2)	56	62	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout_drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	33	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	18	interactions for vitamin b3 ( niacin ) : antihypertensive therapy : nicotinic acid may potentiate the effects of ganglionic_blocking_agents and vasoactive drugs resulting in postural hypotension .
mechanism(e1,e2)	11	21	however , in the second study , administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg cerivastatin_sodium approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin auc of less than 8 % , and a decrease in cmax of about 30 % when compared to dosing cerivastatin sodium alone .
None(e1,e2)	48	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	78	128	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	20	38	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
None(e1,e2)	10	13	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	44	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	8	70	this drug may interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
advise(e1,e2)	5	7	aspirin : concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations , peak plasma levels , and auc values .
None(e1,e2)	6	15	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	65	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	10	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	32	38	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
mechanism(e1,e2)	0	32	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	15	29	in patients who have been reported to be well controlled on tricyclic antidepressants receiving concurrent cimetidine therapy , discontinuation of cimetidine has been reported to decrease established steady-state serum tricyclic_antidepressant levels and compromise their therapeutic effects .
None(e1,e2)	2	16	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
None(e1,e2)	12	14	hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with propranolol , diltiazem , and verapamil .
None(e1,e2)	114	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	4	6	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	38	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	57	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	30	34	although it has not been established that there is an interaction between clozapine and benzodiazepines or other psychotropics , caution is advised when clozapine is initiated in patients taking a benzodiazepine or any other psychotropic_drug .
None(e1,e2)	2	73	tolbutamide : aprepitant , when given as 125 mg on day 1 and 80 mg/day on days 2 and 3 , decreased the auc of tolbutamide ( a cyp2c9 substrate ) by 23 % on day 4 , 28 % on day 8 , and 15 % on day 15 , when a single dose of tolbutamide 500 mg was admini , stered orally prior to the administration of the 3-day regimen of aprepitant and on days 4,8 , and 15 .
None(e1,e2)	17	25	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	2	12	coadministration of terfenadine with itraconazole has led to elevated plasma concentrations of terfenadine , resulting in rare instances of life- threatening cardiac dysrhythmias and one death .
None(e1,e2)	9	35	if desipramine hydrochloride is to be combined with other psychotropic_agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	49	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	23	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	30	38	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	97	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	94	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	9	the pharmacokinetics of fenofibric_acid were not significantly affected by atorvastatin
None(e1,e2)	24	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	25	risk of anaphylactic reaction : although it is known that patients on beta-blockers may be refractory to epinephrine in the treatment of anaphylactic shock , beta-blockers can , in addition , interfere with the modulation of allergic reaction and lead to an increased severity and/or frequency of attacks .
None(e1,e2)	26	28	the pharmacokinetics of terfenadine and its acid metabolite and the electrocardiographic qt c interval were measured during both periods : with terfenadine alone , and with terfenadine plus dirithromycin .
None(e1,e2)	0	11	digoxin : the concomitant administration of dynacirc ( isradipine ) and digoxin in a single-dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of digoxin .
int(e1,e2)	13	18	data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following : sertraline and paroxetine .
None(e1,e2)	12	16	no significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , cimetidine and phenobarbital .
None(e1,e2)	24	43	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	20	22	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	15	23	reports in the literature suggest that plasma levels of doxorubicin ( and its active metabolite doxorubicinol ) may be increased when paclitaxel and doxorubicin are used in combination .
None(e1,e2)	10	15	toxicology studies of heroin-related deaths reveal frequent involvement of other central_nervous_system_depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	22	34	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	57	63	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	0	9	corticosteroids may increase the clearance of chronic high dose aspirin .
None(e1,e2)	19	21	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	31	33	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	69	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	49	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	5	20	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic_acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	20	24	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl_alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	22	29	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	31	39	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	11	tambocor has been used in a large number of patients receiving diuretics without apparent interaction .
mechanism(e1,e2)	0	9	paroxetine produced only minor changes in the levels of clozapine and its metabolites .
None(e1,e2)	2	9	the effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide , ketoconazole , methotrexate , phenytoin , tolbutamide , and warfarin have been studied in vivo and clinically important interactions have not been found .
None(e1,e2)	0	7	mao_inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	4	6	the safety of using stadol_ns and imitrex ( sumatriptan ) nasal spray during the same episode of migraine has not been established .
None(e1,e2)	16	20	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	26	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	2	8	ethosuximide : amphetamines may delay intestinal absorption of ethosuximide .
None(e1,e2)	5	7	information on concurrent usage of atenolol and aspirin is limited .
None(e1,e2)	12	16	aspirin/acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
None(e1,e2)	0	16	non-steroidal_anti-inflammatory_drugs ( but not aspirin ) : these drugs in combination with very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies .
None(e1,e2)	38	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	21	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	10	18	the use of antacids should be considered in place of h2_blockers or proton pump inhibitors in patients receiving sprycel therapy .
None(e1,e2)	11	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel-blocking_drugs , and isoniazid .
None(e1,e2)	46	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	108	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	47	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the auc of ethinyl estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	5	10	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
None(e1,e2)	13	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	2	alcohol , barbiturates , or narcotics : potentiation of orthostatic hypotension may occur .
None(e1,e2)	30	32	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	23	33	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	0	4	antacids : administration of flurbiprofen to volunteers under fasting conditions , or with antacid suspension yielded similar serum flurbiprofen time profiles in young subjects ( n=12 ) .
None(e1,e2)	38	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	17	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	13	25	the results from a study in which eight hiv-infected individuals were treated with zidovudine , 8 +/- 0.4 mg/kg/day , showed that the pharmacokinetics of zidovudine were not affected during concomitant administration of itraconazole , 100 mg b.i.d .
None(e1,e2)	26	43	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	88	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	22	alcohol : alcohol ( 0.5 g/kg body weight : approximately 40 ml of absolute alcohol in a 70 kg person ) and vardenafil plasma levels were not altered when dosed simultaneously .
None(e1,e2)	0	4	colestipol -concomitant intake of colestipol and vitamin k may reduce the absorption of vitamin k .
mechanism(e1,e2)	4	7	this may occur because diflunisal competitively displaces coumarins from protein binding sites .
None(e1,e2)	0	28	levothyroxine_sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous_sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	1	16	and calcium_channel_antagonists e.g. , verapamil ) , cyp1a2 inducers ( omeprazole ) and cyp1a2 inhibitors ( furafylline and clarithromycin ) .
None(e1,e2)	0	13	antidiabetic_drugs : ( oral agents and insulin ) - dosage adjustment of the antidiabetic_drug may be required .
None(e1,e2)	20	22	rhabdomyolysis has been observed in patients receiving hmg-coa reductase inhibitors administered alone ( at recommended dosages ) or concomitantly with immunosuppressive_drugs including cyclosporine .
None(e1,e2)	8	10	other drugs : drugs such as quinidine , disopyramide , procainamide , phenothiazines , antihistamines , and tricyclic antidepressants may be associated with qt-interval prolongation and an increased risk of ventricular arrhythmia .
None(e1,e2)	26	32	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	16	23	an alternative non-cyp3a4 substrate hypnotic agent may be considered in patients taking cyp3a4 inducers such as rifampin , phenytoin , carbamazepine , and phenobarbital .
None(e1,e2)	46	56	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	16	32	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
None(e1,e2)	34	48	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	5	7	indomethacin - concomitant use of l-glutamine and indomethacin may ameliorate increased intestinal permeability caused by indomethacin .
None(e1,e2)	7	9	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	32	61	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	30	42	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	80	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	70	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	0	3	isoproterenol_hydrochloride injection and epinephrine should not be administered simultaneously because both drugs are direct cardiac stimulants and their combined effects may induce serious arrhythmias .
None(e1,e2)	0	13	5ht3_antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	35	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	68	71	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	30	42	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	3	5	antidiabetic agents ( insulin , sulfonylureas ) : requirements for insulin or oral antidiabetic agents may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
None(e1,e2)	0	5	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
None(e1,e2)	44	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	13	43	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	13	21	reported examples of this interaction include the following : immunosuppressives : cyclosporine ( cyp3a4 substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine .
None(e1,e2)	0	10	antifungals : in vitro and/or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	15	18	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	78	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	79	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	38	42	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
mechanism(e1,e2)	3	10	coadministration of oral contraceptives increased the maximum plasma concentration of alprazolam by 18 % , decreased clearance by 22 % , and increased half-life by 29 % .
None(e1,e2)	23	28	hormonal contraceptives co-administration of trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components , ethinylestradiol ( ee ) and levonorgestrel ( lng ) .
None(e1,e2)	0	31	metoprolol - administration of 20 mg/day lexapro for 21 days in healthy volunteers resulted in a 50 % increase in cmax and 82 % increase in auc of the beta-adrenergic blocker metoprolol ( given in a single dose of 100 mg ) .
None(e1,e2)	4	8	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
None(e1,e2)	69	97	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	42	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	25	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
effect(e1,e2)	14	25	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	22	36	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin-_converting_enzyme_(_ace_)_inhibitors , betablockers , calcium-channel blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	41	71	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	11	13	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium_channel_blockers , beta_blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	22	24	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	3	18	digoxin : when starlix 120 mg before meals was administered in combination with a single 1-mg dose of digoxin to healthy volunteers , there were no clinically relevant changes in the pharmacokinetics of either agent .
None(e1,e2)	82	86	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	26	47	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	12	24	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	6	32	carbamazepine - combined administration of racemic citalopram ( 40 mg/day for 14 days ) and carbamazepine ( titrated to 400 mg/day for 35 days ) did not significantly affect the pharmacokinetics of carbamazepine , a cyp3a4 substrate .
None(e1,e2)	1	19	oral anticoagulants : in some normal volunteers , the concomitant administration of diflunisal and warfarin , acenocoumarol , or phenprocoumon resulted in prolongation of prothrombin time .
None(e1,e2)	10	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	49	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	8	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	12	16	hypotension was more likely to occur if the calcium antagonist were a dihydropyridine_derivative , e.g. , nifedipine , while left ventricular failure and av conduction disturbances , including complete heart block , were more likely to occur with either verapamil or diltiazem .
None(e1,e2)	52	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	12	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
None(e1,e2)	13	45	tell your doctor if you are taking any of the following drugs : blood_thinner s ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle_relaxants birth control pills sleeping pills thyroid medications
effect(e1,e2)	14	17	nonsteroidal anti-inflammatory agents ( nsaids ) : concomitant use of aspirin ( or other nonsteroidal_antiinflammatory_agents ) and corticosteroids increases the risk of gastrointestinal side effects .
None(e1,e2)	10	14	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
None(e1,e2)	13	30	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	7	37	insulin : a clinical study in 6 insulin -dependent diabetic patients demonstrated no effect of extraneal on insulin absorption from the peritoneal cavity or on insulins ability to control blood glucose when insulin was administered intraperitoneally with extraneal .
None(e1,e2)	38	40	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	8	22	cardiovasculars : cardiac glycosides : in patients receiving digoxin therapy , administration of oral amiodarone regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity .
None(e1,e2)	0	11	thioridazine : coadministration of single doses of sonata 20 mg and thioridazine 50 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration .
None(e1,e2)	70	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	21	cardiovasculars : cardiac_glycosides : in patients receiving digoxin therapy , administration of oral amiodarone regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity .
None(e1,e2)	8	10	it is unknown whether the concomitant administration of proton_pump_inhibitors affects duloxetine absorption .
None(e1,e2)	104	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	24	44	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	47	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	25	27	although a causal mechanism and a cause-and-effect relationship have not been established , current evidence suggests that renal function should be monitored in patients on thiazide_diuretics and allopurinol even in the absence of renal failure , and dosage levels should be even more conservatively adjusted in those patients on such combined therapy if diminished renal function is detected..
None(e1,e2)	18	22	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic_acid , and tolbutamide in vitro .
None(e1,e2)	4	18	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
mechanism(e1,e2)	0	7	atromid-s may displace acidic drugs such as phenytoin or tolbutamide from their binding sites .
None(e1,e2)	13	18	also , concomitant administration of quinolones with products containing iron , multivitamins containing zinc , or videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution may result in low urine levels .
None(e1,e2)	31	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	5	- procainamide ( e.g. , pronestyl ) or
None(e1,e2)	2	31	because of foscarnet s tendency to cause renal impairment , the use of foscavir should be avoided in combination with potentially nephrotoxic drugs such as aminoglycosides , amphotericin b and intravenous pentamidine unless the potential benefits outweigh the risks to the patient .
None(e1,e2)	7	16	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	13	19	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	25	34	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
effect(e1,e2)	10	20	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
mechanism(e1,e2)	19	42	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	9	23	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	13	15	in vitro studies indicate cyp3a4 isoform and cyp1a2 isoform mediate the metabolism of levobupivacaine to desbutyl_levobupivacaine and 3-hydroxy levobupivacaine , respectively .
effect(e1,e2)	0	18	cyclophosphamide treatment , which causes a marked and persistent inhibition of cholinesterase activity , potentiates the effect of succinylcholine_chloride .
None(e1,e2)	14	19	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
mechanism(e1,e2)	8	15	in a single subject given one dose of ciprofloxacin 2 hours after a dose of didanosine -placebo tablets , a greater than 50 % reduction in the auc of ciprofloxacin was observed .
None(e1,e2)	10	12	in study 1 , patients with colorectal cancer were given irinotecan /5-fu/ leucovorin ( bolus-ifl ) with or without avastin .
None(e1,e2)	15	30	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	21	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	61	63	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
effect(e1,e2)	7	20	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic_agonists .
None(e1,e2)	3	5	gemfibrozil other fibrates niacin ( nicotinic_acid ) ( =1 g/day )
None(e1,e2)	35	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	5	methotrexate : concomitant administration of methotrexate and some nsaids has been reported to reduce the clearance of methotrexate , enhancing the toxicity of methotrexate .
None(e1,e2)	0	12	ethanol / nutrition / herb interactions : food : cns effects of caffeine may be enhanced if combination hormonal contraceptives are used concurrently with caffeine .
effect(e1,e2)	8	11	marked symptomatic orthostatic hypotension has been reported when calcium_channel_blockers and organic nitrates were used in combination .
None(e1,e2)	19	35	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	4	15	antacids , kaolin-pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
mechanism(e1,e2)	4	22	urinary acidifying agents ( ammonium_chloride , sodium acid phosphate , etc . ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .
None(e1,e2)	52	54	paroxetine : coadministration of once daily doses of aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation , with paroxetine 20 mg once daily , resulted in a decrease in auc by approximately 25 % and cmax , by approximately 20 % of both aprepitant and paroxetine .
None(e1,e2)	2	14	hydrochlorothiazide ( hctz ) alone or in combination with triamterene : concomitant use of hctz alone or in combination with triamterene is contraindicated .
effect(e1,e2)	6	20	given the primary cns effects of clozapine , caution is advised in using it concomitantly with other cns-active drugs or alcohol .
None(e1,e2)	31	36	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	0	8	cimetidine : cimetidine can inhibit the metabolism of chloroquine , increasing its plasma level .
None(e1,e2)	13	30	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	8	10	these medications have included heparin , warfarin , beta-adrenergic_receptor_blockers , calcium_channel_antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	19	38	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
mechanism(e1,e2)	8	24	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
None(e1,e2)	31	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	6	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv_protease_inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	13	34	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium_hydroxide s ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	8	12	oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic_agents , eg , tolbutamide and chlorpropamide , by inhibiting their metabolism in the liver .
None(e1,e2)	36	51	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	7	10	synergism between xanthine bronchodilators ( e.g. , theophylline ) , ephedrine , and other sympathomimetic bronchodilators has been reported .
None(e1,e2)	0	6	antibiotics ( e.g. , erythromycin , trimethoprim and sulfamethoxazole , amoxicillin ) .
None(e1,e2)	15	29	in general , these are drugs that have one or more pharmacologic activities similar to bepridil_hydrochloride , including anti-arrhythmic agents such as quinidine and procainamide , cardiac glycosides and tricyclic_anti-depressants .
None(e1,e2)	0	17	antacids or h 2 -receptor antagonists : the effect of increased gastric ph on the bioavailability of ceftibuten was evaluated in 18 healthy adult volunteers .
None(e1,e2)	22	24	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	18	32	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide_diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin_g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	41	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	23	26	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	8	19	antiretroviral agents : no drug interactions with other antiretroviral_medications have been identified that would warrant alteration of either the enfuvirtide dose or the dose of the other antiretroviral medication .
mechanism(e1,e2)	6	21	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	3	9	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
advise(e1,e2)	5	7	consequently , the combination of methotrexate with acitretin is also contraindicated .
mechanism(e1,e2)	4	18	or with multivitamins containing zinc may substantially interfere with drug absorption and result in insufficient plasma and tissue quinolone concentrations .
mechanism(e1,e2)	16	36	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	5	20	patients receiving both indomethacin and furosemide should be observed closely to determine if the desired diuretic and/or antihypertensive effect of furosemide is achieved .
None(e1,e2)	0	5	aspirin : as with other nsaids , concomitant administration of ponstel and aspirin is not generally recommended because of the potential of increased adverse effects .
None(e1,e2)	21	41	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	34	36	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	0	7	erythromycin : in hypercholesterolemic patients , steady-state cerivastatin auc and cmax increased approximately 50 % and 24 % respectively after 10 days with co-administration of erythromycin , a known inhibitor of cytochrome p450 3a4 .
advise(e1,e2)	7	12	methotrexate : caution should be used if diflunisal is administered concomitantly with methotrexate .
None(e1,e2)	26	37	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin_analog ( e.g. , octreotide ) , sulfonamide antibiotics .
mechanism(e1,e2)	0	26	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	29	31	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	18	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	16	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	78	119	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	22	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	96	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	13	21	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	12	26	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
advise(e1,e2)	14	24	studies with ace inhibitors in combination with diuretics indicate that the dose of the ace_inhibitor can be reduced when it is given with a diuretic .
mechanism(e1,e2)	0	6	enoxacin interferes with the metabolism of theophylline resulting in a 42 % to 74 % dose-related decrease in theophylline clearance and a subsequent 260 % to 350 % increase in serum theophylline levels .
None(e1,e2)	58	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
advise(e1,e2)	9	13	therefore , extreme caution should be exercised when administering dopamine_hcl to patients receiving cyclopropane or halogenated hydrocarbon anesthetics .
None(e1,e2)	7	17	ethanol : clinical evidence has shown that etretinate can be formed with concurrent ingestion of acitretin and ethanol .
None(e1,e2)	0	9	lithium : diclofenac decreases lithium renal clearance and increases lithium plasma levels .
effect(e1,e2)	4	28	in patients receiving nonselective monoamine_oxidase_inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
effect(e1,e2)	5	15	when other antiplatelet agents or anticoagulants are used concomitantly , there is the potential for flolan to increase the risk of bleeding .
advise(e1,e2)	2	7	patients receiving flurbiprofen and furosemide or other diuretics should be observed closely to determine if the desired effect is obtained .
None(e1,e2)	28	38	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	13	17	compounds in these categories result in a decreased efficacy of bromocriptine mesylate : phenothiazines , haloperidol , metoclopramide , pimozide .
None(e1,e2)	27	31	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
None(e1,e2)	31	77	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	102	130	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	34	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	0	32	paroxetine ( 20 mg qd ) increased the concentration of duloxetine ( 40 mg qd ) by about 60 % , and greater degrees of inhibition are expected with higher doses of paroxetine .
None(e1,e2)	61	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	17	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	2	19	if replacing clonidine by beta-blocker therapy , the introduction of beta blockers should be delayed for several days after clonidine administration has stopped .
effect(e1,e2)	11	46	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal_muscle_relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	16	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	0	22	betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 the effect of alternate-day administration of 0.25 mg of betaseron on drug metabolism in ms patients is unknown .
None(e1,e2)	8	12	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	49	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	31	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	1	7	plasma valproate concentration should be monitored when isoniazid and valproate are co administered , and appropriate dosage adjustments of valproate should be made .
None(e1,e2)	58	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	29	54	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
mechanism(e1,e2)	3	10	alprazolam : when fluvoxamine_maleate ( 100 mg qd ) and alprazolam ( 1 mg q.d . were co-administered to steady state , plasma concentration and other pharmacokinetics parameters ( auc , cmax , t1/2 , ) of alprazolam were approximately twice those observed when alprazolam was administered alone ;
None(e1,e2)	35	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	37	40	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
effect(e1,e2)	37	50	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	0	8	olanzapine : coadministration of eszopiclone 3 mg and olanzapine 10 mg produced a decrease in dsst scores .
mechanism(e1,e2)	23	42	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	38	40	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	59	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	15	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	22	35	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	49	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	1	13	- antidiabetic_drugs : ( oral agents and insulin ) dosage adjustment of the antidiabetic_drug may be required
None(e1,e2)	9	27	effects of other antiepilepsy drugs ( aeds ) on gabitril : carbamazepine : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking carbamazepine with or without other enzyme- inducing aeds .
None(e1,e2)	76	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	11	use of prinivil with potassium-sparing diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .
None(e1,e2)	3	30	interactions with other antiretroviral_drugs : significant decreases in the auc of delavirdine ( 20 % ) and indinavir ( 84 % ) occurred following simultaneous administration of these agents with videx .
None(e1,e2)	19	51	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	4	aspirin , warfarin , heparin , nsaids
None(e1,e2)	15	26	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	35	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	22	33	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	11	33	may interact anticoagulants ( altered hypo-prothrombinemic effect ) , barbiturates , rifampin and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of diethylstilbestrol ) , corticosteroids ( increased effect of corticosteroids ) .
None(e1,e2)	44	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	16	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
None(e1,e2)	41	66	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	4	17	these increased exposures of norethindrone and ethinyl estradiol should be taken into consideration when selecting an oral contraceptive for women taking valdecoxib .
None(e1,e2)	81	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	11	22	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	10	30	while it is not known whether this interaction occurs with fibrates other than gemfibrozil , myopathy and rhabdomyolysis have occasionally been associated with the use of fibrates alone , including clofibrate .
None(e1,e2)	0	17	adrenergic_agents : some individuals receiving zyvox may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic_agents , vasopressor or dopaminergic agents .
None(e1,e2)	61	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	0	18	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
mechanism(e1,e2)	0	3	fluvoxamine increased mean alosetron plasma concentrations ( auc ) approximately 6-fold and prolonged the half-life by approximately 3-fold .
mechanism(e1,e2)	2	4	patients taking disopyramide_phosphate and erythromycin concomitantly may develop increased serum concentrations of disopyramide resulting in excessive widening of the qrs complex and/or prolongation of the q-t interval .
None(e1,e2)	34	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	10	23	although these results do not indicate a significant interaction between toradol and warfarin or heparin , the administration of toradol to patients taking anticoagulants should be done extremely cautiously , and patients should be closely monitored .
None(e1,e2)	0	2	probenecid : probenecid , a renal tubular secretion blocking agent , administered at a dose of 500 mg four times a day , did not change the pharmacokinetics of levetiracetam 1000 mg twice daily .
None(e1,e2)	1	11	- vitamin_k ( e.g. , aquamephyton , synkayvite ) use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood
None(e1,e2)	29	33	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic_acid has been reported to both increase and decrease ethosuximide levels ) .
None(e1,e2)	24	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	75	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	27	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	10	13	acute symptoms should be treated with a short-acting , inhaled beta2-agonist such as salbutamol ( the physician should provide the patient with such medication and instruct the patient in how it should be used ) .
None(e1,e2)	23	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	25	36	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin 500 mg bid , verapamil 240 mg qd , saquinavir 1200 mg tid , fluconazole 200 mg qd ) resulted in increases in cmax of eplerenone ranging from 1.4- to 1.6- fold and auc from 2.0- to 2.9- fold .
None(e1,e2)	51	54	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
mechanism(e1,e2)	16	32	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	9	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
effect(e1,e2)	11	51	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	14	30	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	31	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	31	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	19	plasma valproate concentration should be monitored when isoniazid and valproate are co administered , and appropriate dosage adjustments of valproate should be made .
None(e1,e2)	23	56	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	29	31	although the specific drug interaction was not studied in a clinical trial , there have been more than 50 episodes of concomitant use of antifibrinolytic therapies ( i.e. , tranexamic_acid , aminocaproic_acid ) and novoseven .
None(e1,e2)	45	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	2	nafazodone , fluvoxamine , cimetidine ( consider xanax dose reduction ) .
None(e1,e2)	0	2	amiodarone : amiodarone therapy alone can cause hypothyroidism or hyperthyroidism .
advise(e1,e2)	21	26	because there is a theoretical basis that these effects may be additive , use of ergotamine-containing or ergot-type medications ( like dihydroergotamine or methysergide ) and axert within 24 hours of each other should be avoided .
None(e1,e2)	24	34	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
advise(e1,e2)	4	10	it is recommended that buspirone_hydrochloride not be used concomitantly with mao_inhibitors because the effects of concomitant administration of buspirone hcl with most other psychotropic drugs have not been studied , the concomitant use of buspirone hcl with other cns-active drugs should be approached with caution .
mechanism(e1,e2)	2	9	selegiline : combination_hormonal_contraceptives may increase the serum concentration of selegiline .
None(e1,e2)	42	51	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	31	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	39	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	36	42	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	17	20	because there is a theoretical basis that these effects may be additive , use of ergotamine-containing or ergot-type_medications ( like dihydroergotamine or methysergide ) and naratriptan within 24 hours is contraindicated .
None(e1,e2)	16	26	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	72	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	35	venlafaxine : coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine er ( extended release ) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine .
None(e1,e2)	2	18	- a diuretic ( water pill ) such as hydrochlorothiazide ( hctz , hydrodiuril ) , chlorothiazide ( diuril ) , and others ;
None(e1,e2)	0	4	non-steroidal_anti-inflammatory_drugs ( but not aspirin ) : these drugs in combination with very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies .
None(e1,e2)	10	24	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	0	41	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	27	39	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	32	43	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	94	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	22	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	11	21	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine -containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	59	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	4	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	41	96	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	11	42	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
effect(e1,e2)	39	50	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	56	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	16	32	antifungals : in vitro and/or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	6	10	therefore , administration of quinolones with antacids containing calcium , magnesium , or aluminum ;
None(e1,e2)	0	26	theophylline : the effect of steady-state fluvoxamine l50 mg bid on the pharmacokinetics of a single dose of theophylline ( 375 mg ) as 442 mg aminophylline was evaluated in 12 healthy non-smoking , male volunteers .
None(e1,e2)	44	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	13	uricosuric_agents : aspirin may decrease the effects of probenecid , sulfinpyrazone , and phenylbutazone .
None(e1,e2)	37	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	100	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	8	concomitant administration with racemic citalopram citalopram - since escitalopram is the active isomer of racemic citalopram ( celexa ) , the two agents should not be coadministered .
mechanism(e1,e2)	19	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	16	33	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone_classes_of_antipsychotic_agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
advise(e1,e2)	6	19	consequently , it is recommended that fluvoxamine not be used in combination with either terbinafine , astemizole , or cisapride .
None(e1,e2)	41	63	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	24	32	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
mechanism(e1,e2)	0	20	antacids , kaolin-pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	89	112	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	7	coadministration of rifampin with diltiazem lowered the diltiazem plasma concentrations to undetectable levels .
effect(e1,e2)	7	21	magnesium : magnesium-containing preparations ( eg , antacids ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin_d by patients on chronic renal dialysis .
int(e1,e2)	11	21	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
advise(e1,e2)	4	7	if concomitant treatment with axert and an ssri is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	28	143	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	100	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	26	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin_b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	31	51	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	32	34	hormonal contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive ortho-novum produced average decreases of norethindrone and ethinyl_estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	7	11	- a sulfa-based drug such as sulfamethoxazole- trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	74	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	22	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	24	cytochrome p-450 inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately 30 % decrease in plasma clonazepam levels .
None(e1,e2)	3	12	cyp2d6 inhibitors - atomoxetine is primarily metabolized by the cyp2d6 pathway to 4-hydroxyatomoxetine .
None(e1,e2)	0	14	mao_inhibitors : maoi antidepressants , as well as a metabolite of furazolidone , slow amphetamine metabolism .
None(e1,e2)	0	5	valproate : the addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics , but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8 % , which resulted in an increase of approximately 40 % in the free tiagabine concentration .
None(e1,e2)	51	53	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
effect(e1,e2)	18	48	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
None(e1,e2)	4	9	vitamin a and oral retinoids : concomitant administration of vitamin_a and/or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis a .
effect(e1,e2)	0	11	fluothane may augment the hypotension caused by the ganglionic-blocking effect of tubocurarine .
effect(e1,e2)	1	20	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co-administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
None(e1,e2)	24	32	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	9	13	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
None(e1,e2)	144	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	12	the pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide
None(e1,e2)	4	27	although concomitant use of clozapine and carbamazepine is not recommended , it should be noted that discontinuation of concomitant carbamazepine administration may result in an increase in clozapine plasma levels .
None(e1,e2)	0	4	digoxin , methotrexate , cyclosporine : diclofenac , like other nsaids , may affect renal prostaglandins and increase the toxicity of certain drugs .
None(e1,e2)	71	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	22	43	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate_hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic_antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	6	11	antacid : the effect of an aluminum_hydroxide - and magnesium hydroxide-containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
mechanism(e1,e2)	0	11	erythromycin has been reported to decrease the clearance of triazolam and midazolam and thus may increase the pharmacologic effect of these benzodiazepines .
None(e1,e2)	26	28	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	4	7	butyrophenones ( such as haloperidol ) and phenothiazines can suppress the dopaminergic renal and mesenteric vasodilation induced with low dose dopamine infusion .
None(e1,e2)	9	13	therefore , interactions could occur following concomitant administration of psychotropic_drugs ( e.g. , narcotics , analgesics , antiemetics , sedatives , tranquilizers ) .
None(e1,e2)	12	27	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	26	43	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
None(e1,e2)	21	37	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	31	40	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal_muscle_relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	83	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	7	doxorubicin : doxorubicin caused a decrease in zalcitabine phosphorylation ( 50 % inhibition of total phosphate formation ) in u937/molt 4 cells .
None(e1,e2)	23	34	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot_alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
mechanism(e1,e2)	0	7	iron salts may reduce the bioavailability of carbidopa and levodopa .
None(e1,e2)	7	22	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac_tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
mechanism(e1,e2)	4	18	urinary alkalinizing agents ( acetazolamide , some thiazides ) increase the concentration of the non-ionized species of the amphetamine molecule , thereby decreasing urinary excretion .
None(e1,e2)	0	21	morphine : a literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by 44 % compared to gabapentin administered without morphine .
None(e1,e2)	4	13	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
effect(e1,e2)	8	66	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	39	43	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	21	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	46	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	21	35	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
mechanism(e1,e2)	12	14	chlorpropamide : chlorpropamides plasma half-life may be prolonged by allopurinol , since allopurinol and chlorpropamide may compete for excretion in the renal tubule .
mechanism(e1,e2)	0	24	nelfinavir steady-state cmax , a.c. and cmin were increased by 12 % , 15 % , and 14 % , respectively , by concomitant amprenavir .
None(e1,e2)	31	54	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic_acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	0	7	ascorbic_acid : doses of ascorbic acid ( vitamin_c ) 1 g/day have been reported to increase plasma concentration of synthetic estrogens by ~47 % , possibly by inhibiting conjugation ;
None(e1,e2)	17	21	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin_reuptake_inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	91	104	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	12	26	it is , however , possible that concomitant use of other known photosensitizing_agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	6	11	there is limited experience with concomitant antihypertensive_agents such as alpha-blockers , calcium_channel-blockers , ace inhibitors , and diuretics ( both thiazide-like and loop ) .
None(e1,e2)	0	5	potassium-sparing_diuretics such as spironolactone , triamterene , or amiloride , or potassium supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
None(e1,e2)	15	16	non-steroidal anti-inflammatory agents : seizures have been reported in patients taking enoxacin concomitantly with the nonsteroidal_anti-inflammatory_drug fenbufen .
None(e1,e2)	12	20	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	107	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	41	44	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic_antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	69	74	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	35	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	5	warfarin : the effects of warfarin and nsaids on gi bleeding are synergistic , such that users of both drugs together have a risk of serious gi bleeding higher than users of either drug alone .
None(e1,e2)	78	90	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	18	22	these six volunteers received terfenadine alone ( 60 mg twice daily ) for 8 days , followed by terfenadine in combination with dirithromycin ( 500 mg once daily ) for 10 days .
None(e1,e2)	3	20	prior administration of succinylcholine had no effect on the duration of neuromuscular block following initial or maintenance bolus doses of nimbex .
None(e1,e2)	41	61	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	8	21	notably , systemic exposure ( auc0-12 ) of dapsone_hydroxylamine ( dha ) was more than doubled in the presence of tmp/ smx .
effect(e1,e2)	4	20	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
None(e1,e2)	0	16	psychoactive_drugs : hallucinations have been reported when toradol was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .
None(e1,e2)	7	29	warfarin : co- administration of warfarin and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor vii when compared to co-administration of warfarin and placebo .
None(e1,e2)	8	10	administration of doxapram to patients who are receiving sympathomimetic or monoamine_oxidase_inhibiting_drugs may result in an additive pressor effect .
None(e1,e2)	27	33	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
mechanism(e1,e2)	2	8	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
effect(e1,e2)	0	32	selective_serotonin_reuptake_inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1_agonists .
None(e1,e2)	74	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	22	26	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf_blocking_agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	12	14	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	5	22	concomitant administration of naproxen and aspirin is not recommended because naproxen is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations and peak plasma levels .
None(e1,e2)	17	31	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	5	26	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	9	17	use of prinivil with potassium-sparing diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .
None(e1,e2)	8	14	other drugs : drugs such as quinidine , disopyramide , procainamide , phenothiazines , antihistamines , and tricyclic antidepressants may be associated with qt-interval prolongation and an increased risk of ventricular arrhythmia .
None(e1,e2)	42	50	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	4	23	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	94	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	7	29	therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( e.g . ketoconazole , ampicillin esters , iron salts , digoxin ) .
None(e1,e2)	9	26	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	0	17	bacteriostatic_antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
mechanism(e1,e2)	8	15	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide_diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	17	30	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	16	25	protease inhibitors : in vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	75	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	5	oral anticoagulants interaction studies with warfarin and acenocoumarol failed to identify any clinically important effects on the serum concentrations or clinical effects of these anticoagulants .
None(e1,e2)	30	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	13	drugs that may have their plasma concentration altered by dasatinib cyp3a4 substrates : dasatinib is a time-dependent inhibitor of cyp3a4 .
None(e1,e2)	2	18	concomitantly administered iron -fortified infant formula ( 2.2 mg elemental iron/6 oz ) has no significant effect on cefdinir pharmacokinetics .
None(e1,e2)	16	20	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	19	29	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	21	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	34	although it has not been established that there is an interaction between clozapine and benzodiazepines or other psychotropics , caution is advised when clozapine is initiated in patients taking a benzodiazepine or any other psychotropic_drug .
None(e1,e2)	41	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	22	28	ace inhibitors and angiotensin ii receptor antagonists ( hypertension ) - in clinical studies of patients with hypertension , the addition of inspra 50 to 100 mg to ace_inhibitors and angiotensin ii receptor antagonists increased mean serum potassium slightly ( about 0.09-0.13 meq/l ) .
None(e1,e2)	13	30	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	2	phenytoin / phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism .
None(e1,e2)	15	39	oral contraceptive : based on auc and half-life , multiple-dose pharmacokinetic profiles of norethindrone and ethinyl_estradiol following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl estradiol were similar with and without coadministration of gabapentin ( 400 mg tid ;
advise(e1,e2)	14	19	nevertheless , the prothrombin time or other suitable coagulation test should be monitored when warfarin or its derivatives and enoxacin are given concomitantly .
None(e1,e2)	0	6	colestipol -concomitant intake of colestipol and vitamin_k may reduce the absorption of vitamin k .
None(e1,e2)	4	14	estrogens , including oral contraceptives : estrogens may decrease the hepatic metabolism of certain corticosteroids , thereby increasing their effect .
None(e1,e2)	12	21	antihypertensives : amiodarone should be used with caution in patients receiving - receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	4	9	anticoagulants : potentiation of warfarin -type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
None(e1,e2)	11	19	in vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the pk properties of anagrelide , nor does anagrelide affect the pk properties of digoxin or warfarin .
None(e1,e2)	31	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	18	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
None(e1,e2)	12	14	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	18	28	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
mechanism(e1,e2)	18	57	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	22	in patients given very high doses ( 3900 mg ) of aspirin daily , increases in serum salicylate levels were seen when nizatidine , 150 mg b.i.d. , was administered concurrently .
None(e1,e2)	83	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	46	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	4	8	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	18	25	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety_agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	26	28	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
int(e1,e2)	0	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	58	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
mechanism(e1,e2)	2	5	coadministration of itraconazole with oral midazolam or triazolam has resulted in elevated plasma concentrations of the latter two drugs .
None(e1,e2)	85	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	15	19	the following drugs have been coadministered with kerlone and have not altered its pharmacokinetics : cimetidine , nifedipine , chlorthalidone , and hydrochlorothiazide .
None(e1,e2)	0	10	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
advise(e1,e2)	0	19	nabilone should be administered with caution to patients who are taking other psychoactive drugs or cns depressants , including alcohol , barbiturates and narcotic analgesics , or to those with a history of psychiatric disorder ( including manic-depressive illness and schizophrenia ) .
None(e1,e2)	7	9	in another study with intravenous administration of midazolam , aprepitant was given as 125 mg on day 1 and 80 mg/day on days 2 and 3 , and midazolam 2 mg iv was given prior to the administration of the 3-day regimen of aprepitant and on days 4 , 8 , and 15 .
None(e1,e2)	22	32	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	12	15	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
None(e1,e2)	19	119	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	12	antacids ( aluminum- or magnesium -containing ) : concomitant administration of 300-mg cefdinir capsules with 30 ml maalox tc suspension reduces the rate ( cmax ) and extent ( auc ) of absorption by approximately 40 % .
None(e1,e2)	7	20	coadministration of oral contraceptives , diazepam , phenytoin , or quinidine did not seem to change the pharmacokinetic profile of esomeprazole .
None(e1,e2)	2	28	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	34	54	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	24	43	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	17	29	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
effect(e1,e2)	0	23	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	5	7	antacids : concomitant administration of magnesium_hydroxide and aluminum_hydroxide does not interfere with the rate or extent of the absorption of ketoprofen administered as orudis .
None(e1,e2)	13	32	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
mechanism(e1,e2)	2	10	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin 500 mg bid , verapamil 240 mg qd , saquinavir 1200 mg tid , fluconazole 200 mg qd ) resulted in increases in cmax of eplerenone ranging from 1.4- to 1.6- fold and auc from 2.0- to 2.9- fold .
None(e1,e2)	27	62	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	5	15	digoxin : concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels .
None(e1,e2)	28	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	41	54	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
effect(e1,e2)	3	14	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
None(e1,e2)	31	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	13	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	10	28	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	18	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	3	11	plasma concentrations of quinolone_antibiotics are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	13	32	the principal drugs given ( number of patients in parentheses ) were : cardiac_glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	1	29	- non-steroidal_anti-inflammatory_drugs : in some patients , the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium-sparing and thiazide_diuretics .
effect(e1,e2)	1	4	taking amyl_nitrite after drinking alcohol may worsen side effects and may cause severe hypotension and cardiovascular collapse .
effect(e1,e2)	0	14	quinolones , including nalidixic acid , may enhance the effects of the oral anticoagulant warfarin or its derivatives .
int(e1,e2)	0	20	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	47	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic_acid , and acetaminophen .
None(e1,e2)	20	31	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
advise(e1,e2)	4	9	- when bezalip or bezalip_retard is used concurrently with anion-exchange_resins ( e.g . cholestryramine ) , an interval of at least 2 hours should be maintained between the two medicines , since the absorption of bezalip or bezalip retard is impaired
None(e1,e2)	33	35	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	4	antibiotics ( ampicillin , tetracycline ) : pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these antibiotics on plasma concentrations of synthetic steroids .
None(e1,e2)	6	45	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	96	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	38	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac_glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	9	11	drug-drug interactions between keppra and other antiepileptic drugs ( aeds ) phenytoin keppra ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .
None(e1,e2)	36	48	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	42	44	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	19	45	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle_relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	6	13	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	12	18	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	71	117	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	75	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	19	verapamil produced a decrease of 20 % [ 90 % ci : 18-27 ] of the plasma levels of mhd .
None(e1,e2)	51	56	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	24	32	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	57	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	31	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	17	in rheumatoid arthritis , concomitant medications besides mtx were nonsteroidal anti-inflammatory agents , folic_acid , corticosteroids and/or narcotics .
None(e1,e2)	21	31	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type_anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	19	21	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	25	58	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	27	44	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	11	28	antacids : concomitant administration of antacids containing magnesium or aluminum with videx chewable/dispersible buffered tablets or pediatric powder for oral solution may potentiate adverse events associated with the antacid components .
None(e1,e2)	28	34	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	22	30	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
None(e1,e2)	0	3	sedatives /hypnotics : triazolam , midazolam contraindicated due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression .
None(e1,e2)	0	2	selective_serotonin_reuptake_inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	2	9	nevirapine and rifampin should not beadministered concomitantly becausedecreases in nevirapine plasmaconcentrations may reduce the efficacy ofthe drug .
None(e1,e2)	28	130	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	26	in a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram , absorption of the proton_pump_inhibitors was delayed and their bioavailability was reduced by 17 % and 16 % , respectively , when administered concomitantly with sucralfate .
None(e1,e2)	28	51	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	13	21	- a sulfa-based drug such as sulfamethoxazole-trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	23	27	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	3	8	hypotension patients on diuretic therapy : patients on diuretics and especially those in whom diuretic therapy was recently instituted , as well as those on severe dietary salt restriction or dialysis , may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril .
None(e1,e2)	3	23	oral hypoglycemics : bepridil has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral hypoglycemic agents .
None(e1,e2)	59	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	17	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	0	44	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	22	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	69	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	75	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	13	concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone .
None(e1,e2)	32	63	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	52	87	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	27	29	a drug-drug interaction study evaluated the effect of the use of aczone gel , 5 % , in combination with double strength ( 160 mg/800 mg ) trimethoprim / sulfamethoxazole ( tmp/smx ) .
effect(e1,e2)	0	13	ethoxzolamide may increase the action of tricyclics , amphetamines , procainamide , and quinidine .
None(e1,e2)	26	69	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	26	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	28	42	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	21	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	28	38	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	10	18	since bacteriostatic drugs may interfere with the bactericidal action of penicillin , it is advisable to avoid giving tetracyclines in conjunction with penicillin .
None(e1,e2)	21	23	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis_preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
effect(e1,e2)	14	16	there have been reports of theophylline-related side effects in patients on concomitant therapy with quinolones and theophylline .
None(e1,e2)	75	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	11	37	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	10	17	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	1	11	other antiarrhythmic_drugs ( eg , quinidine , procainamide , lidocaine , propranolol ) have occasionally been used concurrently with norpace .
None(e1,e2)	20	58	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic_agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
None(e1,e2)	22	40	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	4	16	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	42	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	36	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	0	5	fluothane augments the action of non-depolarising_muscle_relaxant s and the muscle relaxant effects of aminoglycosides .
None(e1,e2)	20	22	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	21	36	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace_inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	10	30	toxicology studies of heroin-related deaths reveal frequent involvement of other central_nervous_system_depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	8	18	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc . ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
None(e1,e2)	12	21	furosemide : in normal volunteers , the concomitant administration of diflunisal and furosemide had no effect on the diuretic activity of furosemide .
None(e1,e2)	25	27	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
mechanism(e1,e2)	16	21	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	75	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	10	interactions for vitamin_b3 ( niacin ) : antihypertensive therapy : nicotinic_acid may potentiate the effects of ganglionic blocking agents and vasoactive drugs resulting in postural hypotension .
None(e1,e2)	1	5	serum theophylline concentrations increase when grepafloxacin is initiated in a patient maintained on theophylline .
None(e1,e2)	15	19	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type_1c_antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	9	12	if desipramine hydrochloride is to be combined with other psychotropic_agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	6	38	because changes in glucose concentrations with valdecoxib coadministration were within the normal variability and individual glucose concentrations were above or near 70 mg/dl , dose adjustment for glyburide ( 5 mg qd and 10 mg bid ) with valdecoxib coadministration ( up to 40 mg qd ) is not indicated .
None(e1,e2)	7	11	auranofin should not be used together with penicillamine ( depen , cuprimine ) , another arthritis medication .
None(e1,e2)	13	15	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine_oxidase_inhibitors , tricyclic_antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
None(e1,e2)	26	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	24	fifteen to 30 minutes of exposure to 1.25 mac isoflurane or enflurane had minimal effects on the duration of action of initial doses of nimbex and therefore , no adjustment to the initial dose should be necessary when nimbex is administered shortly after initiation of volatile agents .
None(e1,e2)	11	32	no depressant effect on blood levels in humans was noted when colestipol_hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	8	10	no significant interactions were found between nisoldipine and warfarin or digoxin .
effect(e1,e2)	5	20	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin_sodium .
None(e1,e2)	41	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	8	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc . ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
None(e1,e2)	2	12	cns-active drugs ethanol : sonata 10 mg potentiated the cns-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test ( dsst ) , symbol copying test , and the variability component of the divided attention test for 2.5 hours after ethanol administration .
None(e1,e2)	0	21	coumarin_anticoagulants altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative anticoagulants such as warfarin and phenprocoumon .
None(e1,e2)	26	33	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	38	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux_sodium .
None(e1,e2)	54	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	22	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	19	22	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	0	2	potassium-sparing_diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	14	31	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	13	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	0	3	oxytocin or other oxytocics ( concurrent use with dinoprost may result in uterine hypertonus , possibly causing uterine rupture or cervical laceration , especially in the absence of adequate cervical dilatation ;
None(e1,e2)	7	14	loop diuretics : furosemide administered concurrently with captopril does not alter the pharmacokinetics of captopril in renally impaired hypertensive patients .
None(e1,e2)	12	21	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	2	diuretics : diclofenac and other nsaids can inhibit the activity of diuretics .
int(e1,e2)	26	28	although it has not been definitively demonstrated that fluvoxamine is a potent iiia4 inhibitor , it is likely to be , given the substantial interaction of fluvoxamine with alprazolam .
None(e1,e2)	38	40	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 3a4 , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
None(e1,e2)	4	8	fluoxetine , ocs , sertraline , diltiazem , macrolide_antibiotics ( exercise caution ) .
None(e1,e2)	57	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	27	however , in a well-controlled study of patients with lymphoma on combination therapy , allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide , doxorubicin , bleomycin , procarbazine and/or mechlorethamine .
effect(e1,e2)	14	28	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
mechanism(e1,e2)	18	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	10	inhibition of renal lithium clearance leading to increases in plasma lithium concentrations has also been reported .
None(e1,e2)	5	10	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	111	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	11	16	substances that are potent inhibitors of cyp3a4 activity ( eg , ketoconazole and itraconazole ) decrease gefitinib metabolism and increase gefitinib plasma concentrations .
None(e1,e2)	25	41	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	3	11	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	42	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	64	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	8	46	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	12	26	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
effect(e1,e2)	31	33	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	27	32	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	0	5	propanolol : the pharmacokinetics of almotriptan were not affected by coadministration of propranolol .
None(e1,e2)	11	33	these in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine , which may lead to a decreased antiretroviral effect of zalcitabine .
None(e1,e2)	12	20	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
effect(e1,e2)	0	12	amantadine , tricyclic antidepressants , and maois may increase anticholinergic effect of clidinium .
None(e1,e2)	6	13	antacid : the effect of an aluminum_hydroxide - and magnesium hydroxide-containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
None(e1,e2)	21	28	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	9	11	particular caution should be exercised in using preparations containing sulfur , resorcinol , or salicylic acid in combination with differin gel .
None(e1,e2)	37	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	42	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	4	cyclosporine , hexobarbital and phenytoin concentrations .
None(e1,e2)	7	22	the following drugs have been coadministered with kerlone and have not altered its pharmacokinetics : cimetidine , nifedipine , chlorthalidone , and hydrochlorothiazide .
None(e1,e2)	93	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	46	59	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	38	49	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	12	14	no clinically important pharmacokinetic interactions occurred when prinivil was used concomitantly with propranolol or hydrochlorothiazide .
mechanism(e1,e2)	11	30	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
None(e1,e2)	2	31	as most entacapone excretion is via the bile , caution should be exercised when drugs known to interfere with biliary excretion , glucuronidation , and intestinal beta-glucuronidase are given concurrently with entacapone .
None(e1,e2)	21	32	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	13	43	pimozide and celexa - in a controlled study , a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in qtc values of approximately 10 msec compared to pimozide given alone .
int(e1,e2)	4	10	possible drug interactions of humorsol with succinylcholine or with other anticholinesterase_agents .
None(e1,e2)	1	3	because heparin , aspirin , or activase may cause bleeding complications , careful monitoring for bleeding is advised , especially at arterial puncture sites .
advise(e1,e2)	0	12	netilmicin should not be administered concomitantly with potent loop diuretics such as furosemide and ethacrynic acid as the potential for ototoxicity is enhanced by the combination .
mechanism(e1,e2)	2	15	naproxen , naproxen_sodium and other nsaids have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly increasing the toxicity of methotrexate .
None(e1,e2)	14	28	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	37	51	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	13	19	the reddish color is due to the formation of a nonabsorbable complex between cefdinir or its breakdown products and iron in the gastrointestinal tract .
None(e1,e2)	28	30	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	0	31	antibiotics ( ampicillin , tetracycline ) : pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these antibiotics on plasma concentrations of synthetic_steroids .
None(e1,e2)	102	138	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	16	24	insulin : a clinical study in 6 insulin-dependent diabetic patients demonstrated no effect of extraneal on insulin absorption from the peritoneal cavity or on insulin s ability to control blood glucose when insulin was administered intraperitoneally with extraneal .
None(e1,e2)	14	24	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	24	26	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting_enzyme_inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	0	12	valproate : available data suggest that there is no significant effect of valproate on the clearance of felbatol at steady state , therefore , the addition of valproate is not expected to cause a clinically important effect on felbatol ( felbamate ) plasma concentrations .
None(e1,e2)	16	18	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium_channel_blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	2	4	effect of probenecid : probenecid is a blocker of renal tubular secretion .
None(e1,e2)	24	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	10	warfarin : increased inr ( international normalized ratio ) when arava and warfarin were co-administered has been rarely reported .
None(e1,e2)	2	11	interaction of gabitril with other drugs : cimetidine : co-administration of cimetidine ( 800 mg/day ) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics .
effect(e1,e2)	31	33	although clinical studies have not established a cause and effect relationship , physicians should be aware that variable effects an blood coagulation have been reported very rarely in patients receiving oral anticoagulants and chlordiazepoxide .
None(e1,e2)	5	8	antidepressants ( tricyclic ) , atropine or other anticholinergic_agents , or digitalis glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	93	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	44	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	3	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	4	8	use of prinivil with potassium-sparing_diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .
mechanism(e1,e2)	36	64	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	10	21	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	9	28	interactions for vitamin d analogues ( vitamin d2 , vitamin_d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat_soluble_vitamins ;
None(e1,e2)	61	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	20	22	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
None(e1,e2)	0	2	lithium : ibuprofen produced an elevation of plasma lithium levels and a reduction in renal lithium clearance in a study of eleven normal volunteers .
int(e1,e2)	7	27	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	16	21	coumarin anticoagulants altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative_anticoagulants such as warfarin and phenprocoumon .
None(e1,e2)	28	62	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	48	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	79	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	33	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	2	4	interaction between lomefloxacin and cyclosporine has not been studied .
None(e1,e2)	9	29	in eight hiv-infected patients , the steady-state auc of ciprofloxacin was decreased an average of 26 % ( 95 % ci = 14 % , 37 % ) when ciprofloxacin was administered 2 hours prior to a marketed chewable/dispersible tablet formulation of videx .
None(e1,e2)	60	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	10	20	bosentan is also expected to reduce plasma concentrations of other statins that have significant metabolism by cyp3a4 , such as lovastatin and atorvastatin .
None(e1,e2)	53	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	18	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	24	anticholinergic_agents : although ipratropium bromide is minimally absorbed into the systemic circulation , there is some potential for an additive interaction with concomitantly used anticholinergic_medications .
None(e1,e2)	40	45	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
mechanism(e1,e2)	13	19	steroids enhance the renal toxicity of edetate calcium disodium in animals . 7 edetate_calcium_disodium interferes with the action of zinc_insulin preparations by chelating the zinc . 7
None(e1,e2)	38	44	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	18	26	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	29	58	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	12	14	there is limited experience with concomitant antihypertensive agents such as alpha-blockers , calcium_channel-blockers , ace_inhibitors , and diuretics ( both thiazide-like and loop ) .
None(e1,e2)	11	15	dostinex should not be administered concurrently with d2-antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
None(e1,e2)	4	25	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
effect(e1,e2)	3	8	oxytocin or other oxytocics ( concurrent use with dinoprost may result in uterine hypertonus , possibly causing uterine rupture or cervical laceration , especially in the absence of adequate cervical dilatation ;
None(e1,e2)	24	26	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	2	7	antacids , kaolin -pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	6	30	concomitant use of agents in the tricyclic_antidepressant_class ( which includes anafranil ) with drugs that can inhibit cytochrome p450 2d6 may require lower doses than usually prescribed for either the tricyclic_antidepressant_agent or the other drug .
None(e1,e2)	10	32	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	0	9	caverject : the potential for pharmacokinetic drug-drug interactions between alprostadil and other agents has not been formally studied .
None(e1,e2)	6	14	other drugs : drugs such as quinidine , disopyramide , procainamide , phenothiazines , antihistamines , and tricyclic antidepressants may be associated with qt-interval prolongation and an increased risk of ventricular arrhythmia .
None(e1,e2)	38	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	31	41	although no clinical studies have been conducted , it is likely that the metabolism of levobupivacaine may be affected by the known cyp3a4 inducers ( such as phenytoin , phenobarbital , rifampin ) , cyp3a4 inhibitors ( azole antimycotics e.g. , ketoconazole ;
None(e1,e2)	45	62	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	10	13	reports suggest that nsaids may diminish the antihypertensive effect of ace_inhibitors , including lisinopril .
None(e1,e2)	17	29	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	27	32	therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( e.g . ketoconazole , ampicillin esters , iron salts , digoxin ) .
None(e1,e2)	16	20	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	85	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	30	33	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	94	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	30	43	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	1	5	- phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin
None(e1,e2)	87	95	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	49	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	4	9	benzthiazide may interact with alcohol , blood thinners , decongestant_drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
advise(e1,e2)	17	21	anticoagulant therapy should be monitored , particularly during the first few weeks , after initiating therapy with bextra in patients receiving warfarin or similar agents .
None(e1,e2)	0	12	antidepressants : in vitro data indicate that nefazodone inhibits the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	4	16	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium_channel_blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
mechanism(e1,e2)	10	21	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	0	13	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	11	25	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	9	25	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	21	24	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	16	41	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure_agonist_opioid_analgesic such as levo-dromoran .
None(e1,e2)	13	15	co-medications that induce cyp3a4 ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , phenobarbital or st .
None(e1,e2)	9	21	rifabutin , another rifamycin , is structurally similar to rifampin and may possibly have some of the same drug interactions as rifampin .
None(e1,e2)	9	20	iodine or iodine excess may decrease the effect of carbimazole , and an iodine deficiency can increase the effect of carbimazole .
None(e1,e2)	0	15	curariform_muscle_relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
effect(e1,e2)	4	6	concurrent administration of low-dose dopamine_hcl and diuretic_agents may produce an additive or potentiating effect on urine flow .
None(e1,e2)	6	8	urinary acidifying agents these agents ( ammonium_chloride , sodium_acid_phosphate , etc . ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .
None(e1,e2)	33	56	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout_drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	30	33	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	9	14	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine_derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
None(e1,e2)	3	5	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
mechanism(e1,e2)	6	26	plasma levels of several closely related tricyclic_antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	4	24	other drug interactions oral contraceptives keppra ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl_estradiol and 0.15 mg levonorgestrel , or of the luteinizing hormone and progesterone levels , indicating that impairment of contraceptive efficacy is unlikely .
None(e1,e2)	32	36	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	3	7	immunosuppressive drugs , fibric_acid_derivatives , niacin ( nicotinic_acid , erythromycin , azole antifungals : skeletal muscle .
None(e1,e2)	39	52	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	2	15	chlorpropamide : chlorpropamide s plasma half-life may be prolonged by allopurinol , since allopurinol and chlorpropamide may compete for excretion in the renal tubule .
None(e1,e2)	76	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	12	antidepressants ( tricyclic ) , atropine or other anticholinergic agents , or digitalis_glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	22	26	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
None(e1,e2)	0	5	meclofenamate_sodium does not affect serum salicylate levels .
None(e1,e2)	43	56	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2_antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	10	25	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin 500 mg bid , verapamil 240 mg qd , saquinavir 1200 mg tid , fluconazole 200 mg qd ) resulted in increases in cmax of eplerenone ranging from 1.4- to 1.6- fold and auc from 2.0- to 2.9- fold .
None(e1,e2)	96	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	32	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
effect(e1,e2)	8	29	cytotoxic agents : enhanced bone marrow suppression by cyclophosphamide and other cytotoxic agents has been reported among patients with neoplastic disease , except leukemia , in the presence of allopurinol .
None(e1,e2)	37	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	20	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac_tromethamine protein binding .
None(e1,e2)	27	35	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	12	33	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin_d .
None(e1,e2)	0	17	calcium_channel_blockers : isolated cases of conduction disturbance ( rarely with hemodynamic compromise ) have been observed when coreg is co-administered with diltiazem .
None(e1,e2)	96	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	42	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	20	39	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	63	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	27	31	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
effect(e1,e2)	6	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	62	113	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	1	14	micro-dosed progesterone preparations : micro-dosed progesterone preparations ( minipills that do not contain an estrogen ) may be an inadequate method of contraception during accutane therapy .
None(e1,e2)	51	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	9	13	also , concomitant administration of quinolones with products containing iron , multivitamins containing zinc , or videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution may result in low urine levels .
None(e1,e2)	6	25	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	17	22	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	2	27	coadministration of amprenavir and methadone as compared to a non-matched historicalcontrol group resulted in a 30 % , 27 % , and 25 % decrease in serum amprenavir auc , cmax , andcmin , respectively .
None(e1,e2)	55	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	76	80	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	24	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
None(e1,e2)	13	21	no dose adjustment is necessary when simulect is added to triple-immunosuppression regimens including cyclosporine , corticosteroids , and either azathioprine or mycophenolate_mofetil .
None(e1,e2)	10	32	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
None(e1,e2)	25	45	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	12	14	amiodarone or verapamil : the risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the hmg-coa reductase inhibitor class ( see warnings , myopathy/rhabdomyolysis ) .
None(e1,e2)	1	15	anesthetics/sedatives/ hypnotics /opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	2	21	co-administration of naltrexone with acamprosate produced a 25 % increase in auc and a 33 % increase in the cmax of acamprosate .
None(e1,e2)	52	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	11	23	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	33	49	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	1	24	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	12	14	no interactions have been observed between nizatidine and theophylline , chlordiazepoxide , lorazepam , lidocaine , phenytoin , and warfarin .
None(e1,e2)	40	42	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	16	33	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	35	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	24	28	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	34	36	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	33	79	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta_blockers ( 10 ) .
effect(e1,e2)	8	13	caffeine-related adverse effects have occurred in patients consuming caffeine while on therapy with enoxacin .
effect(e1,e2)	3	5	concomitant use of antihistamines with alcohol , tricyclic antidepressants , barbiturates , or other central nervous system depressants may have an additive effect .
effect(e1,e2)	14	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	14	37	the ratios of the aucs of unbound valproate to the aucs of the total valproate were 11.1 % , 13.0 % , and 11.5 % , with coadministration of 0 , 1200 , and 2400 mg/day of felbatol , respectively .
None(e1,e2)	116	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	40	42	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	20	23	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	0	6	anticonvulsants : carbamazepine , phenobarbital , phenytoin
None(e1,e2)	33	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	9	valproate : the addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics , but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8 % , which resulted in an increase of approximately 40 % in the free tiagabine concentration .
None(e1,e2)	8	35	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	9	15	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	62	115	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	7	patients receiving other narcotic_analgesic s , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	14	20	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic_amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
None(e1,e2)	1	12	organic nitrates - l-arginine supplements theoretically may potentiate the effects of organic nitrates if taken concomitantly .
mechanism(e1,e2)	6	8	co-treatment with the potent cyp3a4 inhibitor ketoconazole increases erlotinib auc by 2/3 .
None(e1,e2)	2	10	interactions for vitamin_d_analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	25	27	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	24	26	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central nervous system depressants such as narcotics , non-narcotic_analgesics and barbiturates .
None(e1,e2)	18	38	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	15	21	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	2	28	h2 blockers/ proton_pump_inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	38	40	as mhd , the predominant plasma substrate , is only a weak inducer of udp-glucuronyl transferase , it is unlikely to have an effect on drugs that are mainly eliminated by conjugation through udp-glucuronyl transferase ( e.g. , valproic_acid , lamotrigine ) .
None(e1,e2)	1	8	certain antibiotics , especially neomycin , streptomycin and kanamycin , have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block .
None(e1,e2)	17	27	approximately 2/3 of the patients in the phase 3 study received either prophylactic low dose heparin ( unfractionated_heparin up to 15,000 units/day ) or prophylactic doses of low_molecular_weight_heparins as indicated in the prescribing information for the specific products .
effect(e1,e2)	0	6	steroids enhance the renal toxicity of edetate_calcium_disodium in animals . 7 edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc . 7
None(e1,e2)	0	17	theophylline vioxx 12.5 , 25 , and 50 mg administered once daily for 7 days increased plasma theophylline concentrations ( auc ( 0- ) ) by 38 to 60 % in healthy subjects administered a single 300-mg dose of theophylline .
None(e1,e2)	0	2	antacids containing magnesium_trisilicate , when administered concomitantly with nitrofurantoin , reduce both the rate and extent of absorption .
None(e1,e2)	139	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	18	interactions for vitamin b3 ( niacin ) : antihypertensive therapy : nicotinic acid may potentiate the effects of ganglionic_blocking_agents and vasoactive drugs resulting in postural hypotension .
None(e1,e2)	14	18	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim /sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
effect(e1,e2)	2	17	nicotine : nicotine may provoke vasoconstriction in some patients , predisposing to a greater ischemic response to ergot therapy .
None(e1,e2)	38	44	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	1	15	phenytoin/ phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin_d , but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism .
mechanism(e1,e2)	12	27	co-medications that induce cyp 3a4 ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
None(e1,e2)	24	56	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	36	38	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	10	12	although these results do not indicate a significant interaction between toradol and warfarin or heparin , the administration of toradol to patients taking anticoagulants should be done extremely cautiously , and patients should be closely monitored .
None(e1,e2)	24	38	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux_sodium .
None(e1,e2)	19	42	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	17	26	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	12	33	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide_dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	25	32	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	42	45	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/ sulfamethoxazole or zidovudine .
None(e1,e2)	91	108	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	12	valdecoxib did not have a statistically significant effect on the pharmacokinetics of phenytoin ( a cyp 2c9 and cyp 2c19 substrate ) .
None(e1,e2)	6	11	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	30	44	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine_oxidase_(_mao_)_inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	6	12	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	85	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	31	45	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal_anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	40	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	14	lotensin has been used concomitantly with beta-adrenergic-blocking agents , calcium-channel-blocking agents , diuretics , digoxin , and hydralazine , without evidence of clinically important adverse interactions .
None(e1,e2)	43	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	12	19	a similar association , though less marked , has been suggested with barbiturates , phenyl-butazone , phenytoin sodium , carbamazepine and possibly with griseofulvin , ampicillin , and tetracyclines ( 72 )
None(e1,e2)	18	47	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic_antidepressants
None(e1,e2)	2	13	administration of diltiazem_hydrochloride concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately 50 % .
None(e1,e2)	16	19	while all the selective serotonin reuptake inhibitors ( ssris ) , e. g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	26	60	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	16	24	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
advise(e1,e2)	8	28	the potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via cyp3a4 ( alprazolam , triazolam ) should be considered when coadministering these agents with aprepitant .
None(e1,e2)	36	61	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	0	2	monoamine_oxidase_inhibitors and tricyclic_antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	17	21	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .
None(e1,e2)	116	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	46	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	16	28	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin_b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	6	14	in four subjects with epilepsy ingesting valproate , the steady-state trough ( cmin ) valproate plasma concentration was 63 16 micrograms/ml .
mechanism(e1,e2)	5	24	phenytoin/phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol /ergocalcitriol by accelerating metabolism .
int(e1,e2)	0	28	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	41	interactions may also occur with the following : anti-depressants /anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	23	42	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	20	43	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	24	45	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
mechanism(e1,e2)	11	42	binding to serum proteins : the following agents may either inhibit levothyroxine_sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	16	18	close supervision and careful adjustment of dosage are required when this drug is given concomitantly with anticholinergic or sympathomimetic_drugs .
None(e1,e2)	1	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
advise(e1,e2)	2	10	- when bezalip or bezalip retard is used concurrently with anion-exchange_resins ( e.g . cholestryramine ) , an interval of at least 2 hours should be maintained between the two medicines , since the absorption of bezalip or bezalip retard is impaired
None(e1,e2)	11	27	- methotrexate ( e.g. , mexate ) use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate
None(e1,e2)	7	24	phenytoin/phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol /ergocalcitriol by accelerating metabolism .
effect(e1,e2)	14	22	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
advise(e1,e2)	4	30	therefore , co-administration of tricyclic_antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	12	26	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	66	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
advise(e1,e2)	1	6	since barbiturates are potentiated by the anticholinesterases , they should be used cautiously in the treatment of convulsions .
None(e1,e2)	4	14	other reported interactions with amiodarone : fentanyl ( cyp3a4 substrate ) in combination with amiodarone may cause hypotension , bradycardia , and decreased cardiac output .
effect(e1,e2)	14	31	anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal_anti-inflammatory_drugs ( nsaids ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .
advise(e1,e2)	8	34	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	0	27	methotrexate vioxx 12.5 , 25 , and 50 mg , each dose administered once daily for 7 days , had no effect on the plasma concentration of methotrexate as measured by auc0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis .
None(e1,e2)	87	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	55	59	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	21	70	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	15	27	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	7	10	erythromycin and clarithromycin ( and possibly other macrolide_antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	28	36	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
effect(e1,e2)	28	35	delayed adverse reactions to iodinated contrast media : a review of the literature revealed that 12.6 % ( range 11-28 % ) of 501 patients treated with various interleukin-2 containing regimens who were subsequently administered radiographic_iodinated_contrast_media experienced acute , atypical adverse reactions .
None(e1,e2)	22	39	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	29	33	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
mechanism(e1,e2)	2	21	coadministration of valdecoxib ( 40 mg bid ( day 1 ) and 40 mg qd ( days 2-7 ) ) with glyburide ( 10 mg glyburide bid ) resulted in 21 % increase in glyburide auc0-12 and a 16 % increase in glyburide cmax leading to a 16 % decrease in glucose auc0-24 .
None(e1,e2)	17	20	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot_derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	0	11	anticoagulants : while studies have not shown diclofenac to interact with anticoagulants_of_the_warfarin_type , caution should be exercised , nonetheless , since interactions have been seen with other nsaids .
None(e1,e2)	51	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	7	certain drugs including thiazides , corticosteroids , thyroid_products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	13	20	therophylline : a recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline , and in some instances a slight decrease in the elimination of isoniazid .
None(e1,e2)	40	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	13	31	however , because some quinolones have been reported to enhance the effects of warfarin or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a quinolone_antimicrobial is administered with warfarin or its derivatives .
None(e1,e2)	10	18	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
effect(e1,e2)	6	31	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	29	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	30	34	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	31	51	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	15	25	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	11	14	in separate studies of patients receiving maintenance doses of warfarin , hydrochlorothiazide , or digoxin , irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin ( prothrombin time ) or pharmacokinetics of digoxin .
None(e1,e2)	0	6	acetazolamide increases lithium excretion and the lithium may be decreased .
None(e1,e2)	31	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	24	29	in order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with taxol should be premedicated with corticosteroids ( such as dexamethasone ) , diphen-hydramine and h2_antagonists ( such as cimetidine or ranitidine ) .
None(e1,e2)	3	9	heparin : since heparin is contraindicated in patients with heparin -induced thrombocytopenia , the co-administration of argatroban and heparin is unlikely for this indication .
None(e1,e2)	15	33	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	3	13	amphotericin b or potassium-depleting_diuretics ( benzothiadiazines and related drugs , ethacrynic acid and furosemide ) enhanced hypokalemia .
None(e1,e2)	12	31	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	131	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	17	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	18	20	another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl_estradiol and levonorgestrel ( cyp3a4 substrates ) .
None(e1,e2)	9	16	these would include a variety of preparations which contain androgens , estrogens , progestins , or glucocorticoids .
advise(e1,e2)	7	22	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial_agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	15	18	dostinex should not be administered concurrently with d2-antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
None(e1,e2)	33	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	18	31	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	102	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	46	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	15	40	a clinical study in healthy male volunteers ( n=24 ) demonstrated that mixing novolog with nph_human_insulin immediately before injection produced some attenuation in the peak concentration of novolog , but that the time to peak and the total bioavailability of novolog were not significantly affected .
None(e1,e2)	10	16	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
mechanism(e1,e2)	0	9	ritonavir ( 600 mg b.i.d . ) co-administered with vardenafil 5 mg resulted in a 49-fold increase in vardenafil auc and a 13-fold increase in vardenafil cmax .
None(e1,e2)	16	23	phenytoin : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenytoin with or without other enzyme- inducing aeds .
None(e1,e2)	0	18	insulin or oral hypoglycemics : agents with b-blocking properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics .
None(e1,e2)	10	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	19	levothyroxine_sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum_hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
advise(e1,e2)	5	29	caution should be taken when enablex is used concomitantly with medications that are predominantly metabolized by cyp2d6 and which have a narrow therapeutic window , such as flecainide , thioridazine and tricyclic antidepressants ( see clinical pharmacology ) .
None(e1,e2)	9	33	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	28	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
advise(e1,e2)	15	22	drug-drug interactions given the primary cns effects of aripiprazole , caution should be used when abilify is taken in combination with other centrally_acting_drugs and alcohol .
None(e1,e2)	11	27	since the concomitant administration of these two drugs can lead to phenytoin intoxication , prior to administering disulfiram to a patient on phenytoin therapy , a baseline phenytoin serum level should be obtained .
None(e1,e2)	0	14	amiodarone taken concomitantly with procainamide for less than seven days increases plasma concentrations of procainamide and n-acetyl procainamide by 55 % and 33 % , respectively .
None(e1,e2)	26	45	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle_relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	14	21	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	10	15	tablet if a patient receiving clonidine hydrochloride is also taking tricyclic_antidepressants , the effect of clonidine may be reduced , thus necessitating an increase in dosage .
None(e1,e2)	7	17	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	63	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	10	43	however , a crossover study in healthy subjects receiving either tagamet 300 mg q.i.d . or 800 mg h.s . concomitantly with a 300 mg b.i.d . dosage of theophylline ( theo-dur , key pharmaceuticals , inc. ) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s . regimen , particularly in subjects aged 54 years and older .
None(e1,e2)	1	29	if rifampicin therapy is required , isradipine concentrations and therapeutic effects are likely to be markedly reduced or abolished as a consequence of increased metabolism and higher clearance of isradipine .
None(e1,e2)	3	30	ketoconazole ) , macrolide_antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	0	8	immunosuppressive_drugs , fibric acid derivatives , niacin ( nicotinic_acid , erythromycin , azole antifungals : skeletal muscle .
None(e1,e2)	11	29	no depressant effect on blood levels in humans was noted when colestipol_hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic_acid ( niacin ) , tolbutamide , phenytoin or warfarin .
advise(e1,e2)	19	29	in patients receiving concurrent therapy with clonidine , if therapy is to be discontinued , it is suggested that zebeta be discontinued for several days before the withdrawal of clonidine .
advise(e1,e2)	0	21	nabilone should be administered with caution to patients who are taking other psychoactive drugs or cns depressants , including alcohol , barbiturates and narcotic analgesics , or to those with a history of psychiatric disorder ( including manic-depressive illness and schizophrenia ) .
None(e1,e2)	15	23	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
mechanism(e1,e2)	19	28	however , other published reports describe modest elevations ( less than two-fold ) of clozapine and metabolite concentrations when clozapine was taken with paroxetine , fluoxetine , and sertraline .
None(e1,e2)	46	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	44	80	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	43	most cases of serious or fatal adverse events involving levo-dromoran reported to the manufacturer or the fda have involved either the administration of large initial doses or too frequent doses of the drug to nonopioid tolerant patients , or the simultaneous administration of levorphanol with other drugs affecting respiration .
None(e1,e2)	9	16	when other potent parental antihypertensive drugs , such as diazoxide , are used in combination with hydralazine , patients should be continuously observed for several hours for any excessive fall in blood pressure .
None(e1,e2)	71	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	27	coadministration of amprenavir and methadone as compared to a non-matched historicalcontrol group resulted in a 30 % , 27 % , and 25 % decrease in serum amprenavir auc , cmax , andcmin , respectively .
None(e1,e2)	0	15	aripiprazole dose should be reduced to one-half of its normal dose when concomitant administration of quinidine with aripiprazole occurs .
mechanism(e1,e2)	8	13	cytochrome p-450 inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately 30 % decrease in plasma clonazepam levels .
effect(e1,e2)	23	29	h2 blockers/proton pump inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	65	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	22	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	61	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	10	probenecid : as with other b-lactam_antibiotics , renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80 % increase in the auc for loracarbef .
None(e1,e2)	32	42	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	53	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	93	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	15	acidifying agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic_acid , fruit juices , etc . ) lower absorption of amphetamines .
None(e1,e2)	29	33	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	4	9	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	95	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	51	61	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	12	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv_protease_inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	13	24	these data indicate that levetiracetam does not influence the plasma concentration of other aeds and that these aeds do not influence the pharmacokinetics of levetiracetam .
None(e1,e2)	34	59	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
advise(e1,e2)	4	25	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	0	31	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	4	29	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	18	25	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim /sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	92	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	22	24	potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated , and concomitant use of vardenafil and nitrates is contraindicated .
None(e1,e2)	0	9	anticoagulants : ten patients who were stabilized on oral anticoagulants were given guanfacine , 1-2 mg/day , for 4 weeks .
None(e1,e2)	25	33	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	15	51	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	15	63	however , there are limited in vivo data suggesting a modest cyp2d6 inhibitory effect for escitalopram , i.e. , coadministration of escitalopram ( 20 mg/day for 21 days ) with the tricyclic antidepressant desipramine ( single dose of 50 mg ) , a substrate for cyp2d6 , resulted in a 40 % increase in cmax and a 100 % increase in auc of desipramine .
None(e1,e2)	76	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	46	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	8	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum alkaloids may be reduced by sympathomimetics .
mechanism(e1,e2)	2	20	terfenadine , astemizole and cisapride are all metabolized by the cytochrome p450iiia4 isozyme , and it has been demonstrated that ketoconazole , a potent inhibitor of iiia4 , blocks the metabolism of these drugs , resulting in increased plasma concentrations of parent drug .
advise(e1,e2)	12	47	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	8	58	this drug may interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	13	28	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
None(e1,e2)	19	21	magnesium/aluminum-containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium/ aluminum -containing antacid_products .
mechanism(e1,e2)	9	25	limited data in patients receiving known enzyme inducers ( phenytoin , phenobarbital , carbamazepine ) indicate only a 30 % increase in the rate of flecainide elimination .
advise(e1,e2)	4	7	nafazodone , fluvoxamine , cimetidine ( consider xanax dose reduction ) .
mechanism(e1,e2)	19	40	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide_class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	5	10	coadministration of oral contraceptives , diazepam , phenytoin , or quinidine did not seem to change the pharmacokinetic profile of esomeprazole .
None(e1,e2)	0	22	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythmics propafenone and flecainide ) .
int(e1,e2)	5	8	a possible drug interaction of foscavir and intravenous pentamidine has been described .
None(e1,e2)	116	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	20	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	21	35	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis_preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	87	126	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	34	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
mechanism(e1,e2)	9	26	drug interactions with antacids administration of 120 mg of fexofenadine_hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	0	14	probenecid : as with other b-lactam antibiotics , probenecid inhibits the renal excretion of cefdinir , resulting in an approximate doubling in a.c. a 54 % increase in peak cefdinir plasma levels , and a 50 % prolongation in the apparent elimination half-life .
None(e1,e2)	57	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	34	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .
None(e1,e2)	13	22	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	57	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	79	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	53	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	4	6	thus patients receiving oral anticoagulants and fluvoxamine tablets should have their prothrombin time monitored and their anticoagulant dose adjusted accordingly .
mechanism(e1,e2)	19	29	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	7	29	monoamine oxidase inhibitors and tricyclic antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	24	34	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
mechanism(e1,e2)	2	10	mercaptopurine/azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid .
None(e1,e2)	0	22	antifungals : in vitro and/or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	13	40	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	28	38	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	16	31	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	59	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	36	53	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	129	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	111	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	9	18	spontaneous reports of serotonin syndrome associated with co-administration of zyvox and serotonergic agents , including antidepressants such as selective_serotonin_reuptake_inhibitors ( ssris ) , have been reported .
None(e1,e2)	33	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	1	8	magnesium/ aluminum -containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium/aluminum-containing antacid products .
None(e1,e2)	14	35	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	78	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	28	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	0	2	warfarin - vitamin_k can antagonize the effect of warfarin
None(e1,e2)	17	25	the hypotensive effect of sodium nitroprusside is augmented by that of most other hypotensive drugs , including ganglionic_blocking_agents , negative inotropic agents , and inhaled anesthetics .
mechanism(e1,e2)	0	5	acetazolamide reduces urinary excretion of quinidine and may enhance its effect .
None(e1,e2)	80	147	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	29	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	29	41	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	53	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	1	3	- corticosteroids , acth : intensified electrolyte depletion , particularly hypokalemia
None(e1,e2)	0	6	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	20	23	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
None(e1,e2)	65	74	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	21	23	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
None(e1,e2)	8	17	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	5	21	since the therapeutic range of theophylline is narrow theophylline serum levels should be monitored closely , and appropriate dosage adjustments of theophylline should be made .
None(e1,e2)	37	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	13	folic acid in large amounts may counteract the antiepileptic effect of phenobarbital , phenytoin and primidone , and increase the frequency of seizures in susceptible pediatric patients .
None(e1,e2)	0	2	digoxin : digoxin concentrations are increased by about 15 % when digoxin and carvedilol are administered concomitantly .
None(e1,e2)	0	9	copaxone has not been formally evaluated in combination with interferon_beta .
None(e1,e2)	0	4	diuretics : patients on diuretics , especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with lotensin .
advise(e1,e2)	7	25	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
effect(e1,e2)	0	2	lamivudine and zalcitabine may inhibit the intracellular phosphorylation of one another .
None(e1,e2)	8	10	other antiarrhythmic drugs ( eg , quinidine , procainamide , lidocaine , propranolol ) have occasionally been used concurrently with norpace .
None(e1,e2)	6	13	the potential for drug interactions with emtriva has been studied in combination with indinavir , stavudine , famciclovir , and tenofovir disoproxil fumarate .
None(e1,e2)	10	12	furosemide : in normal volunteers , the concomitant administration of diflunisal and furosemide had no effect on the diuretic activity of furosemide .
None(e1,e2)	24	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	21	31	ketoconazole : when a single 125-mg dose of aprepitant was administered on day5 of a 10-day regimen of 400 mg/day of ketoconazole , a strong cyp3a4 inhibitor , the auc of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold .
None(e1,e2)	15	53	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
mechanism(e1,e2)	2	49	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
effect(e1,e2)	11	22	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic_drugs .
mechanism(e1,e2)	12	14	elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with norfloxacin .
None(e1,e2)	2	6	aspirin : ketoprofen does not alter aspirin absorption ;
None(e1,e2)	11	22	since the concomitant administration of these two drugs can lead to phenytoin intoxication , prior to administering disulfiram to a patient on phenytoin therapy , a baseline phenytoin serum level should be obtained .
None(e1,e2)	19	24	hypersensitivity reactions : patients with a history of severe hypersensitivity reactions to products containing cremophor el ( eg , cyclosporin for injection concentrate and teniposide for injection concentrate ) should not be treated with taxol .
None(e1,e2)	17	29	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , niacin ( nicotinic acid ) , erythromycin , azole antifungals .
None(e1,e2)	8	13	anesthetics/sedatives/hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	46	74	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	12	adequate monitoring of theophylline plasma concentrations should be considered when therapy with vioxx is initiated or changed in patients receiving theophylline .
None(e1,e2)	0	2	ace_inhibitors and angiotensin_ii_receptor_antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin ii receptor antagonists ( acei/arb ) .
None(e1,e2)	13	39	a study in six healthy volunteers has shown a significant increase in peak diltiazem plasma levels ( 58 % ) and auc ( 53 % ) after a 1-week course of cimetidine 1200 mg/day and a single dose of diltiazem 60mg .
None(e1,e2)	3	24	the concentrations of sn38 , the active metabolite of irinotecan , were on average 33 % higher in patients receiving bolus-ifl in combination with avastin when compared with bolus-ifl alone .
None(e1,e2)	0	2	dextromethorphan : dextromethorphan is primarily metabolized by cyp 2d6 and to a lesser extent by 3a4 .
None(e1,e2)	45	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	36	69	cancidas reduced the blood auc0-12 of tacrolimus by approximately 20 % , peak blood concentration ( cmax ) by 16 % , and 12-hour blood concentration ( c12hr ) by 26 % in healthy subjects when tacrolimus ( 2 doses of 0.1 mg/kg 12 hours apart ) was administered on the 10th day of cancidas 70 mg daily , as compared to results from a control period in which tacrolimus was administered alone .
None(e1,e2)	3	14	cholestyramine and colestipol resins : absorption of hydrochlorothiazide is impaired in the presence of anionic_exchange_resins .
None(e1,e2)	12	19	additive cns depression may occur when antihistamines are administered concomitantly with other cns_depressants including barbiturates , tranquilizers , and alcohol .
None(e1,e2)	19	79	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta_blockers ( 10 ) .
None(e1,e2)	18	54	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium_hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	11	23	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
None(e1,e2)	24	49	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	9	11	in patients receiving a potent cyp3a4 inducer such as rifampicin or phenytoin , a dose increase to 500 mg daily should be considered in the absence of severe adverse drug reaction , and clinical response and adverse events should be carefully monitored ( see clinical pharmacology-pharmacokinetics-drug-drug interactions and dosage and administration-dosage adjustment sections ) .
None(e1,e2)	7	9	co-medications that induce cyp3a4 ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , phenobarbital or st .
None(e1,e2)	0	7	imipramine : coadministration of single doses of sonata 20 mg and imipramine 75 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration .
None(e1,e2)	146	153	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	33	39	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	13	20	fluconazole , and the 5-ht3 antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	27	29	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	0	2	somatrem / somatropin : excessive concurrent use of thyroid hormone may accelerate epiphyseal closure .
None(e1,e2)	14	22	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	116	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	6	24	anticholinergics : concurrent administration of certain anticholinergic_compounds , such as belladonna alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
None(e1,e2)	0	40	valproate : available data suggest that there is no significant effect of valproate on the clearance of felbatol at steady state , therefore , the addition of valproate is not expected to cause a clinically important effect on felbatol ( felbamate ) plasma concentrations .
None(e1,e2)	30	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	74	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	45	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	10	platelet_inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
effect(e1,e2)	0	15	diphenhydramine_hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
mechanism(e1,e2)	3	5	concomitant administration of diltiazem with carbamazepine has been reported to result in elevated serum levels of carbamazepine ( 40 % to 72 % increase ) , resulting in toxicity in some cases .
effect(e1,e2)	9	32	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	6	14	no interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa/dopa-decarboxylase inhibitor .
None(e1,e2)	21	42	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	9	14	- lofexidine may enhance the cns depressive effects of alcohol , barbiturates and other sedatives
None(e1,e2)	26	30	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	4	10	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	14	32	an adequate period of observation must be provided for any patient in whom either long-acting_benzodiazepines ( such as diazepam ) or large doses of short-acting benzodiazepines ( such as 10 mg of midazolam ) have been used .
None(e1,e2)	26	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	8	13	in one man , the c max of terfenadine was 8.1 ng/ml with terfenadine alone and 7.2 ng/ml with terfenadine plus dirithromycin .
None(e1,e2)	9	15	- anticoagulants : interaction studies in humans have shown bumetanide to have no effect on warfarin metabolism or on plasma prothrombin activity .
None(e1,e2)	5	31	erythromycin co-administration of felodipine ( plendil ) with erythromycin resulted in approximately 2.5- fold increase in the auc and cmax , and about 2- fold prolongation in the half- life of felodipine .
int(e1,e2)	0	25	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	44	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	19	23	doxazosin mesylate has been administered without any evidence of an adverse drug interaction to patients receiving thiazide diuretics , beta-blocking_agent s , and nonsteroidal_anti-inflammatory_drugs .
None(e1,e2)	2	12	antidepressants , tricyclic amphetamines may enhance the activity of tricyclic antidepressants or sympathomimetic_agents ;
None(e1,e2)	6	10	there are no significant effects on cefdinir pharmacokinetics if the antacid is administered 2 hours before or 2 hours after cefdinir .
None(e1,e2)	0	16	antacids ( aluminum- or magnesium-containing ) : concomitant administration of 300-mg cefdinir capsules with 30 ml maalox_tc suspension reduces the rate ( cmax ) and extent ( auc ) of absorption by approximately 40 % .
None(e1,e2)	30	40	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	11	26	for example , when vitamin k antagonists are administered concomitantly with nilutamide , prothrombin time should be carefully monitored and if necessary , the dosage of vitamin_k_antagonists should be reduced .
None(e1,e2)	22	25	although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral agents , including protease inhibitors , macrolide_antibiotics , and azole_antifungals , the effect of panretin gel on the steady-state concentrations of these drugs is not known .
effect(e1,e2)	13	16	this could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when corticosteroid is withdrawn .
None(e1,e2)	0	1	aminophylline etomidate antagonism
None(e1,e2)	37	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	0	2	acetazolamide and sodium_bicarbonate used concurrently increases the risk of renal calculus formation .
None(e1,e2)	44	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	22	38	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
None(e1,e2)	7	43	in another study with intravenous administration of midazolam , aprepitant was given as 125 mg on day 1 and 80 mg/day on days 2 and 3 , and midazolam 2 mg iv was given prior to the administration of the 3-day regimen of aprepitant and on days 4 , 8 , and 15 .
mechanism(e1,e2)	9	36	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 3a4 , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
advise(e1,e2)	7	13	oral anticoagulants caution should be exercised when coumarin_anticoagulants are given in conjunction with tricor .
mechanism(e1,e2)	6	14	plasma exposure ( auc ) to valdecoxib was increased 62 % when coadministered with fluconazole and 38 % when coadministered with ketoconazole .
None(e1,e2)	35	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	10	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
advise(e1,e2)	2	4	patients taking isoniazid when disulfiram is given should be observed for the appearance of unsteady gait or marked changes in mental status ;
None(e1,e2)	14	25	however , other published reports describe modest elevations ( less than two-fold ) of clozapine and metabolite concentrations when clozapine was taken with paroxetine , fluoxetine , and sertraline .
None(e1,e2)	0	4	acetaminophen and methotrexate - l-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate .
None(e1,e2)	14	22	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	24	40	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
effect(e1,e2)	9	12	nephrotoxicity has been reported following concomitant administration of other cephalosporins with potent diuretics such as furosemide .
None(e1,e2)	6	19	drug/laboratory test interaction after treatment with ampicillin , a false-positive reaction for glucose in the urine may occur with copper_sulfate tests ( benedicts solution , fehlings solution , or clinitest tablets ) but not with enzyme based tests such as clinistix and glucose enzymatic test strip usp .
None(e1,e2)	30	40	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	0	7	antidepressants : in vitro data indicate that nefazodone inhibits the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	43	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	20	34	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	9	36	drugs that may have their plasma concentration altered by gleevec gleevec increases the mean cmax and auc of simvastatin ( cyp3a4 substrate ) 2- and 3.5-fold , respectively , suggesting an inhibition of the cyp3a4 by gleevec .
None(e1,e2)	18	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	32	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
None(e1,e2)	15	23	after 14 days of co-administration , mean trough concentrations of clozapine and its metabolites , n-desmethylclozapine and clozapine n-oxide , were elevated with fluvoxamine by about three-fold compared to baseline concentrations .
None(e1,e2)	3	20	therefore , if digoxin is administered with vaprisol , the clinician should be alert to the possibility of increases in digoxin levels .
None(e1,e2)	12	29	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	12	14	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	14	50	in another study , toradoliv/im was given with two doses of 5000 u of heparin to 11 healthy volunteers , resulting in a mean template bleeding time of 6.4 minutes ( 3.2 to 11.4 min ) compared to a mean of 6.0 minutes ( 3.4 to 7.5 min ) for heparin alone and 5.1 minutes ( 3.5 to 8.5 min ) for placebo .
None(e1,e2)	59	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	10	38	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	0	29	mao_inhibitors : duragesic is not recommended for use in patients who have received maoi within 14 days because severe and unpredictable potentiation by mao inhibitors has been reported with opioid_analgesics
None(e1,e2)	0	49	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	28	53	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	8	20	co-administration of multiple doses of 10 mg of lenalidomide had no effect on the single dose pharmacokinetics of r- and s-_warfarin .
None(e1,e2)	0	5	cholestyramine and charcoal administration of cholestyramine or activated charcoal in patients ( n=13 ) and volunteers ( n=96 ) resulted in a rapid and significant decrease in plasma m1 ( the active metabolite of leflunomide ) concentration .
mechanism(e1,e2)	2	11	warfarin : quinolones , including enoxacin , decrease the clearance of r-warfarin , the less active isomer of racemic warfarin .
None(e1,e2)	5	13	antacid : when atorvastatin and maalox_tc suspension were coadministered , plasma concentrations of atorvastatin decreased approximately 35 % .
None(e1,e2)	0	10	lithium : lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium , including ace inhibitors .
None(e1,e2)	36	49	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	69	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	35	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic_antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	2	6	antacids and kaolin : antacids and kaolin can reduce absorption of chloroquine ;
None(e1,e2)	56	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	19	24	in general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic_agents such as quinidine and procainamide , cardiac glycosides and tricyclic anti-depressants .
None(e1,e2)	53	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	4	6	the concomitant use of beta-adrenergic_blocking_agents with digitalis and calcium antagonists may have additive effects on prolonging atrioventricular conduction time .
None(e1,e2)	96	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	35	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	5	15	in patients who have received muscle_relaxants , doxapram may temporarily mask the residual effects of muscle_relaxant_drugs .
None(e1,e2)	15	36	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta_blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	37	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	2	antidepressants ( tricyclic ) , atropine or other anticholinergic agents , or digitalis glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	38	42	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	21	27	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	14	33	drugs that inhibit cyp3a4 cyp3a4 is a minor metabolic pathway for the elimination of zaleplon because the sum of desethylzaleplon ( formed via cyp3a4 in vitro ) and its metabolites , 5-oxo-desethylzaleplon and 5-oxo-desethylzaleplon_glucuronide , account for only 9 % of the urinary recovery of a zaleplon dose .
None(e1,e2)	37	44	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin_analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	0	28	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenobarbital ( primidone ) with or without other enzyme-inducing aeds .
None(e1,e2)	40	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	16	in rheumatoid arthritis , concomitant medications besides mtx were nonsteroidal anti-inflammatory agents , folic acid , corticosteroids and/or narcotics .
None(e1,e2)	34	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	11	21	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	5	11	cholestyramine-concomitant intake of cholestyramine and vitamin_k may reduce the absorption of vitamin_k .
None(e1,e2)	8	20	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	19	20	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type_1c_antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	6	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	10	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	10	phenobarbital : estimates of steady-state pharmacokinetic parameters for phenobarbital or gabapentin ( 300 mg tid ;
None(e1,e2)	29	37	because busulfan is eliminated from the body via conjugation with glutathione , use of acetaminophen prior to ( 72 hours ) or concurrent with busulfex may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues .
None(e1,e2)	3	28	therefore , if theophylline is co-administered with fluvoxamine maleate , its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of theophylline should to monitored .
None(e1,e2)	4	7	anticoagulants : potentiation of warfarin -type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
None(e1,e2)	28	36	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	22	24	sumatriptan - there have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a selective_serotonin_reuptake_inhibitor ( ssri ) and sumatriptan .
None(e1,e2)	28	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	31	37	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	40	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	30	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	56	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	29	42	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	72	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	18	24	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	41	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	15	20	cephalosporins-cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
None(e1,e2)	11	18	the pharmacokinetics and protein binding of fosphenytoin , phenytoin , and diazepam were not altered when diazepam and cerebyx were concurrently administered in single submaximal doses .
None(e1,e2)	16	18	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	2	7	antacids containing magnesium , aluminum , or calcium ;
None(e1,e2)	20	52	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	0	5	theophylline : the pharmacokinetics of theophylline ( aminophylline 5.8 mg/kg infused over 20 minutes ) were unchanged following a single oral dose of albendazole ( 400 mg ) in 6 healthy subjects .
effect(e1,e2)	5	8	patients who are treated with zyvox and concomitant serotonergic_agents should be closely observed for signs and symptoms of serotonin syndrome ( e.g. , cognitive dysfunction , hyperpyrexia , hyperreflexia , incoordination ) .
mechanism(e1,e2)	6	13	a number of drugs , including ethacrynic_acid , have been shown to displace warfarin from plasma protein ;
None(e1,e2)	11	13	strong inducers of cytochrome p450 enzymes ( i.e . carbamazepine , phenytoin and phenobarbital ) have been shown to decrease the plasma levels of mhd ( 29-40 % ) .
None(e1,e2)	135	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	45	49	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	55	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	18	interactions for vitamin d analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	5	11	concurrent use of butorphanol with central_nervous_system_depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
None(e1,e2)	7	28	dopamine antagonists : since apomorphine is a dopamine_agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	31	52	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	10	25	results from existing clinical trials suggest no significant interactions between copaxone and other therapies commonly used in ms patients , including the concurrent use of corticosteroids for up to 28 days .
None(e1,e2)	10	27	other substances : grapefruit juice given to healthy volunteers increased amiodarone auc by 50 % and cmax by 84 % , resulting in increased plasma levels of amiodarone .
None(e1,e2)	17	18	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
effect(e1,e2)	3	8	in addition , ketoconazole alone can inhibit adrenal corticosteroid synthesis and may cause adrenal insufficiency during corticosteroid withdrawal .
None(e1,e2)	51	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	35	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	39	ritonavir - combined administration of a single dose of ritonavir ( 600 mg ) , both a cyp3a4 substrate and a potent inhibitor of cyp3a4 , and escitalopram ( 20 mg ) did not affect the pharmacokinetics of either ritonavir or escitalopram .
advise(e1,e2)	9	11	standard monitoring of methotrexate-related toxicity should be continued if vioxx and methotrexate are administered concomitantly .
None(e1,e2)	25	62	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	8	22	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	21	66	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
advise(e1,e2)	13	26	until data on possible interactions between verapamil and disopyramide phosphate are obtained , disopyramide should not be administered within 48 hours before or 24 hours after verapamil administration .
effect(e1,e2)	3	8	digitalis glycosides : amphotericin_b -induced hypokalemia may potentiate digitalis toxicity .
None(e1,e2)	6	13	lotensin has been used concomitantly with beta-adrenergic-blocking_agents , calcium-channel-blocking agents , diuretics , digoxin , and hydralazine , without evidence of clinically important adverse interactions .
mechanism(e1,e2)	11	23	allopurinol : the auc of didanosine was increased about 4-fold when allopurinol at 300 mg/day was coadministered with a single 200-mg dose of videx to two patients with renal impairment ( clcr=15 and 18 ml/min ) .
None(e1,e2)	0	46	praziquantel : in the fed state , praziquantel ( 40 mg/kg ) increased mean maximum plasma concentration and area under the curve of albendazole sulfoxide by about 50 % in healthy subjects ( n=10 ) compared with a separate group of subjects ( n=6 ) given albendazole alone .
effect(e1,e2)	0	15	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
effect(e1,e2)	8	10	vitamin a : because of the relationship of accutane to vitamin_a , patients should be advised against taking vitamin supplements containing vitamin a to avoid additive toxic effects
None(e1,e2)	6	15	carbamazepine - combined administration of racemic citalopram ( 40 mg/day for 14 days ) and carbamazepine ( titrated to 400 mg/day for 35 days ) did not significantly affect the pharmacokinetics of carbamazepine , a cyp3a4 substrate .
None(e1,e2)	1	20	if antacids are required during omnicef therapy , omnicef should be taken at least 2 hours before or after the antacid .
None(e1,e2)	27	42	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	35	20	drugs that inhibit cyp3a4 cyp3a4 is a minor metabolic pathway for the elimination of zaleplon because the sum of desethyl zaleplon ( formed via cyp3a4 in vitro ) and its metabolites , 5-oxo-desethylzaleplon and 5-oxo-desethylzaleplon_glucuronide , account for only 9 % of the urinary recovery of a zaleplon dose .
None(e1,e2)	33	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	6	8	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	17	28	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
advise(e1,e2)	12	29	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
mechanism(e1,e2)	6	45	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/ sulfamethoxazole or zidovudine .
mechanism(e1,e2)	8	24	inhibitors or substrates of cyp2d6 ( i.e. , quinidine , selective serotonin reuptake inhibitors [ ssris ] ) may increase the plasma concentration of doxepin when administered concomitantly .
mechanism(e1,e2)	0	12	bile_acid_binding_resins may also interfere with the absorption of oral phosphate supplements and hydrocortisone .
None(e1,e2)	10	35	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	18	21	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	9	17	therefore , interactions could occur following concomitant administration of psychotropic_drugs ( e.g. , narcotics , analgesics , antiemetics , sedatives , tranquilizers ) .
None(e1,e2)	37	48	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide_diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	5	59	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	12	41	ketoconazole - combined administration of racemic citalopram ( 40 mg ) and ketoconazole ( 200 mg ) decreased the cmax and auc of ketoconazole by 21 % and 10 % , respectively , and did not significantly affect the pharmacokinetics of citalopram .
mechanism(e1,e2)	2	9	carbamazepine : felbatol causes a decrease in the steady-state carbamazepine plasma concentrations and an increase in the steady-state carbamazepine epoxide plasma concentration .
None(e1,e2)	19	27	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic_agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	25	34	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	26	37	propranolol to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability , auc and cmax , differences were 20 % between isradipine given singly and in combination with propranolol , and between propranolol given singly and in combination with isradipine .
None(e1,e2)	0	10	ethopropazine can interact with chlorpromazine , increasing the metabolism of chlorpromazine .
None(e1,e2)	6	13	until data on possible interactions between verapamil and disopyramide phosphate are obtained , disopyramide should not be administered within 48 hours before or 24 hours after verapamil administration .
None(e1,e2)	37	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	29	32	therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( e.g . ketoconazole , ampicillin esters , iron salts , digoxin ) .
None(e1,e2)	16	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	33	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	100	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	81	91	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	5	14	concomitant medications were grouped as ace_inhibitors , oral anticoagulants , calcium channel blockers , beta_blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
effect(e1,e2)	14	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
mechanism(e1,e2)	0	40	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	19	45	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	19	22	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	23	29	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	93	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	71	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	23	tricyclic_antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.it is not known whether the concurrent use of these agents with alphagan_p in humans can lead to resulting interference with the iop lowering effect .
None(e1,e2)	70	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	23	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	40	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	25	36	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
mechanism(e1,e2)	23	31	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	6	16	dosage adjustment may be required if cyclosporine , tacrolimus , or methylprednisolone are given concomitantly with nizoral tablets .
None(e1,e2)	3	7	mao inhibitors , narcotic_analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	53	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	27	29	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
effect(e1,e2)	14	45	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	23	27	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	15	25	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	45	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	24	28	the concurrent use of two or more drugs with anticholinergic activity -- such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian_drug ( eg , trihexyphenidyl ) , and/or a tricyclic antidepressant ( eg , amitriptyline ) -- commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
None(e1,e2)	14	35	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine_antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
mechanism(e1,e2)	11	13	digoxin : digoxin concentrations are increased by about 15 % when digoxin and carvedilol are administered concomitantly .
None(e1,e2)	9	11	patients taking these drugs with lodosyn and levodopa or carbidopa - levodopa combination products should be carefully observed for loss of therapeutic response .
None(e1,e2)	115	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	33	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	11	13	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum_hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	6	15	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	8	14	digoxin : when multiple doses of atorvastatin and digoxin were coadministered , steady-state plasma digoxin concentrations increased by approximately 20 % .
None(e1,e2)	44	59	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	16	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	0	14	coumarin_anticoagulants : there have been rare reports of increased prothrombin time in patients taking coumarin_anticoagulants to whom nifedipine was administered .
None(e1,e2)	15	26	as with other drugs that block angiotensin ii or its effects , concomitant use of potassium-sparing_diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , or salt substitutes containing potassium may lead to increases in serum potassium .
None(e1,e2)	44	46	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic_acid , and acetaminophen .
None(e1,e2)	33	35	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone_classes_of_antipsychotic_agents , monoamine_oxidase_inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	102	143	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	26	the following medications have been administered in clinical trials with simulect with no increase in adverse reactions : atg/alg , azathioprine , corticosteroids , cyclosporine , mycophenolate_mofetil , and muromonab-cd3 .
int(e1,e2)	0	5	beta-adrenergic_blocking_agents may also interact with sympathomimetics .
None(e1,e2)	0	6	digitalis_glycosides enhanced possibility of arrhythmias or digitalis toxicity associated with hypokalemia .
None(e1,e2)	2	23	chlorpromazine : chlorpromazine blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of amphetamines and can be used to treat amphetamine poisoning .
None(e1,e2)	8	21	this drug may interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	4	11	the optimal dose of indinavir , when given in combination with efavirenz , is not known .
None(e1,e2)	44	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	59	97	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	19	30	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	12	16	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	16	48	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	10	27	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	42	49	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	80	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	4	18	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	3	29	acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16 % ( 90 % confidence interval : 8-23 % ) , decrease mean c max digoxin by 26 % ( 90 % confidence interval : 16-34 % ) and decrease mean trough concentrations of digoxin by 9 % ( 90 % confidence limit : 19 % decrease to 2 % increase ) .
None(e1,e2)	2	20	diuretic : hydrochlorothiazide , given concomitantly with ketoprofen , produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone .
mechanism(e1,e2)	8	38	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	29	33	however , in a well-controlled study of patients with lymphoma on combination therapy , allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide , doxorubicin , bleomycin , procarbazine and/or mechlorethamine .
None(e1,e2)	66	126	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	80	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	5	if novolog is mixed with nph_human_insulin , novolog should be drawn into the syringe first .
None(e1,e2)	57	100	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	11	13	compounds tested in man include warfarin , theophylline , phenytoin , diazepam , aminopyrine and antipyrine .
None(e1,e2)	45	51	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	31	33	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	27	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type_anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	97	103	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	36	41	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	12	14	diphenhydramine hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	2	10	co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27 % compared with those achieved with anastrozole alone .
None(e1,e2)	2	6	anticonvulsants : carbamazepine , phenobarbital , phenytoin
None(e1,e2)	15	28	because both of these drugs have negative inotropic properties and the effects of coadministration with tambocor are unknown , neither disopyramide nor verapamil should be administered concurrently with tambocor unless , in the judgment of the physician , the benefits of this combination outweigh the risks .
None(e1,e2)	0	11	probenecid : the oral combination of probenecid before intramuscular injection of pipracil produces an increase in piperacillin peak serum level of about 30 % .
None(e1,e2)	39	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	25	29	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
None(e1,e2)	9	29	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	25	35	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	22	24	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
None(e1,e2)	25	38	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	8	17	since animal studies suggest that the action of barbiturates may be prolonged by therapy with chlorpropamide , barbiturates should be employed with caution .
None(e1,e2)	50	52	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic_acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	35	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	9	known drug interactions include barbiturates , tranquilizers , and alcohol .
None(e1,e2)	7	17	phase ii clinical trial data , where iressa and vinorelbine have been used concomitantly , indicate that iressa may exacerbate the neutropenic effect of vinorelbine .
None(e1,e2)	4	9	however , patients on digoxin may show elevations of digoxin concentrations after initiation of therapy with flolan , which may be clinically significant in patients prone to digoxin toxicity .
None(e1,e2)	11	29	acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16 % ( 90 % confidence interval : 8-23 % ) , decrease mean c max digoxin by 26 % ( 90 % confidence interval : 16-34 % ) and decrease mean trough concentrations of digoxin by 9 % ( 90 % confidence limit : 19 % decrease to 2 % increase ) .
None(e1,e2)	3	8	concomitant administration of kerlone with the oral anticoagulant warfarin has been shown not to potentiate the anticoagulant effect of warfarin .
None(e1,e2)	0	18	enoxaparin dosed as a 1.0 mg/kg subcutaneous injection q12h for four doses did not alter the pharmacokinetics of eptifibatide or the level of platelet aggregation in healthy adults .
mechanism(e1,e2)	11	18	a 30 to 45 % increase in auc and cmax of nisoldipine was observed with concomitant administration of cimetidine_400_mg twice daily .
None(e1,e2)	42	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	9	14	binding to plasma protein is not significantly altered by diazepam , diphenylhydantoin , or phenylbutazone .
None(e1,e2)	14	27	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	24	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting_enzyme_inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal_anti-inflammatory agents , theophylline , and zidovudine ) .
advise(e1,e2)	4	12	it is recommended that gabapentin be taken at least 2 hours following maalox administration .
effect(e1,e2)	3	15	cardiac effects of dopamine are antagonized by beta-adrenergic blocking agents , such as propranolol and metoprolol .
None(e1,e2)	46	60	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin_b12 and folic acid .
mechanism(e1,e2)	16	41	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc . ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
None(e1,e2)	9	18	in vitro studies have shown no binding displacement between entacapone and other highly bound drugs , such as warfarin , salicylic acid , phenylbutazone , and diazepam .
None(e1,e2)	24	26	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease_inhibitors , quinidine , and verapamil .
None(e1,e2)	21	34	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	15	21	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	6	22	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	5	8	with oral dapsone treatment , folic_acid_antagonists such as pyrimethamine have been noted to possibly increase the likelihood of hematologic reactions
effect(e1,e2)	12	23	however , there has been one report of prolonged prothrombin time when buspirone was added to the regimen of a patient treated with warfarin .
None(e1,e2)	90	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	13	20	iodine or iodine excess may decrease the effect of carbimazole , and an iodine deficiency can increase the effect of carbimazole .
None(e1,e2)	13	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	50	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	17	spontaneous reports of serotonin syndrome associated with co-administration of zyvox and serotonergic_agents , including antidepressants such as selective_serotonin_reuptake_inhibitors ( ssris ) , have been reported .
None(e1,e2)	20	24	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium_channel_blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	31	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
advise(e1,e2)	7	46	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist_analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	13	15	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	3	9	the disposition of theophylline was not altered by concomitant cetirizine administration .
None(e1,e2)	0	17	warfarin : in a study in healthy volunteers , no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin ( 0.7 mg/kg body weight ) were administered during 11 days of multipledose treatment with 5 mg b.i.d . isradipine .
None(e1,e2)	11	15	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	17	28	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
None(e1,e2)	5	14	concomitant use of antihistamines with alcohol , tricyclic antidepressants , barbiturates , or other central_nervous_system_depressants may have an additive effect .
None(e1,e2)	13	29	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	8	19	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	9	27	omeprazole : the rate and extent of absorption of ciprofloxacin was bioequivalent when proquin xr was given alone or when proquin xr was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion .
effect(e1,e2)	13	32	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic_blocking_agents , calcium channel blockers , antihistamines or h1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	30	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	21	31	rifampin : when a single 375-mg dose of aprepitant was administered on day9 of a 14-day regimen of 600 mg/day of rifampin , a strong cyp3a4 inducer , the auc of aprepitant decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold .
None(e1,e2)	0	20	adrenergic_agents : some individuals receiving zyvox may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic agents , vasopressor or dopaminergic agents .
mechanism(e1,e2)	6	44	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim /sulfamethoxazole or zidovudine .
None(e1,e2)	30	40	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
mechanism(e1,e2)	11	16	use in conjunction with other antiepileptic drugs : the addition of felbatol to antiepileptic drugs ( aeds ) affects the steady-state plasma concentrations of aeds .
None(e1,e2)	20	33	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	57	81	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	7	12	other : coadministration of grapefruit juice with cisapride increases the bioavailability of cisapride and concomitant use should be avoided .
None(e1,e2)	14	23	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
mechanism(e1,e2)	1	16	some quinolones , including ciprofloxacin , have also been shown to interfere with the metabolism of caffeine .
None(e1,e2)	65	96	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	5	12	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
None(e1,e2)	26	28	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	12	15	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
effect(e1,e2)	14	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	21	34	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace_inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	8	10	similarly , patients receiving the drug and a hydantoin , sulfonamide or sulfonylurea should be observed for signs of toxicity to these drugs .
None(e1,e2)	22	30	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic_acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	53	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	23	52	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	2	6	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
int(e1,e2)	0	35	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	41	45	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	20	25	clinical studies in healthy volunteers show that the pharmacokinetics of cancidas are not altered by itraconazole , amphotericin b , mycophenolate , nelfinavir , or tacrolimus .
None(e1,e2)	46	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	21	erythromycin has been reported to decrease the clearance of triazolam and midazolam and thus may increase the pharmacologic effect of these benzodiazepines .
None(e1,e2)	24	40	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
mechanism(e1,e2)	28	64	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	8	13	cholestyramine : the influence of the bile-acidsequestering agent cholestyramine on the pharmacokinetits of cerivastatin_sodium was evaluated in 12 healthy males in 2 separate randomized crossover studies .
None(e1,e2)	4	6	furthermore , rifampin , phenytoin , phenobarbital , and other inducers of cytochrome p450 3a4 may cause a reduction in plasma bexarotene concentrations .
None(e1,e2)	21	32	drug-drug interactions albuterol - strattera should be administered with caution to patients being treated with systemically-administered ( oral or intravenous ) albuterol ( or other beta2 agonists ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .
effect(e1,e2)	2	32	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants .when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	0	26	naproxen : coadministration ( n=18 ) of naproxen sodium capsules ( 250 mg ) with neurontin ( 125 mg ) appears to increase the amount of gabapentin absorbed by 12 % to 15 % .
None(e1,e2)	1	5	- hydroxychloroquine ( e.g. , plaquenil ) or
None(e1,e2)	40	59	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	24	30	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
mechanism(e1,e2)	5	14	cyclosporin : reports indicate that cyclosporine levels may be increased during concomitant treatment with allopurinol_sodium for injection .
None(e1,e2)	9	22	for comprehensive information concerning laboratory test alterations associated with ritonavir , physicians should refer to the complete prescribing information for norvir ( ritonavir ) .
None(e1,e2)	58	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	4	12	antidepressants , tricyclic : amphetamines may enhance the activity of tricyclic or sympathomimetic_agents ;
None(e1,e2)	7	12	oral contraceptives : the effect of oral contraceptives on the pharmacokinetics of d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp has not been studied .
effect(e1,e2)	4	8	anesthetics/sedatives/hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	57	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	28	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	4	14	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
advise(e1,e2)	4	9	therefore , patients on propranolol should be observed when colestid tablets are either added or deleted from a therapeutic regimen .
effect(e1,e2)	4	17	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	52	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	44	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	17	25	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	44	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	85	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	22	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	28	51	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
effect(e1,e2)	9	42	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	33	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	38	51	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	14	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
mechanism(e1,e2)	0	20	gleevec will increase plasmaconcentration of other cyp3a4 metabolized drugs ( e.g. , triazolo-benzodiazepines , dihydropyridine calcium channel blockers , certain hmg-coa_reductase_inhibitors , etc . ) .
effect(e1,e2)	4	29	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns_depressants , causing increased cns depression .
None(e1,e2)	13	15	the clearance of benzodiazepines metabolized by glucuronidation ( e. g. , lorazepam , oxazepam , temazepam ) is unlikely to be affected by fluvoxamine .
None(e1,e2)	15	19	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns_depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	28	115	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	19	co-administration of cyp3a4 inhibitors ( eg , ketoconazole , itraconazole , erythromycin , grapefruit juice , cimetidine ) with felodipine may lead to several- fold increases in the plasma levels of felodipine , either due to an increase in bioavailability or due to a decrease in metabolism .
None(e1,e2)	37	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	21	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	2	28	may interact anticoagulants ( altered hypo-prothrombinemic effect ) , barbiturates , rifampin and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of diethylstilbestrol ) , corticosteroids ( increased effect of corticosteroids ) .
None(e1,e2)	0	2	digoxin : rofecoxib 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of digoxin after a single 0.5 mg oral dose .
None(e1,e2)	11	30	since entecavir is primarily eliminated by the kidneys , coadministration of baraclude with drugs that reduce renal function or compete for active tubular secretion may increase serum concentrations of either entecavir or the coadministered drug .
None(e1,e2)	3	39	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	4	40	since higher doses of ketoconazole ( 400 mg daily ) may result in higher increases in cmax and auc , a single 2.5 mg dose of vardenafil should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily .
None(e1,e2)	0	31	hormonal_contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	23	30	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic_acid increased the cmax and auc of mefenamic_acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
effect(e1,e2)	4	21	renal clearance measurements of pah can not be made with any significant accuracy in patients receiving sulfonamides , procaine , or thiazolesulfone .
mechanism(e1,e2)	10	18	drugs that may have their plasma concentration altered by gleevec gleevec increases the mean cmax and auc of simvastatin ( cyp3a4 substrate ) 2- and 3.5-fold , respectively , suggesting an inhibition of the cyp3a4 by gleevec .
None(e1,e2)	10	22	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
effect(e1,e2)	7	18	since bacteriostatic drugs , such as the tetracycline_class of antibiotics , may interfere with the bactericidal action of penicillins , it is not advisable to administer these drugs concomitantly .
None(e1,e2)	16	18	renal clearance measurements of pah can not be made with any significant accuracy in patients receiving sulfonamides , procaine , or thiazolesulfone .
None(e1,e2)	6	13	in clinical studies , coadministration of welchol with atorvastatin , lovastatin , or simvastatin did not interfere with the lipid-lowering activity of the hmg-coa reductase inhibitor .
None(e1,e2)	3	7	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
None(e1,e2)	28	33	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	26	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	71	111	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	32	63	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic_acid .
None(e1,e2)	2	6	fluoxetine , fluvoxamine , paroxetine , sertraline ) .
None(e1,e2)	21	54	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	39	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	19	28	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	33	41	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide_dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	63	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	13	rifampin : rifampin increases the metabolism of ethinyl estradiol and some progestins ( norethindrone ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
None(e1,e2)	26	40	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	4	7	single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively .
None(e1,e2)	45	61	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	41	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	21	h2_receptor_antagonists : cimetidine coadministration leads to an increased peak plasma concentration and auc of cisapride , there is no effect on cisapride absorption when it is coadministered with ranitidine .
effect(e1,e2)	21	29	h2 blockers/proton pump inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	23	61	in three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days ( n=18 ) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine ( n=18 ) or with cimetidine 600 mg every 12 hours for 14 days ( n=18 ) under steady state conditions to normal healthy male and female volunteers .
None(e1,e2)	6	17	antihypertensive medications , other , especially diazoxide , or preanesthetic and anesthetic agents used in surgery or skeletal-muscle_relaxants , nondepolarizing , used in surgery
None(e1,e2)	35	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	144	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	36	42	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	87	128	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	25	36	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	0	15	dicumarol : it has been reported that allopurinol prolongs the half-life of the anticoagulant , dicumarol .
None(e1,e2)	8	28	in clinical studies where patients were on chronic theophylline therapy , lomefloxacin had no measurable effect on the mean distribution of theophylline concentrations or the mean estimates of theophylline clearance .
None(e1,e2)	2	32	effects of felbatol on low-dose combination oral contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
None(e1,e2)	76	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	11	may interact anticoagulants ( altered hypo-prothrombinemic effect ) , barbiturates , rifampin and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of diethylstilbestrol ) , corticosteroids ( increased effect of corticosteroids ) .
None(e1,e2)	31	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	29	35	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	118	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	13	29	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine_oxidase_inhibitors , and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic_drugs .
None(e1,e2)	21	32	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace_inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
advise(e1,e2)	18	22	however , due to possible pharmacodynamic interactions , when co-administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
None(e1,e2)	30	35	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	17	ketoconazole : ketoconazole 400 mg daily did not have any clinically important effect on the pharmacokinetics of rofecoxib .
None(e1,e2)	11	30	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	15	19	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	33	43	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
mechanism(e1,e2)	0	8	acarbose has been shown to change the bioavailabillty digoxin when they are co-administered , which may require digoxin dose adjustment .
None(e1,e2)	0	2	sedatives / hypnotics : triazolam , midazolam contraindicated due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression .
None(e1,e2)	20	28	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	4	11	nonsteroidal anti-inflammatory drugs ( nsaids ) -a drug interaction study of eplerenone with an nsaid has not been conducted .
mechanism(e1,e2)	8	21	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	24	47	in vivo studies : nitrates : the blood pressure lowering effects of sublingual nitrates ( 0.4 mg ) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1 , 4 and 8 hours were potentiated by a 20 mg dose of vardenafil in healthy middle-aged subjects .
None(e1,e2)	18	39	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic_antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	21	29	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace_inhibitors , disopyramide , fibrates , fluoxetine , monoamine_oxidase_(_mao_)_inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
mechanism(e1,e2)	1	5	when amiodarone is added to flecainide therapy , plasma flecainide levels may increase two-fold or more in some patients , if flecainide dosage is not reduced .
int(e1,e2)	3	12	clinical studies with celecoxib have identified potentially significant interactions with fluconazole and lithium .
None(e1,e2)	40	42	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	26	34	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	29	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	4	19	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	4	36	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	7	35	inhibitors of this isoenzyme ( e.g. , macrolide_antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
mechanism(e1,e2)	1	5	when itraconazole was coadministered with phenytoin , rifampin , or h2antagonists , reduced plasma concentrations of itraconazole were reported .
advise(e1,e2)	4	10	in addition , most macrolides are contraindicated in patients receiving terfenadine therapy who have pre-existing cardiac abnormalities ( arrhythmia , bradycardia , qt c interval prolongation , ischemic heart disease , congestive heart failure , etc . ) or electrolyte disturbances .
None(e1,e2)	40	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	18	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum -containing antacid preparations .
None(e1,e2)	59	81	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	21	23	adrenergic agents : some individuals receiving zyvox may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic agents , vasopressor or dopaminergic_agents .
None(e1,e2)	27	49	in two controlled crossover clinical pharmacology studies in healthy male ( n=12 in each study ) a nd female ( n=12 in each study ) volunteers , desloratadine 7.5 mg ( 1.5 times the daily dose ) once daily was coadministered with erythromycin 500 mg every 8 hours or ketoconazole 200 mg every 12 hours for 10 days .
None(e1,e2)	4	25	rifampin : co-administration of vioxx with rifampin 600 mg daily , a potent inducer of hepatic metabolism , produced an approximate 50 % decrease in rofecoxib plasma concentrations .
None(e1,e2)	14	22	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	18	20	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	6	11	drug/laboratory test interactions as with other penicillins , the administration of pipracil may result in a false-positive reaction for glucose in the urine using a copper-reduction method .
None(e1,e2)	41	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	53	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	109	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	87	123	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	14	in addition , fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .
None(e1,e2)	0	2	hmg-coa_reductase_inhibitors : simvastatin ( cyp3a4 substrate ) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis .
None(e1,e2)	35	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	6	26	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	16	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
effect(e1,e2)	8	55	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	11	15	more than 600 parkinsons disease patients in clinical trials have used selegiline in combination with entacapone and levodopa/dopa decarboxylase inhibitor .
None(e1,e2)	0	16	lithium reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ace inhibitors , and with some angiotensin ii receptor antagonists .
effect(e1,e2)	7	19	flucytosine : while a synergistic relationship with amphotericin_b has been reported , concomitant use may increase the toxicity of flucytosine by possibly increasing its cellular uptake and/or impairing its renal excretion .
None(e1,e2)	18	29	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	37	69	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	47	coadministration of valdecoxib ( 40 mg bid ( day 1 ) and 40 mg qd ( days 2-7 ) ) with glyburide ( 5 mg qd ) did not affect either the pharmacokinetics ( exposure ) or the pharmacodynamics ( blood glucose and insulin levels ) of glyburide .
None(e1,e2)	25	37	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	52	69	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	45	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic_products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	7	13	drug interactions : a . drugs enhancing heparin effect : oral anticoagulants : heparin_sodium may prolong the one-stage prothrombin time .
None(e1,e2)	3	9	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
mechanism(e1,e2)	2	6	coadministration with valdecoxib increased exposure of omeprazole ( auc ) by 46 % .
None(e1,e2)	0	9	antihistamines : amphetamines may counteract the sedative effect of antihistamines .
None(e1,e2)	10	14	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	17	21	may lead to loss of virologic response and possible resistance to crixivan or to the class of protease_inhibitors or other coadministered antiretroviral_agents .
None(e1,e2)	5	17	investigations into the effect of acitretin on the protein binding of anticoagulants of the coumarin type ( warfarin ) revealed no interaction .
None(e1,e2)	12	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	7	selective_serotonin_reuptake_inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-htv agonists .
None(e1,e2)	54	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	19	25	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	0	22	ampicillin /amoxicillin : an increase in the frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs .
None(e1,e2)	0	17	fluoxetine and its active metabolite , norfluoxe-tine , have long half-lives ( 4 to 16 days for norfluoxetine ) , that may affect strategies during conversion from one drug to the other .
None(e1,e2)	8	32	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	0	11	probenecid : as with other b-lactam antibiotics , renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80 % increase in the auc for loracarbef .
None(e1,e2)	0	20	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
int(e1,e2)	9	19	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
None(e1,e2)	0	2	cimetidine : cimetidine has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various tricyclic antidepressants .
effect(e1,e2)	18	31	as with some other nondepolarizing neuromuscular blocking agents , the time of onset of neuromuscular block induced by nuromax is lengthened and the duration of block is shortened in patients receiving phenytoin or carbamazepine .
None(e1,e2)	23	130	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	23	42	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	42	46	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal_muscle_relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	26	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	20	28	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin_b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	18	31	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
mechanism(e1,e2)	8	21	ketoconazole : when a single 125-mg dose of aprepitant was administered on day5 of a 10-day regimen of 400 mg/day of ketoconazole , a strong cyp3a4 inhibitor , the auc of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold .
None(e1,e2)	19	40	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal_muscle_relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	13	62	the principal drugs given ( number of patients in parentheses ) were : cardiac_glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	0	7	anesthetics /sedatives/hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	30	32	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
mechanism(e1,e2)	0	7	aminosalicylic_acid may also decrease the absorption of vitamin_b12 , which can lead to a deficiency .
None(e1,e2)	16	19	as with other agents with b-blocking properties , if coreg is to be administered orally with calcium_channel_blockers of the verapamil or diltiazem type , it is recommended that ecg and blood pressure be monitored .
None(e1,e2)	30	50	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth_subsalicylate ( pepto-bismol ) ;
None(e1,e2)	2	25	cns-active drugs ethanol an additive effect on psychomotor performance was seen with coadministration of eszopiclone and ethanol 0.70 g/kg for up to 4 hours after ethanol administration .
None(e1,e2)	14	16	consequently , it is recommended that fluvoxamine not be used in combination with either terbinafine , astemizole , or cisapride .
None(e1,e2)	8	14	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	8	16	while all the selective serotonin reuptake inhibitors ( ssris ) , e. g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	28	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	20	32	caution is advised when trisenox is coadministered with other medications that can prolong the qt interval ( e.g . certain antiarrhythmics or thioridazine ) or lead to electrolyte abnormalities ( such as diuretics or amphotericin b ) .
None(e1,e2)	0	8	uricosuric_agents : aspirin may decrease the effects of probenecid , sulfinpyrazone , and phenylbutazone .
None(e1,e2)	25	27	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
mechanism(e1,e2)	12	31	interactions with other antiretroviral drugs : significant decreases in the auc of delavirdine ( 20 % ) and indinavir ( 84 % ) occurred following simultaneous administration of these agents with videx .
None(e1,e2)	16	23	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
int(e1,e2)	0	19	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	135	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	68	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	0	4	amphotericin_b or corticosteroids or corticotropin ( acth )
None(e1,e2)	0	25	exemestane is extensively metabolized by cyp 3a4 , but coadministration of ketoconazole , a potent inhibitor of cyp 3a4 , has no significant effect on exemestane pharmacokinetics .
None(e1,e2)	21	25	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	1	5	certain antibiotic , cisplatin , cyclosporine , diuretic , foscarnet , and vaccines .
None(e1,e2)	3	31	example inhibitors include azole_antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	9	56	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	1	33	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic_acid has been reported to both increase and decrease ethosuximide levels ) .
advise(e1,e2)	4	17	therefore , co-administration of tricyclic_antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	4	6	antipsychotic drugs such as phenothiazines or haloperidol ;
advise(e1,e2)	5	12	it is recommended that if casodex is started in patients already receiving coumarin_anticoagulants , prothrombin times should be closely monitored and adjustment of the anticoagulant dose may be necessary .
None(e1,e2)	22	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	16	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	30	40	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	17	19	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	30	51	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	15	21	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	9	30	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	9	15	in patients in whom cyp3a4 inducers ( eg , dexamethasone , phenytoin , carbamazepine , rifampicin , phenobarbital ) are indicated , alternative agents with less enzyme induction potential should be used .
None(e1,e2)	10	27	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	0	10	coumarin_anticoagulant s : in a small clinical trial in which lovastatin was administered to warfarin treated patients , no effect on prothrombin time was detected .
None(e1,e2)	8	10	cyclopentolate may interfere with the anti-glaucoma action of carbachol or pilocarpine ;
None(e1,e2)	13	18	other concomitant therapy in healthy subjects there were no clinically significant interactions when felodipine was given concomitantly with indomethacin or spironolactone .
None(e1,e2)	22	33	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	65	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	19	24	in psoriatic arthritis clinical trials , concomitant medications included mtx in approximately half of the patients as well as nonsteroidal_anti-inflammatory_agents , folic acid and corticosteroids .
None(e1,e2)	32	34	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	20	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	7	9	certain antibiotic , cisplatin , cyclosporine , diuretic , foscarnet , and vaccines .
None(e1,e2)	4	14	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine_antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	11	35	metformin : in healthy subjects given single 500 mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of 34 % and 24 % , respectively , and metformin mean renal clearance decreased by 14 % .
None(e1,e2)	4	6	however , co-administration of duloxetine with aluminum - and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	28	40	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	40	61	in three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days ( n=18 ) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine ( n=18 ) or with cimetidine 600 mg every 12 hours for 14 days ( n=18 ) under steady state conditions to normal healthy male and female volunteers .
None(e1,e2)	25	40	ace inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin ii receptor antagonists ( acei /arb ) .
effect(e1,e2)	8	17	nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibiotics or potent diuretics such as furosemide .
None(e1,e2)	2	12	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	6	9	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	0	33	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	11	16	these would include a variety of preparations which contain androgens , estrogens , progestins , or glucocorticoids .
None(e1,e2)	15	37	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative /hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
mechanism(e1,e2)	2	9	coadministration of propoxyphene decreased the maximum plasma concentration of alprazolam by 6 % , decreased clearance by 38 % , and increased half-life by 58 % .
None(e1,e2)	1	45	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	1	11	analgesic/ anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	6	21	iron supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	15	24	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
effect(e1,e2)	8	24	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	18	37	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	46	65	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	16	38	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	38	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	32	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	42	45	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	55	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	35	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	21	29	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	20	22	coumarin anticoagulants altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative anticoagulants such as warfarin and phenprocoumon .
None(e1,e2)	4	10	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
None(e1,e2)	15	47	in a phase i trial using escalating doses of taxol ( 110-200 mg/m2 ) and cisplatin ( 50 or 75 mg/m2 ) given as sequential infusions , myelosuppression was more profound when taxol was given after cisplatin than with the alternate sequence ( ie , taxol before cisplatin ) .
None(e1,e2)	133	140	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	40	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	4	7	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	0	2	terfenadine , astemizole and cisapride are all metabolized by the cytochrome p450iiia4 isozyme , and it has been demonstrated that ketoconazole , a potent inhibitor of iiia4 , blocks the metabolism of these drugs , resulting in increased plasma concentrations of parent drug .
mechanism(e1,e2)	3	5	concurrent administration of dyphylline and probenecid , which competes for tubular secretion , has been shown to increase the plasma half-life of dyphylline .
None(e1,e2)	44	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	14	in 5 other schizophrenic patients treated with oral haloperidol and rifampin , discontinuation of rifampin produced a mean 3.3-fold increase in haloperidol concentrations .
None(e1,e2)	2	25	- a steroid_medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	28	40	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	23	27	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimet-ics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	43	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	13	32	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	23	86	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	23	29	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	7	43	dexbrompheniramine can interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	27	48	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	0	8	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	9	21	erythromycin has been reported to decrease the clearance of triazolam and midazolam and thus may increase the pharmacologic effect of these benzodiazepines .
None(e1,e2)	13	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	80	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	14	quinolones , including norfloxacin , may enhance the effects of oral anticoagulants , including warfarin or its derivatives or similar agents .
None(e1,e2)	11	32	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	11	15	compounds tested in man include warfarin , theophylline , phenytoin , diazepam , aminopyrine and antipyrine .
None(e1,e2)	0	3	potassium supplements and potassium-sparing_diuretics : fosinopril sodium can attenuate potassium loss caused by thiazide diuretics .
None(e1,e2)	76	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	8	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	46	71	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	3	15	dosage adjustment of strattera may be necessary when coadministered with cyp2d6 inhibitors , e.g. , paroxetine , fluoxetine , and quinidine .
None(e1,e2)	42	44	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or h1-blocking_agents , tricyclic_antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	1	13	serum lithium levels should be monitored frequently if inspra is administered concomitantly with lithium .
None(e1,e2)	19	46	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	40	42	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	75	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	10	13	concomitant treatment of four patients in the united kingdom with foscavir and intravenous pentamidine may have caused hypocalcemia ;
None(e1,e2)	4	15	potential drug interactions for doxylamine include , increased sedation if doxylamine is combined with other cns_depressant_drugs .
None(e1,e2)	0	21	aspirin : concomitant administration of aspirin with valdecoxib may result in an increased risk of gi ulceration and complications compared to valdecoxib alone .
None(e1,e2)	4	10	ethopropazine can interact with chlorpromazine , increasing the metabolism of chlorpromazine .
None(e1,e2)	8	61	interactions may also occur with the following : anti-depressants /anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
effect(e1,e2)	1	3	both digoxin and coreg slow av conduction .
None(e1,e2)	22	36	lithium : in a study conducted in healthy subjects , mean steady-state lithium plasma levels increased approximately 17 % in subjects receiving lithium 450 mg bid with celebrex 200 mg bid as compared to subjects receiving lithium alone .
None(e1,e2)	11	35	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	29	34	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	36	59	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	38	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	27	37	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	19	23	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	61	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	14	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	9	11	in vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the pk properties of anagrelide , nor does anagrelide affect the pk properties of digoxin or warfarin .
None(e1,e2)	31	87	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	43	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	29	35	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic_hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
advise(e1,e2)	1	18	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
mechanism(e1,e2)	19	66	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	24	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	11	ritonavir and indinavir : upon concomitant administration of 5 mg of vardenafil with 600 mg bid ritonavir , the cmax and auc of ritonavir were reduced by approximately 20 % .
None(e1,e2)	16	22	doxazosin mesylate has been administered without any evidence of an adverse drug interaction to patients receiving thiazide_diuretics , beta-blocking agents , and nonsteroidal_anti-inflammatory_drugs .
mechanism(e1,e2)	13	15	however , in a study of 12 normal subjects , concurrent administration of aspirin decreased ketoprofen protein binding and increased ketoprofen plasma clearance from 0.07 l/kg/h without aspirin to 0.11 l/kg/h with aspirin .
None(e1,e2)	54	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	57	64	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
effect(e1,e2)	5	24	micro-dosed progesterone preparations : micro-dosed progesterone preparations ( minipills that do not contain an estrogen ) may be an inadequate method of contraception during accutane therapy .
None(e1,e2)	12	21	drug/laboratory test interaction fosinopril may cause a false low measurement of serum digoxin levels with the digi- tab ria kit for digoxin .
None(e1,e2)	20	27	however , in a study of 12 normal subjects , concurrent administration of aspirin decreased ketoprofen protein binding and increased ketoprofen plasma clearance from 0.07 l/kg/h without aspirin to 0.11 l/kg/h with aspirin .
None(e1,e2)	2	16	because oral anticoagulants may interfere with the hepatic metabolism of phenytoin , toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently .
None(e1,e2)	22	30	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	3	35	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	21	25	in a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of prinivil alone were compared to prinivil given concomitantly with indomethacin , the use of indomethacin was associated with a reduced antihypertensive effect , although the difference between the two regimens was not significant .
None(e1,e2)	35	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	120	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	30	49	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	18	32	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	44	54	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	62	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	21	rifampin : when a single 375-mg dose of aprepitant was administered on day9 of a 14-day regimen of 600 mg/day of rifampin , a strong cyp3a4 inducer , the auc of aprepitant decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold .
None(e1,e2)	7	41	zebeta should be used with care when myocardial_depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	4	14	drugs that induce cyp3a4 rifampin : cyp3a4 is ordinarily a minor metabolizing enzyme of zaleplon .
advise(e1,e2)	2	29	therefore , nitroglycerin or other nitrates ( as used for management of angina ) or other drugs having vasodilator activity should , if possible , be discontinued before starting captopril .
None(e1,e2)	139	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	17	verapamil : coadministration of almotriptan and verapamil resulted in a 24 % increase in plasma concentrations of almotriptan .
effect(e1,e2)	8	12	in particular , convulsions have been reported when ethionamide is administered with cycloserine and special care should be taken when the treatment regimen includes both of these drugs .
None(e1,e2)	12	18	caution should be exercised when the following drugs are administered concomitantly with lodosyn ( carbidopa ) given with levodopa or carbidopa-levodopa combination products .
None(e1,e2)	81	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	26	in a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram , absorption of the proton_pump_inhibitors was delayed and their bioavailability was reduced by 17 % and 16 % , respectively , when administered concomitantly with sucralfate .
None(e1,e2)	0	5	cimetidine , caffeine , and erythromycin may increase plasma levels of clozapine , potentially resulting in adverse effects .
None(e1,e2)	6	21	no dose adjustment is necessary when simulect is added to triple-immunosuppression regimens including cyclosporine , corticosteroids , and either azathioprine or mycophenolate_mofetil .
None(e1,e2)	13	19	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	30	40	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or h1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	11	24	methotrexate : in an interaction study of rheumatoid arthritis patients taking methotrexate , celebrex did not have a significant effect on the pharmacokinetics of methotrexate .
None(e1,e2)	1	3	sedative/ hypnotics : midazolam , triazolam
None(e1,e2)	85	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	16	fentanyl anesthesia : severe hypotension has been reported during fentanyl anesthesia with concomitant use of a beta_blocker and a calcium channel blocker .
None(e1,e2)	110	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	10	fluconazole , and the 5-ht3_antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	39	41	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic_antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
int(e1,e2)	0	14	sulfapyridine may interact with any of the following : - acetaminophen ( e.g. , tylenol ) ( with long-term , high-dose use ) or
None(e1,e2)	59	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	41	on the basis of the metabolism of bexarotene by cytochrome p450 3a4 , ketoconazole , itraconazole , erythromycin , gemfibrozil , grapefruit juice , and other inhibitors of cytochrome p450 3a4 would be expected to lead to an increase in plasma bexarotene concentrations .
None(e1,e2)	7	21	dopamine antagonists : since apomorphine is a dopamine_agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	34	64	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	19	32	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	15	17	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
None(e1,e2)	59	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	13	27	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
mechanism(e1,e2)	6	42	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	8	10	oral neomycin sulfate may enhance the effect of coumarin in anticoagulants by decreasing vitamin k availability .
None(e1,e2)	19	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	10	20	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	0	9	ergotamine : concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
None(e1,e2)	3	5	the effect of cyclosporine on diltiazem plasma concentrations has not been evaluated .
None(e1,e2)	2	16	ritonavir and indinavir : upon concomitant administration of 5 mg of vardenafil with 600 mg bid ritonavir , the cmax and auc of ritonavir were reduced by approximately 20 % .
None(e1,e2)	11	37	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon_beta-1a ( avonex 30 mcg im once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer_acetate .
None(e1,e2)	19	26	in a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram , absorption of the proton_pump_inhibitors was delayed and their bioavailability was reduced by 17 % and 16 % , respectively , when administered concomitantly with sucralfate .
None(e1,e2)	14	31	the possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril ( captopril tablets , usp ) or initiating therapy with small doses ( 6.25 or 12.5 mg ) .
None(e1,e2)	7	14	diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity .
None(e1,e2)	27	40	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	33	44	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
effect(e1,e2)	13	23	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline_hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	3	19	example inhibitors include azole_antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	71	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	7	cyclosporine : concomitant administration of nicardipine and cyclosporine levels .
None(e1,e2)	71	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	119	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	16	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	2	6	alternatives to clarithromycin , such as azithromycin , should be considered .
advise(e1,e2)	0	18	brovana , as with other beta2-agonists , should be administered with extreme caution to patients being treated with monoamine_oxidase_inhibitors , tricyclic antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	14	17	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	23	29	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns_depressants , causing increased cns depression .
effect(e1,e2)	0	11	cocaine sometimes proves to be fatal when used in combination with heroin .
None(e1,e2)	3	8	the pharmacokinetics of naltrexone and its major metabolite 6-beta-naltrexol were unaffected following co-administration with acamprosate .
None(e1,e2)	0	10	cerivastatin plasma concentrations were also not affected by co-administration of digoxin .
effect(e1,e2)	9	15	nephrotoxicity has been reported following concomitant administration of other cephalosporins with potent diuretics such as furosemide .
None(e1,e2)	8	22	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	0	25	estazolam : interaction with drugs that inhibit metabolism via cytochrome p450 3a ( cyp3a ) : the metabolism of estazolam to the major circulating metabolite 4-hydroxy-estazolam and the metabolism of other triazolobenzodiazepines is catalyzed by cyp3a .
None(e1,e2)	5	26	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin_b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
advise(e1,e2)	4	11	antacids : enteric coated aspirin should not be given concurrently with antacids , since an increase in the ph of the stomach may effect the enteric coating of the tablets .
None(e1,e2)	9	18	concomitantly administered iron-fortified infant formula ( 2.2 mg elemental iron /6 oz ) has no significant effect on cefdinir pharmacokinetics .
None(e1,e2)	94	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	14	coumarin_anticoagulant s : in a small clinical trial in which lovastatin was administered to warfarin treated patients , no effect on prothrombin time was detected .
None(e1,e2)	22	36	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
mechanism(e1,e2)	2	10	increasing the felbamate dose to 2400 mg/day increased the steadystate valproate cmin to 96 25 micrograms/ml .
None(e1,e2)	20	22	drug-drug interactions : no clinically significant drug interactions have been found with theophylline at a low dose , azithromycin , pseudoephedrine , ketoconazole , or erythromycin .
None(e1,e2)	57	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	23	a similar association , though less marked , has been suggested with barbiturates , phenyl-butazone , phenytoin sodium , carbamazepine and possibly with griseofulvin , ampicillin , and tetracyclines ( 72 )
None(e1,e2)	49	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	29	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	8	20	however , because bleeding has been reported when ibuprofen and other nonsteroidal anti-inflammatory agents have been administered to patients on coumarin-type_anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
None(e1,e2)	15	28	approximately 2/3 of the patients in the phase 3 study received either prophylactic low dose heparin ( unfractionated heparin up to 15,000 units/day ) or prophylactic doses of low_molecular_weight_heparins as indicated in the prescribing information for the specific products .
None(e1,e2)	7	22	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine contraindicated due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
None(e1,e2)	21	25	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	25	27	because of the potential for adverse reactions from the drugs in nursing infants , a decision must be made whether to discontinue nursing or discontinue pegasys and copegus treatment .
None(e1,e2)	6	10	no significant interactions were found between nisoldipine and warfarin or digoxin .
effect(e1,e2)	0	4	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating drugs .
None(e1,e2)	29	31	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	2	9	to avoid phenytoin intoxication , appropriate adjustment of the anticonvulsant should be made .
None(e1,e2)	43	47	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	21	in order to maintain phenytoin levels , limit adverse experiences , and achieve the felbamate dose of 3600 mg/day , a phenytoin dose reduction of approximately 40 % was necessary for eight of these 10 subjects .
effect(e1,e2)	3	6	phenothiazines - taking piperazine and a phenothiazine together may increase the risk of convulsions ( seizures ) .
None(e1,e2)	79	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	2	ketoconazole : ketoconazole may inhibit both synthetic and catabolic enzymes of vitamin d .
None(e1,e2)	33	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	23	41	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide_class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	71	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	4	17	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine_oxidase_inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	42	54	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	3	6	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	26	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
advise(e1,e2)	10	18	of particular importance , sufficient time must elapse before initiating tca treatment in a patient being withdrawn from fluoxetine , given the long half-life of the parent and active metabolite ( at least 5 weeks may be necessary ) .
None(e1,e2)	37	40	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	10	19	in a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram , absorption of the proton pump inhibitors was delayed and their bioavailability was reduced by 17 % and 16 % , respectively , when administered concomitantly with sucralfate .
None(e1,e2)	8	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	33	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	8	lithium toxicity was usually reversible upon discontinuation of lithium and the ace inhibitor .
None(e1,e2)	11	23	drug interactions : flupenthixol may interact with some drugs , like monoamine_oxidase_inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
mechanism(e1,e2)	0	6	diuretic_agents reduce the renal clearance of lithium and add a high risk of lithium toxicity .
None(e1,e2)	8	11	therefore the , combination of anakinra with other tnf-blocking_agents , including humira , may also result i n similar toxicities .
None(e1,e2)	0	6	aspirin : concomitant administration of low-dose aspirin with vioxx may result in an increased rate of gi ulceration or other complications , compared to use of vioxx alone .
None(e1,e2)	25	34	since pletal is extensively metabolized by cytochrome p-450 isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a . such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
int(e1,e2)	5	7	ketoconazole : potential interaction of ketoconazole and isoniazid may exist .
None(e1,e2)	65	77	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	23	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	45	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	6	acetazolamide increases lithium excretion and the lithium may be decreased .
mechanism(e1,e2)	10	36	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	12	28	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg-coa_reductase_inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
None(e1,e2)	26	40	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	8	12	similarly , patients receiving the drug and a hydantoin , sulfonamide or sulfonylurea should be observed for signs of toxicity to these drugs .
None(e1,e2)	11	13	in addition , fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic_acid , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .
None(e1,e2)	57	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	56	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	13	28	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	39	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	19	21	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	0	23	warfarin : anticoagulant activity should be monitored , particularly in the first few days after initiating or changing vioxx therapy in patients receiving warfarin or similar agents , since these patients are at an increased risk of bleeding complications .
None(e1,e2)	20	28	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	9	41	ritonavir - combined administration of a single dose of ritonavir ( 600 mg ) , both a cyp3a4 substrate and a potent inhibitor of cyp3a4 , and escitalopram ( 20 mg ) did not affect the pharmacokinetics of either ritonavir or escitalopram .
None(e1,e2)	107	132	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	20	there have been case reports of increased steady-state levels of quinidine , procainamide , and phenytoin during concomitant therapy with amiodarone .
None(e1,e2)	9	11	other cns depressant drugs ( e.g . barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
None(e1,e2)	10	22	in a pharmacokinetic study , 38 healthy female subjects received ketoconazole 200 mg twice daily for 7 days , with coadministration of alosetron 1 mg on the last day .
None(e1,e2)	20	22	in vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol .
None(e1,e2)	35	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	57	65	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	6	18	rifampin : coadministration of rifampin and mepron suspension results in a significant decrease in average steady- state plasma atovaquone concentrations .
None(e1,e2)	4	9	however , co-administration of duloxetine with aluminum- and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
effect(e1,e2)	12	23	the possibility of hypotensive effects can be minimized by either discontinuing the diuretic or increasing salt intake prior to initiation of treatment with fosinopril_sodium .
None(e1,e2)	67	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	25	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	9	11	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine_derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
None(e1,e2)	23	30	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	9	23	in vitro studies have shown no binding displacement between entacapone and other highly bound drugs , such as warfarin , salicylic acid , phenylbutazone , and diazepam .
None(e1,e2)	16	43	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	0	2	beta-blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin .
None(e1,e2)	8	20	in the same study it was shown that didanosine and stavudine had no significant effect on the intracellular phosphorylation of zalcitabine in peripheral blood mononuclear cells .
None(e1,e2)	0	27	antiretroviral_agents : no drug interactions with other antiretroviral medications have been identified that would warrant alteration of either the enfuvirtide dose or the dose of the other antiretroviral_medication .
None(e1,e2)	57	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	5	23	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	1	24	oral anticoagulants interaction studies with warfarin and acenocoumarol failed to identify any clinically important effects on the serum concentrations or clinical effects of these anticoagulants .
None(e1,e2)	12	14	although these results do not indicate a significant interaction between toradol and warfarin or heparin , the administration of toradol to patients taking anticoagulants should be done extremely cautiously , and patients should be closely monitored .
None(e1,e2)	13	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	18	therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , analgesics , antiemetics , sedatives , tranquilizers ) .
None(e1,e2)	32	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	11	33	because severe hypoglycemia has been reported in patients concomitantly receiving oral miconazole ( an imidazole ) and oral hypoglycemic agents , such a potential interaction involving the latter agents when used concomitantly with ketoconazole tablets ( an imidazole ) can not be ruled out .
advise(e1,e2)	10	14	it is recommended that plasma lithium levels be monitored when ketoprofen is coadministered with lithium .
None(e1,e2)	14	20	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	43	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	2	valproate and gabapentin are not .
None(e1,e2)	57	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	7	22	other cns depressant drugs ( e.g . barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
None(e1,e2)	1	14	oral contraceptives rofecoxib did not have any clinically important effect on the pharmacokinetics of ethinyl_estradiol and norethindrone .
None(e1,e2)	23	35	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	12	14	other strong inhibitors of cyp3a4 ( e.g. , itraconazole , clarithromycin , nefazodone , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .
effect(e1,e2)	4	13	skeletal muscle relaxants : amphotericin_b -induced hypokalemia may enhance the curariform effect of skeletal_muscle_relaxants ( e.g. , tubocurarine ) .
None(e1,e2)	11	15	cephalosporins-cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
None(e1,e2)	1	20	serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of crohn s disease including corticosteroids , antibiotics ( metronidazole or ciprofloxacin ) and aminosalicylates .
None(e1,e2)	14	37	because busulfan is eliminated from the body via conjugation with glutathione , use of acetaminophen prior to ( 72 hours ) or concurrent with busulfex may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues .
None(e1,e2)	20	31	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	27	31	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao_inhibitors , and other antidepressants .when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	2	7	coadministration of rifampin with diltiazem lowered the diltiazem plasma concentrations to undetectable levels .
effect(e1,e2)	7	20	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin_sodium .
None(e1,e2)	3	15	other drug interactions cimetidine , erythromycin and dextropropoxyphene had no effect on the pharmacokinetics of mhd .
None(e1,e2)	9	31	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	41	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	40	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	7	22	studies in healthy volunteers have shown that acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin , nifedipine , propranolol , or ranitidine .
None(e1,e2)	9	17	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	18	32	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	76	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	2	12	acetaminophen and methotrexate - l-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate .
None(e1,e2)	8	43	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	19	33	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	67	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	16	therefore smaller alfenta doses will be required with prolonged administration and the duration of action of alfenta my be extended .
None(e1,e2)	27	53	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	85	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	4	magnesium- and aluminum -containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability ( 48 % ) of lomefloxacin .
None(e1,e2)	74	104	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	16	23	dexamethasone : steady-state trough concentrations of albendazole sulfoxide were about 56 % higher when 8 mg dexamethasone was coadministered with each dose of albendazole ( 15 mg/kg/day ) in eight neurocysticercosis patients .
None(e1,e2)	0	2	immunosuppressive_drugs , fibric_acid_derivatives , niacin ( nicotinic acid , erythromycin , azole antifungals : skeletal muscle .
None(e1,e2)	37	39	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
advise(e1,e2)	12	14	based on the chemical resemblance of itraconazole and ketoconazole , coadministration of astemizole with itraconazole is contraindicated .
mechanism(e1,e2)	4	22	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
None(e1,e2)	1	11	racemic citalopram did not alter the mean auc or cmax of pimozide .
effect(e1,e2)	10	33	other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	16	22	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	35	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	3	9	however , neither phenobarbital nor diazepam appears to affect dantrium metabolism .
None(e1,e2)	4	28	monoamine oxidase inhibitors and tricyclic_antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	15	20	no interaction was noted with the mao-b inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa /dopa decarboxylase inhibitor ( n=29 ) .
None(e1,e2)	15	23	in view of the potential risk of dehydration secondary to vomiting and/or diarrhea induced by camptosar , the physician may wish to withhold diuretics during dosing with camptosar and , certainly , during periods of active vomiting or diarrhea .
None(e1,e2)	2	16	when the stadol_ns was administered 30 minutes after the sumatriptan nasal spray , the auc of butorphanol increased 11 % and cmax decreased 18 % .
None(e1,e2)	19	60	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	49	54	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	28	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	65	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	58	62	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	44	48	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	7	12	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	13	17	in patients in whom cyp3a4 inducers ( eg , dexamethasone , phenytoin , carbamazepine , rifampicin , phenobarbital ) are indicated , alternative agents with less enzyme induction potential should be used .
None(e1,e2)	17	30	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	1	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	1	7	both itraconazole and its major metabolite , hydroxyitraconazole , are inhibitors of the cytochrome p450 3a4 enzyme system .
None(e1,e2)	9	19	co-administration of cyp3a4 inhibitors ( eg , ketoconazole , itraconazole , erythromycin , grapefruit juice , cimetidine ) with felodipine may lead to several- fold increases in the plasma levels of felodipine , either due to an increase in bioavailability or due to a decrease in metabolism .
None(e1,e2)	0	12	antihypertensives : amiodarone should be used with caution in patients receiving - receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	11	19	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
None(e1,e2)	8	10	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	44	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	51	56	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout_drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	0	42	phenytoin : no significant differences were observed in mean phenytoin auc , c max , c min or t max ( although c max increased by 11 % ) when extended phenytoin sodium capsules ( 100 mg tid ) were coadministered with lomefloxacin ( 400 mg qd ) for five days in 15 healthy males .
None(e1,e2)	20	45	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic_agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
None(e1,e2)	24	32	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
advise(e1,e2)	2	9	thus , probenecid should not be administered concurrently with bumetanide .
None(e1,e2)	9	26	in vitro studies have shown no binding displacement between entacapone and other highly bound drugs , such as warfarin , salicylic acid , phenylbutazone , and diazepam .
None(e1,e2)	13	33	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	45	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	2	cholinesterase_inhibitors : dipyridamole may counteract the anticholinesterase effect of cholinesterase inhibitors , thereby potentially aggravating myasthenia gravis .
None(e1,e2)	45	47	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/ sulfamethoxazole or zidovudine .
None(e1,e2)	8	15	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	21	52	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	1	7	( thiazides may decrease arterial responsiveness to norepinephrine .
None(e1,e2)	0	24	lithium reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ace inhibitors , and with some angiotensin_ii_receptor_antagonists .
None(e1,e2)	6	8	tolbutamide : in diabetic patients receiving diflunisal and tolbutamide , no significant effects were seen on tolbutamide plasma levels or fasting blood glucose .
None(e1,e2)	1	32	discontinuing colestipol_hydrochloride could pose a hazard to health if a potentially toxic drug that is significantly bound to the resin has been titrated to a maintenance level while the patient was taking colestipol_hydrochloride .
None(e1,e2)	23	27	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	7	13	concomitant use of antihistamines with alcohol , tricyclic_antidepressants , barbiturates , or other central_nervous_system_depressants may have an additive effect .
None(e1,e2)	0	2	anticonvulsants ( phenytoin ) : steady state plasma exposure ( auc ) of valdecoxib ( 40 mg bid for 12 days ) was decreased by 27 % when co-administered with multiple doses ( 300 mg qd for 12 days ) of phenytoin ( a cyp 3a4 inducer ) .
mechanism(e1,e2)	0	11	quinolones have also been shown to interfere with the metabolism of caffeine .
None(e1,e2)	9	13	caution should be exercised when taking this medicine certain antibiotics , such as erythromycin , clarithromycin , or azithromycin .
None(e1,e2)	20	30	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	33	36	high-dose cyclosporin a resulting in concentrations above 2000 ng/ml administered with oral etoposide has led to an 80 % increase in etoposide exposure with a 38 % decrease in total body clearance of etoposide compared to etoposide alone .
None(e1,e2)	10	14	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	0	36	triazolam - combined administration of racemic citalopram ( titrated to 40 mg/day for 28 days ) and the cyp3a4 substrate triazolam ( single dose of 0.25 mg ) did not significantly affect the pharmacokinetics of either citalopram or triazolam .
None(e1,e2)	15	22	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	2	10	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
effect(e1,e2)	4	15	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	10	12	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	3	11	intravenous infusion of iloprost had no effect on the pharmacokinetics of digoxin .
None(e1,e2)	9	15	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine_oxidase_inhibitors or other antidepressants .
None(e1,e2)	26	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	5	7	phenytoin/phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism .
None(e1,e2)	78	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	14	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	26	50	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	27	40	valproate : available data suggest that there is no significant effect of valproate on the clearance of felbatol at steady state , therefore , the addition of valproate is not expected to cause a clinically important effect on felbatol ( felbamate ) plasma concentrations .
None(e1,e2)	0	10	gentamicin - methionine may protect against the ototoxic effects of gentamicin .
None(e1,e2)	4	32	drug-drug interactions albuterol - strattera should be administered with caution to patients being treated with systemically-administered ( oral or intravenous ) albuterol ( or other beta2 agonists ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .
None(e1,e2)	14	18	particular caution should be exercised in using preparations containing sulfur , resorcinol , or salicylic_acid in combination with differin gel .
None(e1,e2)	0	34	cholestyramine and charcoal administration of cholestyramine or activated charcoal in patients ( n=13 ) and volunteers ( n=96 ) resulted in a rapid and significant decrease in plasma m1 ( the active metabolite of leflunomide ) concentration .
None(e1,e2)	13	18	- a diuretic ( water pill ) such as hydrochlorothiazide ( hctz , hydrodiuril ) , chlorothiazide ( diuril ) , and others ;
effect(e1,e2)	6	8	cyclosporine : increased activity of both cyclosporine and corticosteroids may occur when the two are used concurrently .
mechanism(e1,e2)	32	64	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	28	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	10	23	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	0	7	aspirin : concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations , peak plasma levels , and auc values .
None(e1,e2)	0	5	cholestyramine increases enterohepatic elimination of amiodarone and may reduce its serum levels and t1/2 .
None(e1,e2)	3	9	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine
None(e1,e2)	6	8	may interact with cefamandole naftate , cephalothin_sodium , magnesium_sulfate , prednisolone sodium succinate , and prochlorperazine edisylate .
None(e1,e2)	2	29	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	107	153	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	9	15	clearance of hydrodolasetron decreased by about 27 % when dolasetron_mesylate was administered intravenously concomitantly with atenolol .
None(e1,e2)	7	9	co-administration of cyp3a4 inhibitors ( eg , ketoconazole , itraconazole , erythromycin , grapefruit juice , cimetidine ) with felodipine may lead to several- fold increases in the plasma levels of felodipine , either due to an increase in bioavailability or due to a decrease in metabolism .
advise(e1,e2)	15	33	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
None(e1,e2)	98	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	13	co-medications that induce cyp3a4 ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , phenobarbital or st .
None(e1,e2)	10	22	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	3	27	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	0	13	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythrnics propatenone and flecainide ) .
None(e1,e2)	8	28	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	38	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	11	30	these in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine , which may lead to a decreased antiretroviral effect of zalcitabine .
None(e1,e2)	3	10	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	28	30	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	85	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	2	cyclopropane or halogenated_hydrocarbon_anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines , such as dopamine .
None(e1,e2)	22	47	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	8	11	the pharmacokinetics and protein binding of fosphenytoin , phenytoin , and diazepam were not altered when diazepam and cerebyx were concurrently administered in single submaximal doses .
None(e1,e2)	11	27	no depressant effect on blood levels in humans was noted when colestipol_hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	22	25	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .
None(e1,e2)	8	28	heparin sodium injection should not be mixed with doxorubicin , droperidol , ciprofloxacin , or mitoxantrone , since it has been reported that these drugs are incompatible with heparin and a precipitate may form .
None(e1,e2)	37	48	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	66	76	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	38	40	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal_muscle_relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	10	18	it may increase excretion of barbiturates , lithium , and asa and may also increase the toxicity of salicylates .
None(e1,e2)	35	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	27	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
effect(e1,e2)	0	8	clidinium may decrease the effect of phenothiazines , levodopa , and ketoconazole .
None(e1,e2)	29	53	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	12	however , no deleterious interactions were seen when romazicon was administered after narcotics , inhalational anesthetics , muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .
None(e1,e2)	13	20	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	25	29	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	1	2	caffeine theobromine grepafloxacin , like other quinolones , may inhibit the metabolism of caffeine and theobromine .
mechanism(e1,e2)	3	15	the absorption of lymecycline may be affected by the simultaneous administration of indigestion remedies , iron or zinc supplements .
None(e1,e2)	85	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	14	in rheumatoid arthritis , concomitant medications besides mtx were nonsteroidal_anti-inflammatory_agents , folic acid , corticosteroids and/or narcotics .
effect(e1,e2)	9	20	therefore , a slower onset can be anticipated if stadol_ns is administered concomitantly with , or immediately following , a nasal_vasoconstrictor .
None(e1,e2)	3	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	85	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	8	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	9	16	medications can interfere with folate utilization , including : anticonvulsant_medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	3	9	in patients taking furosemide , nifedipine , diltiazem , ace_inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
advise(e1,e2)	5	7	thus , concomitant administration of enoxacin and bismuth_subsalicylate should be avoided .
mechanism(e1,e2)	18	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	10	ketoconazole : co-administration of bosentan 125 mg b.i.d . and ketoconazole , a potent cyp3a4 inhibitor , increased the plasma concentrations of bosentan by approximately 2-fold .
None(e1,e2)	16	26	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic_acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	2	8	methotrexate : ibuprofen , as well as other nonsteroidal_anti-inflammatory_drugs , probably reduces the tubular secretion of methotrexate based on in vitro studies in rabbit kidney slices .
None(e1,e2)	0	20	anticoagulants : potentiation of warfarin-type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
None(e1,e2)	14	16	in addition , drugs that are actively secreted via this route ( e.g. , triamterene , metformin and amiloride ) should be co-administered with care as they might increase dofetilide levels .
None(e1,e2)	8	16	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	95	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	0	8	diphenhydramine_hydrochloride has additive effects with alcohol and other cns_depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	40	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	warfarin : atorvastatin had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment .
mechanism(e1,e2)	10	16	specific effects of felbatol on other antiepileptic drugs phenytoin : felbatol causes an increase in steady-state phenytoin plasma concentrations .
advise(e1,e2)	15	25	because of the possible additive effects of drugs that may depress the nervous system , ethanol or triazolam should be used cautiously in combination with tiagabine .
None(e1,e2)	32	39	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta_adrenergic_blocking_agents .
mechanism(e1,e2)	2	16	absorption of tetracyclines is impaired by antacids containing aluminum , calcium , or magnesium , and iron -containing preparations .
None(e1,e2)	11	22	notably , systemic exposure ( auc0-12 ) of dapsone hydroxylamine ( dha ) was more than doubled in the presence of tmp/ smx .
None(e1,e2)	34	44	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	12	45	however , in another study in healthy volunteers , the pharmacokinetics of butorphanol were significantly altered ( 29 % decrease in auc and 38 % decrease in cmax ) when a 1-mg dose of stadol ns was administered 1 minute after a 20-mg dose of sumatriptan nasal spray .
None(e1,e2)	19	32	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	10	31	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine_hcl was not altered .
None(e1,e2)	21	37	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline_salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	17	26	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	33	52	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	24	31	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
mechanism(e1,e2)	3	6	even when an aminoglycoside and a penicillin -type drug are administered separately by different routes , a reduction in aminoglycoside serum half-life or serum levels has been reported in patients with impaired renal function and in some patients with normal renal function .
None(e1,e2)	57	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	16	antifungals : in vitro and/or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	5	9	compounds tested in man include warfarin , theophylline , phenytoin , diazepam , aminopyrine and antipyrine .
None(e1,e2)	32	34	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	8	14	oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic_agents , eg , tolbutamide and chlorpropamide , by inhibiting their metabolism in the liver .
None(e1,e2)	15	29	in a single subject given one dose of ciprofloxacin 2 hours after a dose of didanosine -placebo tablets , a greater than 50 % reduction in the auc of ciprofloxacin was observed .
None(e1,e2)	0	15	valproic_acid : the mean steady-state trough serum valproic acid concentrations prior to and during concomitant gabapentin administration ( 400 mg tid ;
effect(e1,e2)	8	19	additional reductions in blood pressure may occur when flolan is administered with diuretics , antihypertensive agents , or other vasodilators .
None(e1,e2)	18	20	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	29	35	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	32	39	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
effect(e1,e2)	8	35	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1_agonists .
None(e1,e2)	0	11	cimetldine : cerivastatin plasma concentrations were not affected by co-administration of cimetidine .
None(e1,e2)	11	46	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium_channel_blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide_diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	0	19	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenobarbital ( primidone ) with or without other enzyme-inducing aeds .
None(e1,e2)	14	18	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin /flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	69	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	38	40	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	34	38	limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by 30 to 50 % for the first sixty ( 60 ) minutes following alfenta induction the concomitant use of erythromycin with alfenta can significantly inhibit alfenta clearance and may increase the risk of prolonged or delayed respiratory depression .
None(e1,e2)	4	18	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
effect(e1,e2)	12	15	increases in prothrombin time have been noted in patients receiving long- term warfarin therapy after flutamide was initiated .
mechanism(e1,e2)	9	11	acetaminophen : in normal volunteers , concomitant administration of diflunisal and acetaminophen resulted in an approximate 50 % increase in plasma levels of acetaminophen .
mechanism(e1,e2)	5	13	methotrexate renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin , potentially leading to increased plasma levels of methotrexate .
None(e1,e2)	21	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	45	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	3	15	as with other antihypertensive_agents , the antihypertensive effect of losartan may be blunted by the non-steroidal_anti-inflammatory_drug indomethacin
None(e1,e2)	31	33	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	0	6	anticoagulants : potentiation of warfarin-type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
None(e1,e2)	34	51	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	6	28	digoxin : the concomitant administration of dynacirc ( isradipine ) and digoxin in a single-dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of digoxin .
None(e1,e2)	65	110	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	51	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	24	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	29	31	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
None(e1,e2)	57	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	10	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	6	22	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	20	39	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
effect(e1,e2)	1	27	several tricyclic_antidepressants have been reported to block the pharmacologic effects of guanethidine , clonidine , or similar agents , and such an effect may be anticipated with cmi because of its structural similarity to other tricyclic antidepressants .
None(e1,e2)	15	21	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	87	130	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	37	46	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
mechanism(e1,e2)	16	24	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	29	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	3	insulin or oral hypoglycemics : agents with b-blocking properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics .
None(e1,e2)	96	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	8	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	36	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	25	59	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
effect(e1,e2)	15	23	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists_.
None(e1,e2)	7	24	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
advise(e1,e2)	30	34	however , because bleeding has been reported when ibuprofen and other nonsteroidal anti-inflammatory agents have been administered to patients on coumarin-type anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
effect(e1,e2)	6	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	121	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	14	since acetaminophen in high doses has been associated with hepatotoxicity , concomitant administration of diflunisal and acetaminophen should be used cautiously , with careful monitoring of patients .
None(e1,e2)	32	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	14	however , iloprost has the potential to increase the hypotensive effect of vasodilators and antihypertensive_agents .
None(e1,e2)	7	26	however , the peak plasma level of metformin was reduced by approximately 20 % when taking acarbose due to a slight delay in the absorption of metformin .
None(e1,e2)	13	15	concomitant administration of mefloquine and other related compounds ( eg , quinine , quinidine and chloroquine ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
None(e1,e2)	26	32	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary_vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	93	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	12	15	nonsteroidal anti-inflammatory drugs ( nsaids ) : the concomitant administration of a nonsteroidal_anti_inflammatory_drug with a quinolone may increase the risks of cns stimulation and convulsions .
None(e1,e2)	30	34	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao_inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	26	28	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	28	123	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	29	48	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	5	9	concurrent use of butorphanol with central_nervous_system_depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
None(e1,e2)	11	19	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns_depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	18	25	other drug interactions : no pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , warfarin , digoxin , maalox , and ranitidine .
None(e1,e2)	0	8	antacids : concomitant administration of magnesium hydroxide and aluminum_hydroxide does not interfere with the rate or extent of the absorption of ketoprofen administered as orudis .
None(e1,e2)	0	14	pegasys should be used with caution in patients with creatinine clearance 50 ml/min and copegus should not be administered to patients with creatinine clearance 50 ml/min
None(e1,e2)	8	41	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	151	160	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	56	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	30	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	12	21	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	10	26	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	0	4	thalidomide : co-administration with thalidomide should be employed cautiously , as toxic epidermal necrolysis has been reported with concomitant use .
None(e1,e2)	15	24	the effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis_drug rifampin .
None(e1,e2)	0	6	b-adrenergic_blocking_agents : actions of some of beta-blocking_agents may be impaired when hypothyroid patients become euthyroid .
None(e1,e2)	0	14	antacid : when atorvastatin and maalox tc suspension were coadministered , plasma concentrations of atorvastatin decreased approximately 35 % .
None(e1,e2)	41	43	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	19	23	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	33	45	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	21	23	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type_anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
effect(e1,e2)	4	8	the concomitant administration of quinolones including norfloxacin with glyburide ( a sulfonylurea agent ) has , on rare occasions , resulted in severe hypoglycemia .
None(e1,e2)	10	19	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	26	58	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	8	21	specific interaction studies have demonstrated the following : cyclosporine_a : during the first day of concomitant administration , trough concentrations of bosentan were increased by about 30-fold .
None(e1,e2)	3	20	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	51	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	53	57	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	92	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	35	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
advise(e1,e2)	4	24	therefore , co-administration of tricyclic_antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	8	15	no interaction was noted with the mao-b inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/dopa decarboxylase inhibitor ( n=29 ) .
None(e1,e2)	0	17	glyburide : an increased risk of elevated liver aminotransferases was observed in patients receiving concomitant therapy with glyburide .
None(e1,e2)	0	40	neuromuscular_blockers : in one study of 10 healthy volunteers , administration of precedex for 45 minutes at a plasma concentration of 1 ( one ) ng/ml resulted in no clinically meaningful increases in the magnitude or neuromuscular blockade associated with rocuronium administration .
None(e1,e2)	11	25	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	3	16	potential interactions between taxol , a substrate of cyp3a4 , and protease inhibitors ( ritonavir , saquinavir , indinavir , and nelfinavir ) , which are substrates and/or inhibitors of cyp3a4 , have not been evaluated in clinical trials .
None(e1,e2)	17	37	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
int(e1,e2)	0	22	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	0	8	acetazolamide may prevent the urinary antiseptic effect of methenamine .
None(e1,e2)	38	42	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	38	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	21	31	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	21	28	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
effect(e1,e2)	0	4	ethopropazine may interact with alcohol or other cns depressants , causing increased sedative effects .
None(e1,e2)	0	2	antacids containing magnesium , aluminum , or calcium ;
None(e1,e2)	14	22	preliminary clinical data suggest that the incidence of nephrolithiasis is higher in patients receiving indinavir in combination with ritonavir than those receiving crixivan 800 mg q8h .
None(e1,e2)	6	10	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	24	32	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	30	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	49	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	42	coadministration of valdecoxib ( 40 mg bid ( day 1 ) and 40 mg qd ( days 2-7 ) ) with glyburide ( 10 mg glyburide bid ) resulted in 21 % increase in glyburide auc0-12 and a 16 % increase in glyburide cmax leading to a 16 % decrease in glucose auc0-24 .
None(e1,e2)	11	19	and disulfiram when amitriptyline hcl is given with anticholinergic agents or sympathomimetic drugs , including epinephrine combined with local anesthetics , close supervision and careful adjustment of dosages are required .
None(e1,e2)	0	13	non-steroidal_anti-inflammatory_agents : seizures have been reported in patients taking enoxacin concomitantly with the nonsteroidal_anti-inflammatory_drug fenbufen .
None(e1,e2)	20	29	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	110	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	22	28	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	0	21	ergot_derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine contraindicated due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
None(e1,e2)	9	12	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin sodium .
None(e1,e2)	68	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	22	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic_acid , and tolbutamide in vitro .
None(e1,e2)	3	15	the auc of ciprofloxacin was decreased an average of 15-fold in 12 healthy subjects given ciprofloxacin and didanosine-placebo tablets concurrently .
None(e1,e2)	2	37	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	0	8	lithium_carbonate : the anorectic and stimulatory effects of amphetamines may be inhibited by lithium carbonate .
None(e1,e2)	66	77	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	38	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	49	78	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	19	22	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type_1c_antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	25	27	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	10	15	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	45	47	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or h1-blocking agents , tricyclic_antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
effect(e1,e2)	0	7	fenfluramine may increase slightly the effect of antihypertensive_drugs , e.g. , guanethidine , methyldopa , reserpine .
None(e1,e2)	2	4	- a monoamine_oxidase_inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	0	14	aspirin : concurrent administration of aspirin and flurbiprofen resulted in 50 % lower serum flurbiprofen concentrations .
None(e1,e2)	20	22	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic_acid , and tolbutamide in vitro .
None(e1,e2)	44	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	21	47	beta blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	7	8	concomitant administration of kerlone with the oral anticoagulant warfarin has been shown not to potentiate the anticoagulant effect of warfarin .
None(e1,e2)	3	42	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
mechanism(e1,e2)	19	26	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	33	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	16	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	2	28	combination of amiodarone with other antiarrhythmic therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to amiodarone .
None(e1,e2)	46	54	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	85	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	27	30	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	9	13	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	126	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	26	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	68	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	25	34	coadministration of valdecoxib ( 40 mg bid ( day 1 ) and 40 mg qd ( days 2-7 ) ) with glyburide ( 10 mg glyburide bid ) resulted in 21 % increase in glyburide auc0-12 and a 16 % increase in glyburide cmax leading to a 16 % decrease in glucose auc0-24 .
None(e1,e2)	32	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	2	9	atorvastatin : atorvastatin increases the auc for norethindrone and ethinyl_estradiol .
None(e1,e2)	3	13	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	23	39	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	1	25	phenytoin/ phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol /ergocalcitriol by accelerating metabolism .
None(e1,e2)	2	40	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	65	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	35	40	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	0	23	ketoconazole - combined administration of racemic citalopram ( 40 mg ) and ketoconazole ( 200 mg ) decreased the cmax and auc of ketoconazole by 21 % and 10 % , respectively , and did not significantly affect the pharmacokinetics of citalopram .
None(e1,e2)	3	31	plasma exposure of diazepam ( 10 mg bid ) was increased by 28 % following administration of valdecoxib ( 40 mg bid ) for 12 days , while plasma exposure of valdecoxib ( 40 mg bid ) was not substantially increased following administration of diazepam ( 10 mg bid ) for 12 days .
None(e1,e2)	6	29	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	25	36	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	9	33	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	18	41	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure_agonist_opioid_analgesic such as levo-dromoran .
None(e1,e2)	12	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	24	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	53	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	133	156	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	49	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	13	ethanol or triazolam : no significant differences were observed in the pharmacokinetics of triazolam ( 0.125 mg ) and tiagabine ( 10 mg ) when given together as a single dose .
None(e1,e2)	4	18	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
advise(e1,e2)	0	18	vardenafil dose should not exceed a maximum of 2.5 mg in a 24-hour period in patients receiving concomitant indinavir therapy .
effect(e1,e2)	35	39	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	18	36	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac_glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	24	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	3	5	heparin , other anticoagulants , thrombolytics , and anti platelet agents are associated with an increase in bleeding .
None(e1,e2)	5	12	certain antibiotic , cisplatin , cyclosporine , diuretic , foscarnet , and vaccines .
None(e1,e2)	40	44	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	49	52	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	33	36	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	10	13	toxicology studies of heroin-related deaths reveal frequent involvement of other central_nervous_system_depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	0	13	lithium_carbonate ( 450 mg bid for 7 days ) had no effect on valdecoxib pharmacokinetics .
None(e1,e2)	0	8	warfarin -vitamin k can antagonize the effect of warfarin
None(e1,e2)	20	25	drug/laboratory tests interactions because false positive readings were reported with the ames n-multistix sg dipstick test for urinary protein when gabapentin was added to other antiepileptic_drugs , the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein
None(e1,e2)	49	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	13	21	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	14	16	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	11	36	in separate studies of patients receiving maintenance doses of warfarin , hydrochlorothiazide , or digoxin , irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin ( prothrombin time ) or pharmacokinetics of digoxin .
None(e1,e2)	8	23	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
advise(e1,e2)	4	22	caution is advised when trisenox is coadministered with other medications that can prolong the qt interval ( e.g . certain antiarrhythmics or thioridazine ) or lead to electrolyte abnormalities ( such as diuretics or amphotericin b ) .
None(e1,e2)	4	11	drug/laboratory test interaction because xigris may affect the aptt assay , xigris present in plasma samples may interfere with one-stage coagulation assays based on the aptt ( such as factor viii , ix , and xi assays ) .
None(e1,e2)	24	28	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
mechanism(e1,e2)	16	18	lithium reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ace_inhibitors , and with some angiotensin ii receptor antagonists .
None(e1,e2)	6	14	administration of diltiazem hydrochloride concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately 50 % .
None(e1,e2)	15	27	drug interactions , general : although there have been no formal interaction studies , intravenous fenoldopam has been administered safely with drugs such as digitalis and sublingual nitroglycerin .
None(e1,e2)	46	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	8	18	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , seriraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
mechanism(e1,e2)	36	41	a study in eight healthy volunteers has shown a 50 % increase in mean peak nimodipine plasma concentrations and a 90 % increase in mean area under the curve , after a one week course of cimetidine at 1,000 mg/day and nimodipine at 90 mg/day .
mechanism(e1,e2)	22	28	the following drug interactions have been identified involving nizoral tablets and other drugs metabolized by the cytochrome p450 3a4 enzyme system : ketoconazole tablets inhibit the metabolism of terfenadine , resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite .
None(e1,e2)	0	6	h2_blockers and proton pump inhibitors ( ppis )
None(e1,e2)	40	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	63	73	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	32	35	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	0	5	lithium : inhibition of renal lithium clearance , leading to an increase in plasma lithium concentration , has been reported with some prostaglandin synthesis-inhibiting drugs .
None(e1,e2)	13	19	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	18	46	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	23	44	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim /sulfamethoxazole or zidovudine .
None(e1,e2)	3	5	amphotericin b or corticosteroids or corticotropin ( acth )
None(e1,e2)	0	14	non-steroidal_anti-inflammatory_agents : in some patients with compromised renal function who are being treated with non-steroidal_anti-inflammatory_drugs , the co-administration of lisinopril may result in a further deterioration of renal function .
None(e1,e2)	22	31	although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral agents , including protease inhibitors , macrolide_antibiotics , and azole antifungals , the effect of panretin gel on the steady-state concentrations of these drugs is not known .
None(e1,e2)	5	10	it may increase excretion of barbiturates , lithium , and asa and may also increase the toxicity of salicylates .
None(e1,e2)	44	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	6	17	tablets : the benzodiazepines , including lorazepam , produce cns-depressant effects when administered with such medications as barbiturates or alcohol .
None(e1,e2)	26	30	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	15	40	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	16	18	in addition , certain drugs that are metabolized by this isoenzyme , including many antidepressants ( tricyclic_antidepressants , selective_serotonin_reuptake_inhibitors , and others ) , may inhibit the activity of this isoenzyme , and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system , leading to drug interactions .
None(e1,e2)	4	21	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	24	40	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
effect(e1,e2)	14	28	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine_antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	1	15	because lithium may enhance the serotonergic effects of escitalopram , caution should be exercised when lexapro and lithium are coadministered .
None(e1,e2)	53	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	16	fenfluramine may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , methyldopa , reserpine .
None(e1,e2)	0	15	coumarin_anticoagulants altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative_anticoagulants such as warfarin and phenprocoumon .
None(e1,e2)	38	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	0	3	antipsychotic_drugs such as phenothiazines or haloperidol ;
None(e1,e2)	11	61	in three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days ( n=18 ) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine ( n=18 ) or with cimetidine 600 mg every 12 hours for 14 days ( n=18 ) under steady state conditions to normal healthy male and female volunteers .
None(e1,e2)	3	22	patients receiving other narcotic_analgesics , antipsychotics , antianxiety agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	13	15	compounds in these categories result in a decreased efficacy of bromocriptine mesylate : phenothiazines , haloperidol , metoclopramide , pimozide .
None(e1,e2)	64	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	30	68	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	21	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	18	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	35	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	33	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	46	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	42	60	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	66	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	6	digoxin : enoxacin may raise serum digoxin levels in some individuals .
advise(e1,e2)	0	18	dostinex should not be administered concurrently with d2-antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
None(e1,e2)	2	21	when cholestyramine resin is given for long periods of time , concomitant supplementation with water-miscible ( or parenteral ) forms of fat-soluble_vitamins should be considered .
None(e1,e2)	16	18	doxazosin mesylate has been administered without any evidence of an adverse drug interaction to patients receiving thiazide_diuretics , beta-blocking_agent s , and nonsteroidal anti-inflammatory drugs .
None(e1,e2)	13	15	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	77	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	7	9	two percent of patients treated concurrently with kineret and etanercept developed neutropenia ( anc 1 x 109/l ) .
None(e1,e2)	15	32	the iv methylprednisolone dose should be reduced by approximately 25 % , and the oral methylprednisolone dose should be reduced by approximately 50 % when coadministered with aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without aprepitant .
None(e1,e2)	22	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	4	long acting nitrates : nifedipine may be safely co-administered with nitrates , but there have been no controlled studies to evaluate the antianginal effectiveness of this combination .
None(e1,e2)	14	16	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	1	27	since pletal is extensively metabolized by cytochrome p-450 isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a . such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
None(e1,e2)	3	20	the effect of toradol on plasma lithium has not been studied , but cases of increased lithium plasma levels during toradol therapy have been reported .
None(e1,e2)	11	16	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
advise(e1,e2)	6	8	it is suggested to monitor both ketoconazole and phenytoin .
None(e1,e2)	35	42	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	65	116	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	11	13	at a median follow-up of 33 months , the combination of arimidex and tamoxifen did not demonstrate any efficacy benefit when compared with tamoxifen in all patients as well as in the hormone receptor-positive subpopulation .
mechanism(e1,e2)	2	8	prednisolone : ethinyl_estradiol may inhibit the metabolism of prednisolone , leading to increased plasma concentrations .
None(e1,e2)	33	36	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	1	25	because eprosartan is not metabolized by the cytochrome p450 system , inhibitors of cyp450 enzyme would not be expected to affect its metabolism , and ketoconazole and fluconazole , potent inhibitors of cyp3a and 2c9 , respectively , have been shown to have no effect on eprosartan pharmacokinetics .
None(e1,e2)	11	37	drug interactions : flupenthixol may interact with some drugs , like monoamine_oxidase_inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic_antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	19	136	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	18	coumarin_anticoagulants : there have been rare reports of increased prothrombin time in patients taking coumarin anticoagulants to whom nifedipine was administered .
None(e1,e2)	21	28	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	133	138	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	43	reported examples of this interaction include the following : immunosuppressives : cyclosporine ( cyp3a4 substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine .
None(e1,e2)	12	33	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	11	40	in three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days ( n=18 ) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine ( n=18 ) or with cimetidine 600 mg every 12 hours for 14 days ( n=18 ) under steady state conditions to normal healthy male and female volunteers .
int(e1,e2)	4	6	the extent to which ssri - tca interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the ssri involved .
advise(e1,e2)	5	10	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
None(e1,e2)	2	13	because of foscarnet s tendency to cause renal impairment , the use of foscavir should be avoided in combination with potentially nephrotoxic drugs such as aminoglycosides , amphotericin b and intravenous pentamidine unless the potential benefits outweigh the risks to the patient .
None(e1,e2)	5	8	erythromycin co-administration of felodipine ( plendil ) with erythromycin resulted in approximately 2.5- fold increase in the auc and cmax , and about 2- fold prolongation in the half- life of felodipine .
None(e1,e2)	17	19	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	20	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	21	44	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	15	33	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	3	8	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	2	4	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	120	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	44	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	30	41	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine_oxidase_(_mao_)_inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	33	53	because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis , it is particularly important that physicians query patients or their guardians carefully about benzodiazepine , alcohol and sedative use as part of the history prior to any procedure in which the use of romazicon is planned .
None(e1,e2)	38	40	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	27	32	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	3	18	as with other antihypertensive_agents , the antihypertensive effect of losartan may be blunted by the non-steroidal anti-inflammatory drug indomethacin
None(e1,e2)	50	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	26	after the coadministration of 200 mg oral ketoconazole twice daily and one 20 mg dose of loratadine to 11 subjects , the auc and cmax of loratadine averaged 302 % ( 142 s.d . ) and 251 % ( 68 s.d . ) , respectively , of those obtained after co-treatment with placebo .
int(e1,e2)	3	7	diphenoxylate hcl and atropine_sulfate may interact with mao_inhibitors in studies with male rats , diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of 2 mg/kg/day .
None(e1,e2)	31	36	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	8	15	therefore , administration of these agents should precede lomefloxacin dosing by 4 hours or follow lomefloxacin dosing by at least 2 hours .
None(e1,e2)	25	31	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	8	13	clonidine hydrochloride may enhance the cns-depressive effects of alcohol , barbiturates or other sedatives .
None(e1,e2)	35	44	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim /sulfamethoxazole or zidovudine .
None(e1,e2)	17	30	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	21	34	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type_anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic_antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	38	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	14	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	19	36	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the auc of ethinyl_estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	21	23	beta blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e_._45 ( dihydroergotamine_mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	4	9	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	0	21	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	42	44	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim /sulfamethoxazole or zidovudine .
effect(e1,e2)	6	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	40	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	2	4	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	26	41	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	17	19	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
None(e1,e2)	69	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	38	45	also , due to the potential for additive effects such as bradycardia and av block , caution is warranted in patients receiving clonidine with agents known to affect sinus node function or av nodal conduction ( e.g. , digitalis , calcium channel blockers , and beta-blockers . )
None(e1,e2)	15	19	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	0	10	uricosuric_agents : aspirin may decrease the effects of probenecid , sulfinpyrazone , and phenylbutazone .
None(e1,e2)	2	19	interaction of gabitril with other drugs : cimetidine : co-administration of cimetidine ( 800 mg/day ) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics .
None(e1,e2)	34	49	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting_enzyme_(_ace_)_inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	5	9	certain antibiotic , cisplatin , cyclosporine , diuretic , foscarnet , and vaccines .
None(e1,e2)	96	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	8	28	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	37	43	carbamazepine : coadministration of carbamazepine ( 200 mg bid ) , a potent cyp3a4 inducer , with aripiprazole ( 30 mg qd ) resulted in an approximate 70 % decrease in cmax and auc values of both aripiprazole and its active metabolite , dehydro-aripiprazole .
None(e1,e2)	16	28	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	2	18	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	7	11	co-medications that induce cyp3a4 ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , phenobarbital or st .
None(e1,e2)	18	20	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
mechanism(e1,e2)	6	43	plasma levels of several closely related tricyclic_antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	5	7	probenecid : as with other b-lactam_antibiotics , probenecid inhibits the renal excretion of cefdinir , resulting in an approximate doubling in a.c. a 54 % increase in peak cefdinir plasma levels , and a 50 % prolongation in the apparent elimination half-life .
effect(e1,e2)	6	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
int(e1,e2)	26	28	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .
None(e1,e2)	19	33	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	3	11	results demonstrate that oxcarbazepine and its pharmacologically active 10-monohydroxy metabolite ( mhd ) have little or no capacity to function as inhibitors for most of the human cytochrome p450 enzymes evaluated ( cyp1a2 , cyp2a6 , cyp2c9 , cyp2d6 , cyp2e1 , cyp4a9 and cyp4a11 ) with the exception of cyp2c19 and cyp3a4/5 .
advise(e1,e2)	24	27	because prostaglandins play an important role in hemostasis , and nsaids affect platelet function as well , concurrent therapy with all nsaids , including diclofenac , and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required .
None(e1,e2)	20	41	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure_agonist_opioid_analgesic such as levo-dromoran .
None(e1,e2)	49	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	31	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine_hcl was not altered .
effect(e1,e2)	9	20	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin_sodium .
None(e1,e2)	0	10	ranitidine 150 mg twice daily did not interact significantly with nisoldipine ( auc was decreased by 15-20 % ) .
None(e1,e2)	6	8	reported examples include the following : protease_inhibitors : protease_inhibitors are known to inhibit cyp3a4 to varying degrees .
None(e1,e2)	15	21	reports in the literature suggest that plasma levels of doxorubicin ( and its active metabolite doxorubicinol ) may be increased when paclitaxel and doxorubicin are used in combination .
None(e1,e2)	0	20	intestinal_adsorbents ( e. g. , charcoal ) and digestive enzyme preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
advise(e1,e2)	23	30	due to wide interindividual variability in the dose adjustment required , it is recommended that cyclosporine concentrations be monitored closely after initiation of carvedilol therapy and that the dose of cyclosporine be adjusted as appropriate .
None(e1,e2)	0	5	anticholinergics antagonize the effects of antiglaucoma_agents .
None(e1,e2)	68	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	2	15	results with warfarin wshow no evidence of interaction with either single or repeated doses of trileptal .
None(e1,e2)	0	15	venlafaxine : coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine er ( extended release ) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine .
None(e1,e2)	0	27	valproate : available data suggest that there is no significant effect of valproate on the clearance of felbatol at steady state , therefore , the addition of valproate is not expected to cause a clinically important effect on felbatol ( felbamate ) plasma concentrations .
advise(e1,e2)	5	19	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	9	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	37	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	13	however , patients receiving infusions of flolan in clinical trials were maintained on anticoagulants without evidence of increased bleeding .
None(e1,e2)	2	22	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	10	12	controlled and uncontrolled domestic studies suggest that concomitant use of diltiazem_hydrochloride and beta-blockers is usually well tolerated , but available data are not sufficient to predict the effects of concomitant treatment in patients with left ventricular dysfunction or cardiac conduction abnormalities .
effect(e1,e2)	1	11	several tricyclic_antidepressants have been reported to block the pharmacologic effects of guanethidine , clonidine , or similar agents , and such an effect may be anticipated with cmi because of its structural similarity to other tricyclic antidepressants .
effect(e1,e2)	10	12	compounds in these categories result in a decreased efficacy of bromocriptine_mesylate : phenothiazines , haloperidol , metoclopramide , pimozide .
None(e1,e2)	59	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	19	35	cmax and auc values are 3 % to 4 % lower , respectively , after administration of 125 mg neurontin and 21 % to 22 % lower , respectively , after administration of 500 mg neurontin .
None(e1,e2)	12	37	evidence supporting the conclusion that it is inadvisable to co-administer fluvoxamine and diazepam is derived from a study in which healthy volunteers taking 150 mg/day of fluvoxamine were administered a single oral dose of 10 mg of diazepam .
None(e1,e2)	21	30	when duloxetine was administered ( at a dose of 60 mg bid ) in conjunction with a single 50-mg dose of desipramine , a cyp2d6 substrate , the auc of desipramine increased 3-fold .
None(e1,e2)	9	13	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
int(e1,e2)	0	7	diphenoxylate_hcl and atropine sulfate may interact with mao_inhibitors in studies with male rats , diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of 2 mg/kg/day .
None(e1,e2)	2	20	the effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide , ketoconazole , methotrexate , phenytoin , tolbutamide , and warfarin have been studied in vivo and clinically important interactions have not been found .
None(e1,e2)	78	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	65	79	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	27	39	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan_kerastick for topical solution .
None(e1,e2)	79	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	5	7	similarly , the effects of phenytoin on phenobarbital , valproic acid and sodium plasma valproate concentrations are unpredictable
None(e1,e2)	51	62	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	11	16	therefore , it would be expected that a dosing schedule of cerivastatin_sodium given at bedtime and cholestyramine given before the evening meal would not result in a significant decrease in the clinical effect of cerivastatin sodium .
effect(e1,e2)	16	39	epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic_drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an nsaid or aspirin potentiated the risk of bleeding .
None(e1,e2)	19	130	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	53	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	27	29	therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( e.g . ketoconazole , ampicillin esters , iron salts , digoxin ) .
effect(e1,e2)	0	9	chlorthalidone and related drugs may increase the responsiveness to tubocurarine .
None(e1,e2)	80	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	11	colestipol : plasma concentrations of atorvastatin decreased approximately 25 % when colestipol and atorvastatin were coadministered .
mechanism(e1,e2)	7	9	ketoconazole : co-administration of 200 mg twice-daily ketoconazole with aliskiren resulted in an approximate 80 % increase in plasma levels of aliskiren .
None(e1,e2)	14	27	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
mechanism(e1,e2)	18	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	50	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	14	flurbiprofen pretreatment attenuated the hypotensive effect of a single dose of propranolol but not atenolol .
None(e1,e2)	1	5	- quinidine ( e.g. , quinidex ) or
None(e1,e2)	15	25	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .
None(e1,e2)	44	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	11	metformin : in healthy subjects given single 500 mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of 34 % and 24 % , respectively , and metformin mean renal clearance decreased by 14 % .
None(e1,e2)	8	15	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	3	10	antidiabetic agents ( insulin , sulfonylureas ) : requirements for insulin or oral antidiabetic agents may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
None(e1,e2)	6	8	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	51	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	3	7	concurrent use of tetracycline may render oral contraceptives less effective .
None(e1,e2)	42	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	11	13	theophylline : as with some other quinolones , concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life .
None(e1,e2)	21	26	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary_vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	0	26	hormonal_contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	146	150	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	100	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	13	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	25	in general , most patients treated with dirithromycin who are receiving concomitant theophylline therapy may not require empiric adjustment of theophylline dosage or monitoring of theophylline plasma concentrations .
None(e1,e2)	47	54	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic_acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	56	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	9	corticosteroids : a relationship of functional antagonism exists between vitamin_d analogues , which promote calcium absorption , and corticosteroids , which inhibit calcium absorption .
None(e1,e2)	5	7	coadministration of itraconazole with oral midazolam or triazolam has resulted in elevated plasma concentrations of the latter two drugs .
None(e1,e2)	47	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	1	23	hormonal contraceptives co-administration of trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components , ethinylestradiol ( ee ) and levonorgestrel ( lng ) .
None(e1,e2)	44	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	4	12	the hypotensive effect of sodium_nitroprusside is augmented by that of most other hypotensive_drugs , including ganglionic blocking agents , negative inotropic agents , and inhaled anesthetics .
None(e1,e2)	36	45	in a phase i trial using escalating doses of taxol ( 110-200 mg/m2 ) and cisplatin ( 50 or 75 mg/m2 ) given as sequential infusions , myelosuppression was more profound when taxol was given after cisplatin than with the alternate sequence ( ie , taxol before cisplatin ) .
None(e1,e2)	10	20	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	6	13	the adverse experience profile seen with kemstrotm was similar to that seen with baclofen tablets .
None(e1,e2)	0	7	valproic_acid : the mean steady-state trough serum valproic_acid concentrations prior to and during concomitant gabapentin administration ( 400 mg tid ;
None(e1,e2)	98	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	22	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl_alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	38	40	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	35	37	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	49	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	15	19	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	25	42	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	78	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	2	12	antibiotics : macrolide_antibiotics have been reported to cause a significant decrease in corticosteroid clearance .
None(e1,e2)	3	7	patients receiving other narcotic_analgesics , antipsychotics , antianxiety_agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	8	12	in patients taking an anticonvulsant ( eg , valproic_acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	11	29	in vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the pk properties of anagrelide , nor does anagrelide affect the pk properties of digoxin or warfarin .
None(e1,e2)	31	44	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	19	86	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	3	10	bacteriostatic antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
mechanism(e1,e2)	8	13	antacids or h 2 receptor antagonists : when dirithromycin is administered immediately following antacids or h 2 -receptor antagonists , the absorption of dirithromycin is slightly enhanced .
None(e1,e2)	105	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	13	25	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	108	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	19	28	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	30	32	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	0	10	aspirin : concomitant aspirin may decrease the metabolic clearance of nicotinic_acid .
None(e1,e2)	23	25	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	24	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	44	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	4	antacids ( aluminum- or magnesium -containing ) : concomitant administration of 300-mg cefdinir capsules with 30 ml maalox tc suspension reduces the rate ( cmax ) and extent ( auc ) of absorption by approximately 40 % .
None(e1,e2)	25	43	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	8	10	inhibitors or substrates of cyp2d6 ( i.e. , quinidine , selective_serotonin_reuptake_inhibitors [ ssris ] ) may increase the plasma concentration of doxepin when administered concomitantly .
None(e1,e2)	49	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	29	37	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	0	2	antacid ( magnesium-aluminum_hydroxide ) : cerivastatin plasma concentrations were not affected by co-administration of antacid .
None(e1,e2)	16	39	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	0	18	carbamazepine_epoxide steady-state cmin concentrations increased 57 % from 1.0 0.3 to 1.6 0.4 micrograms/ml with the addition of felbamate .
None(e1,e2)	10	30	in another drug interaction study , co-administration of orally inhaled ciclesonide and oral ketoconazole , a potent inhibitor of cytochrome p450 3a4 , increased the exposure ( auc ) of des-ciclesonide by approximately 3.6-fold at steady state , while levels of ciclesonide remained unchanged .
None(e1,e2)	13	40	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum_hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	50	69	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	4	20	terfenadine , astemizole and cisapride are all metabolized by the cytochrome p450iiia4 isozyme , and it has been demonstrated that ketoconazole , a potent inhibitor of iiia4 , blocks the metabolism of these drugs , resulting in increased plasma concentrations of parent drug .
None(e1,e2)	1	19	because nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of nalfon , the concomitant use of nalfon and salicylates is not recommended .
None(e1,e2)	137	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	4	24	for example , when vitamin_k_antagonists are administered concomitantly with nilutamide , prothrombin time should be carefully monitored and if necessary , the dosage of vitamin_k_antagonists should be reduced .
effect(e1,e2)	6	38	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	16	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
None(e1,e2)	135	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	37	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	5	27	- phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin
None(e1,e2)	8	15	amiodarone may suppress certain cyp450 enzymes , including cyp1a2 , cyp2c9 , cyp2d6 , and cyp3a4 .
None(e1,e2)	18	28	oral contraceptives : valdecoxib ( 40 mg bid ) did not induce the metabolism of the combination oral contraceptive norethindrone/ethinyl estradiol ( 1 mg /35 mcg combination , ortho-novum 1/35 ) .
None(e1,e2)	1	3	potential terfenadine , astemizole , and cisapride interactions
None(e1,e2)	0	17	nonsteroidal_anti-inflammatory_agents ( nsaids ) : concomitant use of aspirin ( or other nonsteroidal antiinflammatory agents ) and corticosteroids increases the risk of gastrointestinal side effects .
None(e1,e2)	5	18	although the pressor activity of desmopressin is very low compared to its antidiuretic activity , large doses of desmopressin tablets should be used with other pressor agents only with careful patient monitoring .
None(e1,e2)	10	15	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	29	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	24	45	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	11	16	consequently , drugs with a low therapeutic margin , such as vitamin_k_antagonists , phenytoin , and theophylline , could have a delayed elimination and increases in their serum half-life leading to a toxic level .
None(e1,e2)	5	6	selegiline - l-phenylalanine and the selective_mao_inhibitor selegiline may have synergistic antidepressant activity if used concomitantly .
None(e1,e2)	11	32	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle_relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	11	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	50	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	23	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	38	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	0	10	salicylic_acid : combination hormonal contraceptives may increase the clearance of salicylic_acid .
None(e1,e2)	14	16	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-htv agonists .
mechanism(e1,e2)	18	51	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	37	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	10	cancidas has no effect on the pharmacokinetics of itraconazole , amphotericin_b , or the active metabolite of mycophenolate .
None(e1,e2)	21	29	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	7	20	dexbrompheniramine can interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
effect(e1,e2)	5	11	agents increasing serum potassium : prinivil attenuates potassium loss caused by thiazide-type_diuretics .
None(e1,e2)	4	8	the administration of local anesthetic_solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .
None(e1,e2)	0	6	digoxin : the concomitant administration of dynacirc ( isradipine ) and digoxin in a single-dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of digoxin .
None(e1,e2)	23	30	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	4	6	hmg-coa reductase inhibitors : lovastatin , simvastatin
None(e1,e2)	8	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	29	45	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3_antagonist_class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	1	5	- acetohydroxamic_acid ( e.g. , lithostat ) or
None(e1,e2)	0	22	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
None(e1,e2)	12	19	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	9	15	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide_diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	4	27	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating_drugs .
None(e1,e2)	38	47	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	5	7	no clinically significant effect of famotidine , valproate , or lithium was seen on the pharmacokinetics of aripiprazole ( see clinical pharmacology : drug- drug interactions ) .
None(e1,e2)	6	43	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	0	13	dicumarol : it has been reported that allopurinol prolongs the half-life of the anticoagulant , dicumarol .
None(e1,e2)	11	16	in healthy subjects , no significant drug-drug interaction was observed when norpace was coadministered with either propranolol or diazepam .
None(e1,e2)	57	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	0	3	phospholine_iodide potentiates other cholinesterase_inhibitors such as succinylcholine or organophosphate and carbamate insecticides .
None(e1,e2)	10	18	patients should be advised against the simultaneous use of other cns_depressant_drugs , and cautioned that the effect of alcohol may be increased .
None(e1,e2)	17	39	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central_nervous_system_depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	8	11	antidepressants ( tricyclic ) , atropine or other anticholinergic_agents , or digitalis_glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	18	35	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid products .
None(e1,e2)	14	23	however , other published reports describe modest elevations ( less than two-fold ) of clozapine and metabolite concentrations when clozapine was taken with paroxetine , fluoxetine , and sertraline .
None(e1,e2)	0	19	warfarin : quinolones , including enoxacin , decrease the clearance of r-warfarin , the less active isomer of racemic warfarin .
effect(e1,e2)	1	13	several tricyclic_antidepressants have been reported to block the pharmacologic effects of guanethidine , clonidine , or similar agents , and such an effect may be anticipated with cmi because of its structural similarity to other tricyclic antidepressants .
None(e1,e2)	45	53	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	9	other cns_depressant_drugs ( e.g . barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
None(e1,e2)	57	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	20	no significant drug-drug pharmacokinetic ( or pharmacodynamic ) interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , and nifedipine .
None(e1,e2)	3	26	oral hypoglycemics : bepridil has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral hypoglycemic_agents .
None(e1,e2)	0	9	alcohol : it should be borne in mind that alcohol ingestion may increase the danger inherent in any intentional or unintentional sinequan overdosage .
None(e1,e2)	0	13	doxil may interact with drugs known to interact with the conventional formulation of doxorubicin_hcl .
None(e1,e2)	16	22	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	18	47	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	9	11	may interact anticoagulants ( altered hypo-prothrombinemic effect ) , barbiturates , rifampin and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of diethylstilbestrol ) , corticosteroids ( increased effect of corticosteroids ) .
None(e1,e2)	11	27	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	0	7	vitamin_a : because of the relationship of accutane to vitamin a , patients should be advised against taking vitamin supplements containing vitamin a to avoid additive toxic effects
None(e1,e2)	5	7	given the anticonvulsant properties of carbamazepine , equetrotm may reduce the thyroid function as has been reported with other anticonvulsants .
effect(e1,e2)	8	10	preliminary studies indicate that the concomitant use of dobutamine and nitroprusside results in a higher cardiac output and , usually , a lower pulmonary wedge pressure than when either drug is used alone .
mechanism(e1,e2)	0	10	probenecid depresses tubular secretion of certain weak acids such as pah .
None(e1,e2)	31	45	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	20	26	there were no reports of skeletal myopathy in a placebo-controlled phase i trial in which 10 healthy subjects on stable simvastatin therapy were treated concurrently with daptomycin ( 4 mg/kg once every 24 hours ) for 14 days .
None(e1,e2)	16	22	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
effect(e1,e2)	3	10	concomitant use of antihistamines with alcohol , tricyclic antidepressants , barbiturates , or other central nervous system depressants may have an additive effect .
None(e1,e2)	9	21	ketoconazole : co-administration of 200 mg twice-daily ketoconazole with aliskiren resulted in an approximate 80 % increase in plasma levels of aliskiren .
None(e1,e2)	46	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	47	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	18	- a diuretic ( water pill ) such as hydrochlorothiazide ( hctz , hydrodiuril ) , chlorothiazide ( diuril ) , and others ;
None(e1,e2)	21	27	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	13	19	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	1	5	- divalproex ( e.g. , depakote ) or
None(e1,e2)	15	17	hormonal contraceptives : it has not been established if there is a pharmacokinetic interaction between acitretin and combined_oral_contraceptives .
None(e1,e2)	9	33	if desipramine hydrochloride is to be combined with other psychotropic_agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	7	25	naproxen : coadministration ( n=18 ) of naproxen_sodium capsules ( 250 mg ) with neurontin ( 125 mg ) appears to increase the amount of gabapentin absorbed by 12 % to 15 % .
None(e1,e2)	17	21	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	0	15	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
effect(e1,e2)	14	34	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
effect(e1,e2)	9	15	spontaneous reports of serotonin syndrome associated with co-administration of zyvox and serotonergic agents , including antidepressants such as selective serotonin reuptake inhibitors ( ssris ) , have been reported .
None(e1,e2)	12	14	such individuals are referred to as poor metabolizers of drugs such as debrisoquin , dextromethorphan , and the tricyclic antidepressants .
int(e1,e2)	2	11	therefore , linezolid has the potential for interaction with adrenergic and serotonergic_agents .
None(e1,e2)	3	24	in case of theophylline toxicity and/or elevated serum theophylline levels , the dose of theophylline should be reduced while the patient is receiving concomitant erythromycin therapy .
None(e1,e2)	15	17	concomitant administration with racemic citalopram citalopram - since escitalopram is the active isomer of racemic citalopram ( celexa ) , the two agents should not be coadministered .
None(e1,e2)	9	13	strong inducers of cytochrome p450 enzymes ( i.e . carbamazepine , phenytoin and phenobarbital ) have been shown to decrease the plasma levels of mhd ( 29-40 % ) .
None(e1,e2)	59	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	11	diphenhydramine hydrochloride has additive effects with alcohol and other cns_depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	4	12	no dose adjustment of bosentan is necessary , but increased effects of bosentan should be considered .
None(e1,e2)	11	29	however , if argatroban is to be initiated after cessation of heparin therapy , allow sufficient time for heparins effect on the aptt to decrease prior to initiation of argatroban therapy .
None(e1,e2)	5	15	tablet if a patient receiving clonidine_hydrochloride is also taking tricyclic antidepressants , the effect of clonidine may be reduced , thus necessitating an increase in dosage .
None(e1,e2)	22	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	28	35	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	6	12	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	28	51	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	11	28	may interact anticoagulants ( altered hypo-prothrombinemic effect ) , barbiturates , rifampin and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of diethylstilbestrol ) , corticosteroids ( increased effect of corticosteroids ) .
None(e1,e2)	3	10	specific effects of felbatol on other antiepileptic drugs phenytoin : felbatol causes an increase in steady-state phenytoin plasma concentrations .
None(e1,e2)	33	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	8	central_nervous_system_depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	51	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	3	5	therefore , when hydrochlorothiazide and non-steroidal_anti-inflammatory_agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained .
int(e1,e2)	0	7	dexbrompheniramine can interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	13	26	the hypotensive effect of sodium nitroprusside is augmented by that of most other hypotensive_drugs , including ganglionic blocking agents , negative inotropic agents , and inhaled anesthetics .
None(e1,e2)	118	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	30	in addition , oxcarbazepine and mhd induce a subgroup of the cytochrome p450 3a family ( cyp3a4 and cyp3a5 ) responsible for the metabolism of dihydropyridine calcium antagonists and oral contraceptives , resulting in a lower plasma concentration of these drugs .
None(e1,e2)	0	22	sumatriptan - there have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a selective_serotonin_reuptake_inhibitor ( ssri ) and sumatriptan .
None(e1,e2)	110	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	30	43	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium_salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	80	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	18	in rheumatoid arthritis , concomitant medications besides mtx were nonsteroidal anti-inflammatory agents , folic acid , corticosteroids and/or narcotics .
None(e1,e2)	29	31	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	0	23	ritonavir and indinavir : upon concomitant administration of 5 mg of vardenafil with 600 mg bid ritonavir , the cmax and auc of ritonavir were reduced by approximately 20 % .
None(e1,e2)	20	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	91	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	12	27	hormonal contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	19	27	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric_acid_derivatives , niacin ( nicotinic acid ) , erythromycin , azole antifungals .
None(e1,e2)	7	53	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	11	59	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa_reductase_inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	0	16	fluconazole : concomitant administration of fluconazole at 200 mg qd resulted in a two-fold increase in celecoxib plasma concentration .
None(e1,e2)	9	32	in a phase i trial using escalating doses of taxol ( 110-200 mg/m2 ) and cisplatin ( 50 or 75 mg/m2 ) given as sequential infusions , myelosuppression was more profound when taxol was given after cisplatin than with the alternate sequence ( ie , taxol before cisplatin ) .
None(e1,e2)	13	15	dicumarol : it has been reported that allopurinol prolongs the half-life of the anticoagulant , dicumarol .
None(e1,e2)	87	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	19	phenobarbital or primidone : no formal pharmacokinetic studies have been performed examining the addition of tiagabine to regimens containing phenobarbital or primidone .
None(e1,e2)	17	21	drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin , warfarin , quinidine , clarithromycin or amoxicillin .
effect(e1,e2)	14	16	although there was a slight reduction in blood sugar concentrations during concomitant administration of flurbiprofen and hypoglycemic_agents , there were no signs or symptoms of hypoglycemia .
effect(e1,e2)	6	46	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	27	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	0	14	lithium : inhibition of renal lithium clearance , leading to an increase in plasma lithium concentration , has been reported with some prostaglandin synthesis-inhibiting drugs .
None(e1,e2)	9	26	ephedrine : ephedrine may enhance the metabolic clearance of corticosteroids , resulting in decreased blood levels and lessened physiologic activity , thus requiring an increase in corticosteroid dosage .
None(e1,e2)	95	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	9	mercaptopurine/ azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid .
None(e1,e2)	115	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	16	hormonal_contraceptives : it has not been established if there is a pharmacokinetic interaction between acitretin and combined_oral_contraceptives .
None(e1,e2)	15	35	a pharmacokinetic study evaluating the administration of a single dose of inspra 100 mg with ketoconazole 200 mg bid , a potent inhibitor of the cyp3a4 pathway , showed a 1.7-fold increase in cmax of eplerenone and a 5.4-fold increase in auc of eplerenone .
None(e1,e2)	0	2	amiodarone , disopyramide , lidocaine
None(e1,e2)	9	21	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	4	13	when concomitant treatment with agents_with_b-blocking_properties and clonidine is to be terminated , the b-blocking_agent should be discontinued first .
None(e1,e2)	61	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	52	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	53	66	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	18	30	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium_antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	20	52	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium_channel_blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	12	20	no significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , cimetidine and phenobarbital .
None(e1,e2)	16	18	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
None(e1,e2)	6	8	the concurrent use of tetracycline and penthrane ( methoxyflurane ) has been reported to result in fatal renal toxicity .
None(e1,e2)	50	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	29	35	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	0	24	propranolol : in normal volunteers , there was no clinically significant pharmacokinetic or pharmacodynamic interaction with concomitant administration of single doses of lovastatin and propranolol .
None(e1,e2)	40	45	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or h1-blocking agents , tricyclic_antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	1	17	among aspirin or nsaid users , the incidence of upper gastrointestinal adverse events in patients treated with ibandronate 2.5 mg daily ( 28.9 % ) was similar to that in placebo-treated patients ( 30.7 % ) .
None(e1,e2)	30	33	these in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine , which may lead to a decreased antiretroviral effect of zalcitabine .
None(e1,e2)	25	39	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	41	61	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	65	69	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	41	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	116	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	54	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	28	32	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	39	41	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	44	49	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	4	6	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	23	25	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	1	3	and disulfiram when amitriptyline_hcl is given with anticholinergic agents or sympathomimetic drugs , including epinephrine combined with local anesthetics , close supervision and careful adjustment of dosages are required .
None(e1,e2)	2	8	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
None(e1,e2)	0	13	metformin : in healthy subjects given single 500 mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of 34 % and 24 % , respectively , and metformin mean renal clearance decreased by 14 % .
None(e1,e2)	15	21	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	7	9	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	9	29	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	2	46	carbamazepine : carbamazepine causes an approximate 50 % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate 40 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
mechanism(e1,e2)	2	8	phenytoin : amphetamines may delay intestinal absorption of phenytoin ;
None(e1,e2)	6	20	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic_acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	20	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	46	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	34	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	37	53	because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis , it is particularly important that physicians query patients or their guardians carefully about benzodiazepine , alcohol and sedative use as part of the history prior to any procedure in which the use of romazicon is planned .
None(e1,e2)	0	10	acetylsalicylic_acid did not alter the clearance ( pharmacokinetics ) of iloprost .
effect(e1,e2)	0	13	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	0	2	tricyclic_antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination hormonal contraceptives , increasing plasma levels of antidepressant ;
None(e1,e2)	26	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	25	31	drug-drug interactions albuterol - strattera should be administered with caution to patients being treated with systemically-administered ( oral or intravenous ) albuterol ( or other beta2_agonists ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .
None(e1,e2)	50	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	19	no interactions have been observed between nizatidine and theophylline , chlordiazepoxide , lorazepam , lidocaine , phenytoin , and warfarin .
None(e1,e2)	9	14	there was a small increase in plasma concentrations of capecitabine and one metabolite ( 5-dfcr ) ;
None(e1,e2)	19	56	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout_drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	59	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	13	18	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , seriraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	13	15	there have been no reported cases from spontaneous reports of drug interaction between ssris and d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp .
advise(e1,e2)	10	41	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole_antifungal_agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	10	26	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	0	2	antimycobacterial : rifampin
None(e1,e2)	14	26	the effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
None(e1,e2)	5	8	drugs that induce cyp3a4 ( rifampicin ) racemic zopiclone exposure was decreased 80 % by concomitant useof rifampicin , a potent inducer of cyp3a4 .
None(e1,e2)	5	29	other drug interactions oral contraceptives keppra ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel , or of the luteinizing hormone and progesterone levels , indicating that impairment of contraceptive efficacy is unlikely .
None(e1,e2)	76	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	27	- methotrexate ( e.g. , mexate ) use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate
None(e1,e2)	33	36	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	17	23	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	34	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	3	17	heparin : since heparin is contraindicated in patients with heparin-induced thrombocytopenia , the co-administration of argatroban and heparin is unlikely for this indication .
None(e1,e2)	4	8	other reported interactions with amiodarone : fentanyl ( cyp3a4 substrate ) in combination with amiodarone may cause hypotension , bradycardia , and decreased cardiac output .
None(e1,e2)	73	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	24	because prostaglandina play an important role in hemostasis and ketoprofen has an effect on platelet function as well , concurent therapy with ketoprofen and warfarin requires close monitoring of patients on both drugs .
None(e1,e2)	0	11	methotrexate : in an interaction study of rheumatoid arthritis patients taking methotrexate , celebrex did not have a significant effect on the pharmacokinetics of methotrexate .
None(e1,e2)	83	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	10	immunosuppressive drugs , fibric_acid_derivatives , niacin ( nicotinic acid , erythromycin , azole antifungals : skeletal muscle .
None(e1,e2)	17	21	ibandronate should be taken at least 60 minutes before any oral medications containing multivalent cations ( including antacids , supplements or vitamins ) .
None(e1,e2)	25	29	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
effect(e1,e2)	1	15	if desipramine_hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/ hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	4	11	the effects of mixing novolog with insulins of animal source or insulin preparations produced by other manufacturers have not been studied .
None(e1,e2)	1	29	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
None(e1,e2)	12	14	non-selective monoamine oxidase ( mao ) inhibitors - including phenelzine sulfate , tranylcypromine_sulfate and pargyline hc1 .
None(e1,e2)	39	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	20	26	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf_blocking_agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	29	31	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	36	41	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	32	34	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	53	64	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	87	150	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	3	13	in vitro , propranolol appears to be displaced from its binding sites by diltiazem .
None(e1,e2)	9	31	phenytoin : no significant differences were observed in mean phenytoin auc , c max , c min or t max ( although c max increased by 11 % ) when extended phenytoin_sodium capsules ( 100 mg tid ) were coadministered with lomefloxacin ( 400 mg qd ) for five days in 15 healthy males .
None(e1,e2)	37	41	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	12	15	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	26	42	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	7	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum-containing antacid preparations .
None(e1,e2)	22	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	19	24	another oral azole antifungal , ketoconazole , inhibits the metabolism of astemizole , resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong qt intervals .
None(e1,e2)	3	25	in addition , oxcarbazepine and mhd induce a subgroup of the cytochrome p450 3a family ( cyp3a4 and cyp3a5 ) responsible for the metabolism of dihydropyridine_calcium_antagonists and oral contraceptives , resulting in a lower plasma concentration of these drugs .
None(e1,e2)	30	46	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	21	46	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	15	34	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium_hydroxide s ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	17	25	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	28	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	6	methenamine therapy : urinary excretion of amphetamines is increased , and efficacy is reduced , by acidifying agents used in methenamine therapy .
None(e1,e2)	7	9	albuterol , antihistamines , antidiabetic drugs , diuretics , digitalis .
None(e1,e2)	9	11	compounds tested in man include warfarin , theophylline , phenytoin , diazepam , aminopyrine and antipyrine .
None(e1,e2)	0	24	vardenafil ( 20 mg ) did not potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with alcohol ( 0.5 g/kg body weight ) .
effect(e1,e2)	8	64	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	9	15	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	16	35	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	43	48	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	17	39	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
mechanism(e1,e2)	18	29	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	62	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	34	39	this observed increase in the bioavailability of fexofenadine may be due to transport-related effects , such as p-glycoprotein . in vivo animal studies also suggest that in addition to enhancing absorption , ketoconazole decreases fexofenadine gastrointestinal secretion , while erythromycin may also decrease biliary excretion .
None(e1,e2)	20	29	other drug interactions oral contraceptives keppra ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel , or of the luteinizing hormone and progesterone levels , indicating that impairment of contraceptive efficacy is unlikely .
None(e1,e2)	29	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	32	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
effect(e1,e2)	9	11	- phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin
None(e1,e2)	13	22	hiv protease inhibitors : indinavir ( 800 mg t.i.d . ) co-administered with vardenafil 10 mg resulted in a 16-fold increase in vardenafil auc , a 7-fold increase in vardenafil cmax and a 2-fold increase in vardenafil half-life .
None(e1,e2)	7	12	population pharmacokinetic analyses revealed that mtx , nsaids , corticosteroids , and tnf_blocking_agents did not influence abatacept clearance .
None(e1,e2)	32	68	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	2	4	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	144	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	96	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	27	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	10	40	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	32	34	ace inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace_inhibitors or angiotensin_ii_receptor_antagonists ( acei/arb ) .
effect(e1,e2)	9	11	these in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine , which may lead to a decreased antiretroviral effect of zalcitabine .
None(e1,e2)	94	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	62	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	0	7	prostin_e2 may augment the activity of other oxytocic_drugs .
None(e1,e2)	24	41	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	0	9	caffeine -related adverse effects have occurred in patients consuming caffeine while on therapy with enoxacin .
None(e1,e2)	81	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	27	29	protein binding in vitro , diclofenac interferes minimally or not at all with the protein binding of salicylic acid ( 20 % decrease in binding ) , tolbutamide , prednisolone ( 10 % decrease in binding ) , or warfarin .
None(e1,e2)	0	25	quinidine : immediate release capsules : there have been rare reports of an interaction between quinidine and nifedipine ( with a decreased plasma level of quinidine ) .
None(e1,e2)	24	29	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium_channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	7	9	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
None(e1,e2)	80	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	12	26	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid -associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	0	20	anticholinergics or other medications with anticholinergic activity - anticholinergic effects may be potentiated when these medications are used concurrently with diphenidol ;
None(e1,e2)	18	20	caution should be exercised when the following drugs are administered concomitantly with lodosyn ( carbidopa ) given with levodopa or carbidopa -levodopa combination products .
None(e1,e2)	22	45	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	66	95	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	16	cephalosporins -cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
None(e1,e2)	7	13	cardiac effects of dopamine are antagonized by beta-adrenergic_blocking_agents , such as propranolol and metoprolol .
None(e1,e2)	66	134	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
int(e1,e2)	0	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
advise(e1,e2)	5	10	caution should be used if ibuprofen is administered concomitantly with methotrexate .
None(e1,e2)	21	23	as with other agents with b-blocking properties , if coreg is to be administered orally with calcium channel blockers of the verapamil or diltiazem type , it is recommended that ecg and blood pressure be monitored .
None(e1,e2)	35	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	4	7	the pressor effects of catecholamines such as dopamine or norepinephrine are enhanced by bretylium tosylate .
None(e1,e2)	0	13	anticonvulsants ( phenytoin ) : steady state plasma exposure ( auc ) of valdecoxib ( 40 mg bid for 12 days ) was decreased by 27 % when co-administered with multiple doses ( 300 mg qd for 12 days ) of phenytoin ( a cyp 3a4 inducer ) .
None(e1,e2)	21	24	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
